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1 INTRODUCTION 
Modern biotechnology e.g. recombinant DNA technology is more and more used in plant 
breeding to enhance crop productivity or to improve health and nutrition benefits for 
consumers (e.g. increased vitamin contents of crops, lower level of anti-nutrients) by 
integrating new genes into plants (BOUIS et al., 2003). 
However, such new agricultural products have aroused an increased concern about the 
safety of genetically modified (GM) plants which are introduced into the food chain (ILSI, 
2003). The possible appearance of “unintended effects”, e.g. compositional or nutritional 
changes as a result of the genetic modification process, is one of the key elements of 
safety assessment procedures (e.g. KUIPER et al., 2003; EFSA, 2008). Novel dietary 
bioactive substances are an additional aspect of concern (ILSI, 2004). 
So far, a main consensus of most safety assessments has been that GM plants without 
substantial changes in their composition do not significantly differ in their nutritional value 
from those of their nearest isogenic varieties and do not affect the health of the 
organisms which ingested the plants. Detailed overviews were given by FLACHOWSKY 
(2005), FLACHOWSKY et al. (2007) and EFSA (2008). Only few findings have proven 
possible “unintended effects” in genetically modified plants such as an increased protein 
content in GM rice (MOMMA et al., 1999) or augmented glycoalkaloid content in GM 
potatoes (HASHIMOTO et al., 1999). In addition, the minority of the publications reported 
on physiological effects of GM plants when ingested by animals in feeding trials (e.g. 
PRESCOTT et al., 2005: altered immunogenicity in mice; MALATESTA et al., 2002: 
influence on zymogen synthesis in mice).  
However, the adequacy of conventional methods for the nutritional evaluation of GM 
foods has been criticized (MILLSTONE et al. 1999; CLARK et al. 2001; LIU-STRATTON 
et al., 2004). Conventional approaches for detecting effects of genetically modified food 
crops have been primarily based on measurements of single compounds or features. 
LIU-STRATTON et al. (2004) in contrast suggested studying expression, proteomic and 
metabolomic profiles of genetically modified foods. They also proposed expression 
profiling in tissues from experiments with humans or animals who have ingested such 
foods and to compare them with the corresponding traditional food as a reference for a 
complete safety assessment and in order to increase the probability of detecting 
unexpected effects. Indeed, the examination of large scale gene expression changes 
could be a sensitive and useful method for characterizing physiological side effects of 
GM foods, especially in the light of known impacts of macro- and micronutrients as well 
as dietary bioactive molecules on gene expression (DE CATERINA et al., 2004). First 
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expression profiling assays within this context have been carried out by NARASAKA et 
al. (2006) and EFSA (2008). 
 
The present work aimed to evaluate the application of comparative expression profiling 
by using microarray technology in the characterization of “unintended” physiological 
effects of GM feed components. Within this study the physiological impact of specific GM 
feed components was characterized in feeding experiments with rats. Firstly, a 
recombinant VP60 (viral antigen) expressing potato was fed. Secondly, a recombinant 
potato, which expressed solely a marker gene that is used for plant selection, was given. 
In an additional experiment inactivated recombinant VP60-baculovirus were 
administered. Expression profiles were compared to control groups which were fed the 
near-isogenic non-GM potatoes or wildtype baculovirus additives, respectively.  
As a prerequisite for this expression study different approaches for data analysis in 
microarray experiments were compared, as it is known that they can have a profound 
influence on the results and on the conclusions (QUACKENBUSH, 2001). Special 
attention was turned to criteria for defining differentially expressed genes (DEG) since 
that is the fundament on which most of subsequent analyses and interpretation are 
usually based. To determine which genes show significant expression changes, it is 
common to perform a t-test and a “False Discovery Rate” (FDR) correction. The FDR 
correction adjusts/corrects the p-values for high numbers of expected false positives 
which can arise in microarray studies because thousands of comparisons are done 
simultaneously (ALLISON et al., 2006). Though, there is no common agreement for 
which FDR level significance should then be assumed. According to literature thresholds 
varying between 5 % – 20 % (FDR) are used in combination with different fold change 
filters (FC  1.3 to 2.0) to define genes, that are “differentially expressed” between the 
two experimental groups (BOOTH et al., 2004; ADARICHEV et al., 2005; RUIZ-
BALLESTEROS et al., 2005; ZHU et al., 2005; HAN et al., 2006; PONSUKSILI et al., 
2007). It is consequential that using different thresholds and filter criteria can have a 
profound influence on the number of DEGs (PAN et al., 2005). However, the lists of 
DEGs are the base for the identification of affected biological processes and thus for the 
conclusion to be drawn from the results. Therefore, a second aim of this work was to 
study the effect of different thresholds and filters (FDR, FC) on the number of DEGs and 
on biological processes identified as being diet-affected. These results built the 
precondition for the characterization of physiological effects of GM feed components and 
were based on data of the feeding experiment carried out with rats fed a recombinant 
baculovirus feed additive. 
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2 LITERATURE REVIEW 
2.1 Structural and functional genome analysis in farm animals 
In general genomics aim to gain a comprehensive understanding of the structure and the 
function of genomes (HOCQUETTE, 2005). The term “genomics” was proposed by 
Thomas Roderick in 1986 to characterize the scientific discipline of mapping, sequencing 
and analyzing genomes (MCKUSICK, 1997). In present literature genomics is described 
as the study of genes and their function in an organism (WHITFIELD, 2007) and may be 
divided into structural genomics and functional genomics. Structural genomics deal with 
the characterization of the physical nature. The target of research is DNA which 
corresponds to the organisms’ genetic background, whereas functional genomics 
research concentrate on the key molecules which give life to the cells: RNA, proteins and 
metabolites (HIETER & BOGUSKI, 1997; HOCQUETTE, 2005).  
 
 
Figure 1: Molecular basis of the phenotype (modified from NEUSCHWANDER, 2001) 
 
DNA sequence serves as “blueprint” of an organism and determines the basic amino 
acid sequences in proteins and ultimately determines the structural and functional nature 
of encoded proteins (see Figure 1). The sequence of a gene typically has a regulatory, a 
coding and a non-coding part. The gene regulatory sequence consists of DNA patterns 
that control how this gene is to be utilized at a given time point and under specific 
conditions. The coding sequence is composed of a series of coding regions (exons) 
whose information is transcribed into messenger RNA (mRNA), interspersed with non-
coding regions (introns) whose information cannot be translated into RNA; although they 
might have other functions. RNA is further modified (introns are spliced, RNA is 
polyadenylated and capped) and transported into the cytosol. Ribosomes bind to the cap 
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structure and the RNA is translated into a polypeptide. Finally, posttranslational 
modifications convert the polypeptide into a functional protein. Regulation of expression 
takes place at different steps between transcription and synthesis of the final active 
protein product. All biological processes are regulated by the information flow in this 
pathway. Although this process is controlled by the basic genetic determinants, external 
or environmental factors can also have an impact; e.g. disease challenge, exposure to 
environmental toxins or nutrient supply (NEUNSCHWANDER, 2001; REECE, 2003; 
DAWSON, 2006; MARTENS et al., 2007). 
 
2.1.1 Structural genomics 
Structural genomics was referred to as physical (physical localization of the genes along 
the chromosomes) and genetic mapping (representation of the genetic distances 
between genes; this is assessed on the basis of their recombination rate) and 
sequencing of a genome (MCKUSICK, 1997). HIETER & BOGUSKI (1997) stated that 
structural genomics represented the initial phase of genome analysis with a clear end-
point – the construction of high-resolution genetic, physical and transcript maps of an 
organism. Other authors did not limit the term to the gene sequence but also include 
determination of three-dimensional structures of the encoded proteins and derivation of 
knowledge about their function (THORNTON et al., 2000; BRENNER, 2001). According 
to SCHWERIN (2000) structural genome analysis comprises also the identification of the 
genetic variation which determines phenotypic variation. 
Nowadays, the individual can be characterized at the level of its genomic DNA or its 
genotype. The genotype refers to the full hereditary information (DNA). The vast majority 
of DNA sequence is equal between mammalian organisms. Humans for instance differ 
by some animal species only 1 % in terms of DNA sequence. Among individuals of the 
same species differences are even less. In human 99.9 % of DNA is identical from 
person to person. The reason why individuals look and act differentially is attributed to 
only 0.1 % DNA which differs amongst them (HOCQUETTE, 2005). These differences or 
alternative forms of genes that are located at a specific position on a specific 
chromosome are called alleles. The alleles that are present in an individual constitute its 
genotype. Different alleles can produce variation in inherited characteristics and result in 
a variation of phenotypic traits. The phenotype of an organism comprises its actual 
physical properties, such as height, milk yield etc. Genetic variation, in the form of 
multiple alleles of many genes, exists in most natural populations (REECE, 2003).  
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2.1.1.1 Identification of trait-associated genetic variants 
For hundreds of years man has improved successfully livestock production (e.g. growth 
rate, meat quality, egg production) by selection and improving the environmental 
conditions for the animals (KAPPES, 2003). Nevertheless, in traits with a low heritability, 
with late development or negative correlated traits, further progress is limited 
(SCHWERIN, 2003). The use of genomic information can help to overcome these 
limitations; it did and will increase selection efficiency in livestock (ELSEN, 2003). This 
has especially become an interesting approach since improvements in the efficiency of 
DNA sequencing have allowed the sequencing of several genomes. The human and the 
mouse genome for example are completely sequenced. Assemblies of 33 other mammal 
genomes, including agriculturally relevant genomes like pig and cattle are available and 
40 mammal genome projects are in progress (http://www.ncbi.nlm.nih.gov/genomes). 
The availability of such extensive sequence information enables a better understanding 
of the genome structure and the searching for trait associated genetic variants 
(HOCQUETTE, 2005). Identified genetic variants are independent of age, gender, 
environmental factors and generally evenly distributed across the whole genome 
whereas traditional breeding selection criteria like performance etc. are prone to these 
factors. Consequently, in modern breeding beneficial genetic variants, which are known 
to be associated with a certain phenotype (e.g. meat quality), can be used to improve 
this trait (NEUENSCHWANDER, 2001). To select for those advantageous genetic 
variants two types of genetic markers are typically used: 
 Linked markers are loci that are sufficiently close to the trait-gene on the 
chromosome such that in general, alleles at the marker and the trait-gene are 
inherited together. 
 Direct markers are loci that code for the functional polymorphism in the gene that 
controls variation in the trait. 
Linked markers can only be used at population level to predict the phenotype after the 
association between the marker alleles and the trait-gene has been confirmed. 
Inheritance of the marker and that trait-gene is studied in a family and once confirmed 
only valid within that family. Moreover, the association may change in subsequent 
generation through recombination events. Commonly mutations or microsatellite markers 
are used. Microsatellite markers usually contain five to 20 copies of a short sequence 
motif that is between 2 bp and 4 bp in length and repeated in tandem. The number of 
repeats varies between individuals resulting in a large number of alleles for a given 
locus.  
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Direct markers or causal mutations in contrast are more useful because once the 
functional polymorphism is known it is possible to predict the effect of particular alleles in 
all animals in a population. The mutations are either insertions or deletions of DNA 
sequences or changes in nucleotide sequence (single nucleotide polymorphism: SNP). 
These alterations in sequence may either have no effect on the protein coded by the 
gene or result in a change of amino acid sequence and may affect functionality of the 
protein. However, causative mutations are hard to find and difficult to verify (DEKKERS & 
HOSPITAL, 2002; DEKKERS, 2004; WILLIAMS, 2005). Nevertheless, they have been 
proven to be especially useful to advance monogenetic traits e.g. inherited diseases 
(NEUENSCHWANDER, 2001). In the case of monogenetic traits the variation is directly 
controlled by a single gene and in the simplest case this gene will only have two alleles. 
Although most traits that are important in livestock production are generally more 
complex, such examples exist (e.g. coat color, muscle hypertrophy, glycogen content in 
skeletal muscle of pigs and ovulation rate). In general they include genetic disorders and 
genetic defects (DEKKERS, 2004). Multifactorial traits like e.g. growth rate and milk yield 
have a very large range of variation in the observed phenotype. The variation in such 
quantitative traits is controlled by several loci (region that harbors one or more genes 
affecting the trait) and each of them is responsible for a small amount of the overall 
variation (quantitative trait loci: QTL; ANDERSSON, 2001; WILLIAMS, 2005). Examples 
for loci already used as gene test in commercial breeding are given in Table 1. To 
identify marker or loci that underlie a phenotypic variation, two approaches or a 
combination of those are generally used:  
 association tests using candidate genes 
 genome scans based on linkage mapping with anonymous DNA markers 
The candidate gene approach has the advantage that even loci with small effects can be 
detected. Nevertheless, this strategy will only be successful provided that the candidate 
represents a true causative gene, which is hard to find. Moreover, certain a priori 
knowledge about the function of genes in order to select a candidate, which is going to 
be tested, is required. A genome scan will always find the map location of a trait locus 
with major effects; provided that an appropriate genetic model has been used, a 
reasonable sample size is available and that the marker set provides full genome 
coverage. However, genome scans can only identify regions of chromosomes that affect 
the trait. Usually an area of 10-20 cM is defined but the exact position and number of 
QTL in the region is unknown (ANDERSSON, 2001; DEKKERS & HOSPITAL, 2002; 
GELDERMANN, 2005). 
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Table 1: Examples of gene tests used in commercial breeding for different species (D = dairy cattle, B 
= beef cattle, C = poultry, P = pigs, S = sheep) by trait category and type of marker (modified from 
DEKKERS, 2004) 
Trait category Direct marker Linked marker  
Congenital 
defects 
BLAD(D) 
Citrulinaenemia (D,B) 
DUMPS (D) 
Mannosidosis (D,B) 
RYR (Pa) 
 
 
 
 
RYR ( Pb) 
SHUSTER et al. (1992) 
DENNIS et al. (1989) 
SCHWENGER et al. (1993) 
BERG et al. (1997) 
aFUJII et al. (1991), bHANSET et al. (1995) 
Milk quality -casein (D) 
-lactoglobulin (D) 
FMO3 (D) 
 MEDRAN & AQUILAR-COROVA (1990), RINCON & 
MEDRANO (2003) 
LUNDEN et al. (2002) 
Meat quality RYR (Pc) 
RN/PRKAG3 (Pe) 
 
RN/PRKAG3 (Pf) 
A-FABP/FAB4 (P) 
H-FABP/FAB3 (P) 
CAST (Pg,Bh) 
THYR (B) 
Leptin (B) 
cFUJII et al. (1991), 
eMILAN et al. (2000), fCIOBANU et al. (2001) 
GERBENS et al. (1998) 
GERBENS et al. (1999) 
gCIOBANU et al. (2004), hBARENDSE (2001) 
BARENDSE et al. (2001) 
BUCHANAN et al. (2002) 
Feed intake  MC4R (P)  KIM et al. (2000) 
Disease Prp (Si) 
F18 (Pk) 
 
B blood group (Cj) 
K88 (Pl) 
iBELT et al. (1995), jHANSEN et al. (1967),  
kVOGELI et al. (1997), kMEIJERINK et al. (2000), 
lJØRGENSEN et al. (2003) 
Reproduction Booroola (Sm) 
Inverdale (So) 
 
Hanna (Sq) 
Booroola (Sn) 
ESR (Pp) 
 
PRLR (Pr) 
RBP4 (P) 
mWILSON et al. (2001), nLORD et al. (1998) 
oGALLOWAY et al. (2000), pROTHSCHILD et al. 
(1996) 
qMCNATTY et al. (2001), rVINCENT et al. (1998) 
ROTHSCHILD et al. (2000) 
Groth and 
composition 
MC4R (Ps) 
IGF-2 (Pt) 
 
Myostatin (B) 
Callipyge (S) 
CAST (Pu) 
IGF-2 (Pu) 
sKIM et al. (2000), uCIOBANU et al. (2004) 
tGEORGES et al. (2003), uJEON et al. (1999), 
uNEZER  et al. (1999) 
GROBET et al. (1998) 
FREKING et al. (2002) 
Milk yield and 
composition 
DGAT (Sv) 
GRH (D) 
-casein (D) 
PRL (Dw) vGRISART et al. (2002), wCOWAN et al. (1990) 
BLOTT et al. (2003) 
MEDRANO & AQUILAR-COROVA (1990), RINCON 
& MEDRANO (2003) 
 
2.1.1.2 Limitations of structural genomics 
On the one hand, structural genomics provide information about molecular functions, 
such as what a protein binds to or reacts with (BRENNER, 2001). Moreover, it can help 
to improve the understanding of the genetic background of trait characteristics and 
variation. A marker assisted selection can thus contribute to the genetic improvement of 
the phenotype. On the other hand, this information does not provide information about 
what all the genes do, how cells work, how organisms form or how they react in disease 
states (LOCKHART & WINZELER, 2000). Nor do they account for environmental 
influences when we look at trait characteristics in the organism (SCHWERIN, 2003). In 
addition, gene-gene interactions are not detected in structural analysis although they 
play an important role in trait characteristics. Thus, the realization that the genome 
sequence fails to explain the fundamental nature of many biological processes has led to 
profound changes in this field of genomic research (WHITFILED, 2007). Not only 
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mapping and sequencing but also the investigation of genome function became a major 
objective (HIETER & BOGUSKI, 1997).  
 
2.1.2 Functional genomics 
Instead of focusing on DNA and sequence, functional genomics research concentrates 
on RNA, proteins and metabolites (see Figure 1) in order to extend the knowledge about 
what these molecules do and how they react in the organism (HIETER & BOGUSKI, 
1997; HOCQUETTE, 2005). By analyzing RNA, proteins or metabolites insight into which 
genes are “in use” in certain tissues or in a concrete situation can be gained. This might 
help to enlarge the knowledge about disease development or trait performance which is 
determined by genetic and environmental factors (SCHWERIN, 2003). Moreover, 
functional genomics enlarge the dimension of biological investigation from studying 
single genes, transcripts, proteins or metabolites to studying all genes, transcripts 
(transcriptomics), proteins (proteomics) or metabolites (metabolomics) simultaneously. It 
aims to integrate knowledge from all levels of scientific areas instead of studying them by 
independent approaches (HIENDLEDER et al., 2005; see Figure 2). 
 
 
 
 
 
 
 
 
 
 
Figure 2: Levels of gene expression and 
their approaches of genome analysis 
(modified from HOCQUETTE et al. (2005) 
 
 
With the completion of e.g. the bovine genome sequence and an eased availability of 
high-throughput technologies, these developments could also be advantageous for 
agricultural research. A simultaneous measurement of changes in expression of 
thousands of genes in relation to environmental and physiological challenges can now be 
done. By correlating genes and pathways with metabolic changes, functional genomics 
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has the potential to identify new candidate genes to improve genetic selection programs 
and to improve performance and well-being of the animal (PÉREZ LASPUIR & FERRIS, 
2005; HOCQUETTE et al., 2007). 
 
2.1.2.1 Expression profiling – Characterizing the influence of genetic and 
environmental factors on trait expression 
Gene expression can be analyzed at RNA or protein level. In most cases protein 
production is the ultimate output and RNA is an intermediate on the way to the functional 
protein. Nevertheless, RNA based approaches are commonly used because measuring 
RNA levels is generally less difficult, more sensitive and has a higher through-put than 
protein-based approaches. Moreover, mRNA levels are immensely informative about cell 
state and activity of genes. For most genes, changes in mRNA abundance are related to 
changes in protein abundance (LOCKHART & WINZELER, 2000). Several tools for 
studying gene expression at the level of transcription are available and can be divided 
into three major groups (KOZIAN & KIRSCHBAUM, 1999):  
 Hybridization-based techniques (e.g. northern blotting, DNA arrays),  
 PCR-based techniques (e.g. reverse transcription PCR (RT-PCR), differential display 
(DD, DDRT-PCR)  
 Sequence based techniques (e.g. Serial analysis of gene expression (SAGE), DNA 
sequencing chip)  
Measuring the expression of genes (transcription level) can help gaining information 
about cells´ activity under certain conditions and it is widely used in different fields of 
human but also of agricultural research. In general, two different questions are asked 
when investigating expression levels. Either the aim is to measure the expression level of 
a particular gene in different samples (individuals). Or information about which genes 
(gene families) are differentially expressed under different conditions (genetic or 
environmental) such as healthy versus diseased states and high productive versus low 
productive tissues is needed (NEUENSCHWANDER, 2001; HOCQUETTE et al., 2005). 
With the availability of high-throughput technologies like DNA arrays, the second 
question has become more and more important. Examples of some expression studies in 
cattle including array technology are given in Table 2. Nowadays for several farm 
animals commercial DNA arrays are available (e.g. pig, chicken, cattle) though custom 
made arrays are still used especially in cases when tissue specific or specialized arrays 
are needed. 
 
LITERATURE REVIEW 
 
10
Table 2: Examples of expression studies in cattle (modified from HOCQUETTE et al., 2005 and 
DAWSON, 2006) 
Technical 
approach 
Topic Literature 
Microarray Differential gene expression associated with 
pathogenic microorganisms, disease and 
immune function 
MOODY et al., 2003; DAVIES et al., 2006; 
KLENER et al., 2006; MARSH et al., 
2006; PATEL et al., 2006 
Microarray Differential gene expression associated with 
pregnancy 
ISHIWATA et al., 2003; HERATH et al., 
2004; LOOR et al., 2005, 2006 
Microarray Differential gene expression associated with 
milk performance, muscle development and 
meat quality 
REVERTER et al., 2003, LEHNERT et al., 
2004; LEHNERT et al., 2007 
Microarray Differential gene expression in genes that 
are important in follicular development and 
embryo development 
USHIWAZA et al., 2004; CORCORAN et 
al., 2006; KLEIN  et al., 2006; ZIALEK et 
al., 2007 
Transcriptomics, 
Proteomics 
Differential expression between different 
tissues and organs 
CHO et al., 2002; SUCHYTA et al., 2003; 
TALAMO et al., 2003 
Differential 
Display 
Differential expression between different 
genetic types 
DORROCH, 2001 
 
The major outcome of these studies is the identification of genes or physiological 
pathways which may be of importance in biological functions, since their expression 
differs depending either on genetic or environmental factors (HOCQUETTE, 2005). This 
can be seen as the main advantage of functional genomics (i.e. gene expression studies 
in contrast to structural genomics). Results account for environmental effects on the 
phenotype whereas in investigating only genetic factors (genotype), this aspect is left 
aside. Especially for quantitative traits it is essential that genetic as well as environmental 
factors are influencing the phenotype and the agronomical trait, respectively. In short, the 
individual's phenotype is the sum of effects of the genotypic and the environmental 
effects (phenotype = genotype + environmental effects; see also Figure 3). Thus, gene 
expression studies can provide information about both genotypic and environmental 
influence on a phenotype and they are nowadays more and more used in livestock 
research. 
 
 
Figure 3: Influence of genetic and environmental factors on gene expression and phenotype (modified 
from NEUSCHWANDER, 2001) 
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Genetic factors  
Genetic factors are especially interesting for animal breeding. Thus, the knowledge about 
expression differences of certain genes in samples, which differ in agricultural interesting 
traits (e.g. breeds with high milk yield and low milk yield), can help to identify 
associations between the trait and the genetic variants which occur in the population. 
BASS et al. (1999) showed for example the association of myostatin with the number of 
muscle fibers in cattle by using gene expression analysis. Modern techniques like 
microarray analysis, which allow the simultaneous measurement of the expression level 
of thousands of genes and whole genomes, respectively enable the scientist to identify 
new molecules and resulted in a wide spread application of this approach in livestock but 
also in other fields of research. BERNARD et al. (2007) were able to identify the gene 
DNAJA1 using microarray technology which explains up to 63 % of the variability in meat 
tenderness in charolais cattle. PONSUKSILI et al. (2005) discovered several possible 
candidate genes for body composition by expression analyses in pigs. WAYNE and 
MCINTYRE (2002) proposed to combine global gene expression analysis with QTL 
mapping to identify candidate genes that are associated with the trait of interest. RON et 
al. (2007) applied this approach to their study and combined a mouse mammary gland 
gene expression analysis and comparative mapping for identifying candidate genes in 
QTL of milk production traits in cattle. In addition, large-scale expression profiling 
enables the identification not only of single candidate genes but of whole trait associated 
biological pathways which alter among different samples. In that way a better 
understanding of the molecular mechanisms, underlying the performance or phenotypic 
trait characteristics, could be gained. PONSUKSILI et al. (2007) found an 
overrepresentation of differentially expressed genes in lipid metabolism, protein 
synthesis, cell growth and cell proliferation when comparing two commercially used pig 
breeds (German Landrace versus Pietrain).  
 
Environmental factors  
Additionally, gene expression studies allow the identification of genes which are affected 
by different “environmental” conditions (e.g. diets, temperature and infection). Thus, 
physiological effects on the organism can be estimated by relating differentially 
expressed genes to their known function or their involvement in physiological pathways. 
SCHWERIN et al. (2003) for example observed significant changes in the transcription 
level of genes involved in the metabolism of stress response in pigs, chronically fed a 
protein-restricted diet (based on soy protein isolate) in comparison to pigs fed a casein-
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based diet. In addition, the enlightenment of molecular mechanisms underlying the 
organisms’ reactions towards certain environmental challenges, as for instance infection, 
can be studied. WELLNITZ & KERR (2004) proved the involvement of TNF-, lactoferrin 
and serum amyloid A in the inflammatory response towards Staphylococcus aureus 
infection in bovine mammary gland epithelial cells. It may even be possible to derive 
practical recommendations for livestock production. BYRNE et al. (2005) showed the 
involvement of genes that are associated with protein turnover, cytoskeletal remodeling 
and metabolic homeostasis due to nutritional restriction in steers. LOOR et al. (2006) 
proposes for example a controlled energy intake for cows during the periparturient 
period.  Based on findings from a microarray study and real-time RT-PCR results they 
found this could confer an advantage to the animal by activating hepatic molecular 
adaptations well ahead parturition. These last two examples emphasize the importance 
of gene expression studies in relation to nutrition, which have become more and more 
important also in human research and which have led to the development of the research 
field of nutrigenomics. 
 
2.1.2.2 Interaction of nutrients and gene expression – nutritional genomics 
Nutritional genomics deals with the investigation of the interaction of genomic and dietary 
factors and how these interactions influence for instance health (BROWN & OUDERAA, 
2007). In the strict sense, nutritional genomics includes two main research fields: 
nutrigenomics and nutrigenetics. The science of “nutrigenomics” implies the study of how 
molecular expression, metabolism and ultimately health in individuals are altered due to 
ingested nutrients or other food components (FOGG-JOHNSON & KAPUT, 2003; 
GERMAN, 2005). The term has to be distinguished from “nutrigenetics” which comprises 
how genetic variation affects the interaction between dietary components and the health 
and disease potential of the individual (DEBUSK et al., 2005). The general term 
nutritional gen-”omics” also implies the integration of high-through-put techniques in 
nutritional studies. Diet-gene specific interactions have been recognized and investigated 
for a long time. But modern profiling technologies (e.g. transcriptomics) bring a new 
perspective to this approach because dietary effects on thousand of genes can be 
studied simultaneously (ROBERTS et al., 2001). These “omics” technologies applied in 
the context of nutrition and health have the potential to deliver biomarkers that respond 
to a certain nutrient, treatment or diet or to discover bioactive food components as well 
as to assess the safety and functionality of new foods and food ingredients (DANIEL, 
2002; KUSSMANN et al., 2006).  
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This seems especially applicable because it is known that dietary components can affect 
gene expression by acting as signals which are monitored by the nutrient sensors in the 
biological system. This activation can either be a direct interaction of the nutrient with 
transcription factors or can happen indirectly by regulating the secretion or intracellular 
action of one or more hormones (for example insulin, glucocorticoids, thyroid hormone) 
which themselves alter gene expression (DE CATERINA & MADONNA, 2004). Nutrients 
like carbohydrates, lipids, proteins or calcium are directly involved in hormone secretion 
and action. Glucose can for instance increase lipogenesis and the expression of 
lipogenic genes by stimulating the release of insulin from pancreas (KERSTEN, 2001). 
However, in addition to hormone-mediated alterations of the cellular metabolism these 
nutrients are able to interact with nuclear receptors and response elements. Several 
molecular studies have demonstrated that dietary chemicals or their metabolites interact 
in that way and can bind directly to nuclear receptors (Table 3 and FOGG-JOHNSON & 
KAPUT, 2003).  
 
Table 3: Transcription factor pathway mediating nutrient-gene interactions (MÜLLER & KERSTEN, 
2003) 
Nutrient Compound Transcription factor 
Macronutrients   
Fats Fatty acids 
Cholesterol 
PPARs, SREBPs, LXR, HNF4, ChREBP 
SREBPs, LXRs, FXR 
Carbohydrates Glucose USFs, SREBPs, ChREBP 
Proteins Amino acids C/EBPs 
Micronutrients   
Vitamins Vitamin A 
Vitamin D 
Vitamin E 
RAR, RXR 
VDR 
PXR 
Minerals Calcium 
Iron 
Zinc 
Calcineurin/NF-ATs 
IRP1, IRP2 
MTF1 
Other food components   
 Flavonoids ER, NFkB, AP1 
 Xenobiotics CAR, PXR 
AP1, activating protein1; CAR, constitutively active receptor; C/EBP, CAAT/enhancer binding protein; ChREBP, carbohydrate 
responsive element binding protein; ER, oestrogen receptor; FXR, farnesoid X receptor; HNF, hepatocyte nuclear factor; IRP, 
iron regulatory protein; LXR, liver X receptor; MTF1, metal-responsive transcription factors; NFkB, nuclear factor kB; NF-AT, 
nuclear factor of activated t cells; PPAR, peroxisome proliferators-activated receptor; PXR, pregnane X receptor; RAR, retinoic 
acid receptor; RXR, retinoid X receptor; SREBP, sterol-responsive-element binding protein; USF, upstream stimulatory factor; 
VDR, vitamin D receptor. 
 
In that way gene expression can reflect for example metabolic stress, which describes 
changes in the plasma and/or cellular concentration of nutrients and metabolites, which 
might lead to the disturbance of cellular functions (MÜLLER & KERSTEN, 2003). Amino 
acids for instance are known to control gene expression of key enzymes involved in their 
metabolism. CHOP (CCAAT/enhancer-binding homologous protein) encodes for a 
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ubiquitous transcription factor that accounts for cellular response to dietary deprivation of 
several amino acids (BRUHAT et al., 1999; DE CATERINA & MADONNA, 2004). 
Another gene that shows transcriptional increase in response to amino acid deficit is the 
insuline-like growth factor-binding protein-1 (IGFBP-1; DE CATERINA & MADONNA, 
2004). Fatty acids regulate the activity of several transcription factors including PPAR, 
LXR or HNF-4 by binding directly to the specific factor (JUMP, 2004). PPAR is mostly 
expressed in liver and is up-regulated during food deprivation. It is involved in cellular 
proliferation, fatty-acid oxidation but also in acute-phase response (MÜLLER & 
KERSTEN, 2003). Endogenous or exogenous toxic substances are sensed amongst 
others by the xenobiotic receptors CAR and PXR which then mediate regulation of 
xenobiotic metabolism mainly through cytochrome P450 enzymes (FRANCIS et al., 
2003; TIMSIT & NEGISHI, 2007). Against the background of these examples, gene 
expression patterns could be also regarded as “dietary signatures” which may be used 
for elucidating the effects of certain diets or nutrients on physiology and health (DANIEL, 
2002). These interactions between nutrients and health of an organism are of common 
interest. Nutritional deficiencies or disorders such as diabetes, cardiovascular diseases 
or obesity are known to be influenced by diet. Consequently determining the composition 
of foods and understanding how food components can modulate health, may contribute 
to the successful management of diet-related diseases (WHITFIELD, 2007). The 
awareness about this link between nutrition and health has stimulated increasing interest 
in nutrition-based health management and especially in functional foods. These foods 
are developed in order to improve the nutritional characteristics and to affect health 
positively, beyond the traditional nutritional value (BROWN & VAN DER OUDERAA, 
2007). Among those, genetically modified plants with improved nutritional characteristics 
are also to be found. 
 
2.2 Genetically modified plants in animal feeding 
Genetically modified plants have been altered in their genetic composition by means of 
genetic engineering. The modification involves the insertion of a specific gene, generally 
with desired characteristics, into the genome of the plant to be modified. The typical 
insert (gene construct) is composed of a promoter element (on/off switch for gene 
expression), the gene sequence which codes for the specific selected feature and the 
terminator element which functions as stop signal (MARZOK, 2004). In addition, a 
marker gene is generally attached which usually confers resistance to an antibiotic or 
herbicide and allows only cells, that have integrated and expressed the foreign 
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sequences, to survive during plant regeneration in culture (ROSELLINI et al., 2007). 
Such plant transformation methods have opened up new possibilities for agricultural 
research in terms of optimization of plant production and the development of new crops 
with improved constituents.  
 
2.2.1 First and second generation crops 
The worldwide cultivation of genetically modified crops (e.g. soybean, maize, rapeseed 
or cotton) increased distinctively from 1.7 (1996) to 90 million ha/year (2005) in the 
recent years (GÓMEZ-BARBERO & RODRÍGUEZ-CEREZO, 2007; FLACHOWSKY 
2007). Most of these crops belong to the so-called “first generation” plants which are 
characterized by the modification of agronomically important input traits such as 
tolerance against pesticides, herbicides or insects (some examples are given in Table 4). 
In general, these plants do not have any intended changes in nutrient composition or 
nutritional quality. A well known example of this group is insect resistant Bt-maize which 
has been developed by genetic modification to resist European borer infection (TONY et 
al., 2003). 
The “second generation” genetically modified plants include the functional/novel foods 
which are defined as foods and food ingredients that have so far not been used for 
human consumption to a significant degree within the European Community (European 
Regulation of Novel Foods and Novel food ingredients, No. 258/97). They are 
characterized by the modification of certain output traits meaning that they have 
nutritional or health benefits including improved nutritional quality or nutrient availability 
and/or reduced amount of toxic, allergenic and antinutritive compounds, respectively 
(examples are given in Table 5; PERSLEY, 2003; ILSI, 2004; FLACHOWSKY, 2005). 
The so-called “golden rice” is an example of this group. It produces ß-carotene 
(provitamin A). With the development of this rice line one intended to alleviate vitamin A 
deficiency in developing countries (AL-BABILI & BEYER, 2005). The main objects of 
genetic modification of plants with respect to food and feed production are summarized 
by MATISSEK (1998) as follows: 
 
A) Direct increase in yield by creating high productive plant varieties 
B) Enhancement of productivity by elimination or reduction of disturbing biotic and 
 abiotic influences and limitations (pest and disease control) 
C) Improvement of post harvest management and storage features 
D) Improvement of food and feed qualities by improving nutritive value or eliminating 
 unfavorable ingredients and increasing health benefit substances 
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Table 4: Examples of “first generation” GM crops with improved agronomically input traits (tolerances; 
modified from CLARK & LEHMAN, 2001) 
Type of 
tolerance 
Transgene Comments 
Glyphosate Non-selective, broad spectrum herbicide; inhibits EPSPS enzyme of the 
shikimic acid pathway that produces phenylalanine, tyrosine and tryptophane; 
e.g. Roundup Herbicide 
Bromoxynil Post-emergence herbicide for dicot weeds; acts as potent inhibitor of electron 
transport at the photosystem II site; uncouples oxidative and PS 
phosphorylation; e.g. BXN cotton 
Bt Highly selective, naturally occurring insecticide, although selectivity appears to 
be lost when introduced transgenically; crystals formed during sporulation of 
Bacillus thuringiensis, a soil microbe, contain proteins (endotoxins) that 
become toxic when ingested by particular classes of insects Insect 
tolerance Lectin proteins Carbohydrate-binding plant proteins, similar to protease and amylase 
inhibitors; different plant families produce different lectins; e.g. the snowdrop 
lectin (GNA) of EWEN & PUSZTAI (1999) protects transgenic tobacco, 
potatoes and lettuce against sap-sucking insects, as peach potato aphid 
(Myzus persicae) 
Virus 
tolerance 
Coat proteins, satellite RNAs, replicase, antisense, defective interfering, Cis-acting elements, 
movement proteins, ribozymes 
Fungal 
tolerance 
Phytoalexins, ribosome inactivation proteins, chitinases and glucanases 
Bacterial 
tolerance 
Lysozymes, lytic peptides, toxines, H2O2 
Stress 
tolerance 
-  Drought tolerance (e.g. elevated concentrations of praline or fructans to enhance osmolality) in 
   tobacco 
-  Oxidatative stress tolerance, via anti-oxidant enzyme over-expression, conferring drought or 
   chilling tolerance in tobacco, alfalfa and cotton 
-  Cold tolerance in tomato and tobacco 
-  Salinity tolerance in tobacco 
 
Group D comprises the functional foods discussed above. Promising functional foods 
belonging to this group are plant-based or edible vaccines. During the past two decades 
numerous species of plants have been genetically modified to produce vaccines (FLOSS 
et al., 2007). On the one hand, this could be an interesting approach for the treatment 
and prevention of diseases (CARTER et al., 2002) and a milestone on the road to 
creating inexpensive and easily deliverable vaccines (SWAMY KRISHNA TRIPURANI et 
al., 2003; WARZECHA & MASON, 2003). CASTANON et al. (1999) did successfully 
insert the major structural protein VP60 of rabbit hemorrhagic disease virus (RHDV) in 
potatoes. Rabbits immunized with leaf extracts from potatoes expressing the VP60 were 
fully protected against RHDV. Further examples of plant-based vaccines are reviewed by 
STREATFIELD & HOWARD (2003). On the other hand, the genetic modification 
ultimately results in the introduction of new proteins into food or feed plants and therefore 
the safety of the newly introduced protein as well as potential unintended effects caused 
by the process of transgene insertion has to be assessed (TAYLOR & HEFLE, 2001; 
CELLINI et al., 2004). 
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Table 5: Examples of “second generation” GM crops with nutritionally improved traits intended to 
provide health benefits to consumers and domestic animals (modified from ILSI, 2004; review) 
Crop/Species Trait Transgene 
Alfalfa + Phytase 
+ Resveratrol 
Lignin  
Phytase (Aspergillus) 
Resveratrol glucoside 
Down-regulation of caffeic acid 3-O-methytransferase and 
caffeoyl CoA 3-O methyltransferase 
Lupin Methionine  Seed albumin (sunflower) 
Maize Methionine  
Protein with favorable 
amino acid profile 
Vitamin C  
mRNA stability by intron switching Dzr1 target 
-Lactoalbumin (porcine) 
 
Wheat dehydroascorbate reductase (DHAR) 
Potato Inulin molecules  
 
 
+ Sulphur-rich protein 
 
Solanin  
1-SST (sucrose:sucrose 1-fructosyltransferase) and the 1-FFT 
(fructan:fructan 1-fructosyltransferase) genes of globe artichoke 
(Cynara scolymus) 
Non-allergenic seed albumin gene (Amaranthus 
hypochondriacus) 
Antisense sterol glycol transferase (Sgt) gene 
Sorghum Improved digestibility of 
livestock feed 
Mutated Brown midrib (Bmr) reduced activity of caffeic acid O-
methyltransferase (COMT), a lignin-producing enzyme 
Soybeans Improved amino acid 
composition 
Immunodominant 
Allergen  
Synthetic proteins 
 
Gene silencing of cystein protease P34 (34kDa) 
Sweet potato Protein content  Artificial storage protein (ASP-1) gene 
 = reduced content of the specific substance 
 = elevated content of the specific substance 
+ = additionally producing the specific substance 
 
2.2.2 Effect of genetic modification and conventional breeding on nutrient 
composition in plants 
Although traditional plant breeding results in changes of the heritable traits of organisms, 
the great variety of new crops does not differ significantly from older varieties regarding 
composition. Nevertheless, in few cases unintended effects did occur in traditional 
breeding (ILSI, 2004, see Table 6). Modern biotechnology in turn offers more accurate 
and efficient methods of improving certain traits in the plant (ILSI, 2004; TAYLOR, 1997). 
Thus, the occurrence of unintended effects should be considered particularly.  
Unintended effects are defined as “consistent” differences between the genetically 
modified plant and its nearest isogenic counterpart (control line) which exceed normal 
expected variance between lines and the primary expected effects of the introduced 
target gene (EFSA, 2008). These differences include the formation of new metabolites or 
altered levels of existing metabolites which can include nutritional, anti-nutritional as well 
as toxic or allergenic factors (KUIPER et al., 2001; PERSLEY, 2003; CELLINI et al., 
2004; EFSA, 2008). Such effects may occur due to genetic rearrangements, gene 
disruption or sequence changes as a consequence of the recombination event because 
DNA integration is random (RISCHER & OKSMAN-CALDENTEY, 2006; ILSI, 2007). In 
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addition, somaclonal variation – a reprogramming during plant regeneration – or 
pleiotropic effects of the newly introduced gene might cause such interactions (MOHAN 
JAIN 2001; SHEPARD, 2006).  
 
Table 6: Unintended effects in traditional breeding (modified from ILSI, 2004) 
Host plant/trait Unintended effect Reference 
Barley/Powdery mildew 
resistance 
Low yield THOMAS et al. (1998) 
Celery/Pest resistance High furanocoumarins content BEIER (1990) 
Maize/High lysine content Low yield MERTZ (1992) 
Potato/Pest resistance Low yield, high glycoalkaloid 
content 
HARVEY et al. (1985) 
Squash, Zucchini/Pest 
resistance 
High cucurbitacin content COULSTON & KOLBYE (1990) 
 
A well-known case of unintended effects is the newly introduced allergenic potential of 
methionine-rich soybeans (Glycine max) in which the 2S albumin gene from the Brazil-
nut was inserted and in that way identified as the major allergen of Brazil-nuts 
(NORDLEE et al., 1996). In that case the allergenic properties of the Brazil-nut were 
transferred unintentionally to the soybean. Nevertheless, the Brazil-nut was a known 
allergenic food but in other cases the allergenic potential of plants or certain genes might 
not be known before (due to gene silencing) and could appear due to genetic 
modification. 
Moreover, the use of marker genes for selection of cells with successful construct-
insertion, which often code for resistance to antibiotics, are a common concern. 
However, according to FAO/WHO (1996) the transfer of antibiotic resistance genes from 
plants to micro-organisms in the human gastro-intestinal tract is unlikely to occur. In 
addition, FUCHS et al. (1993) proved that the ingestion of genetically engineered plants 
which are producing the NPTII protein (coding for resistance against several antibiotics) 
poses no safety concerns. 
“Substantial equivalence” is a commonly used concept to identify unintended effects in 
genetically modified foods or feeds. The Food and Agriculture Organization (FAO) and 
the World Health Organization (WHO) of the United Nations recommend this concept as 
the most practical approach to address the safety evaluation of foods, feeds or food 
components derived from modern biotechnology (FAO/WHO, 1991, 1996, 2000). It is 
based on the idea that existing foods with a long history of safe use can serve as basis 
for comparing the properties of a GM food with an appropriate counterpart (KUIPER et 
al., 2001). The application of this concept is not a safety assessment per se but it helps 
to identify differences between conventional and GM crops which could then be used to 
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decide about further safety assessment. The key element in the concept of substantial 
equivalence is a compositional analysis of main nutritional components (ILSI, 2004). 
 
Table 7: Unintended effects in genetic engineering breeding (modified from CELLINI et al., 2004) 
Host plant  Trait Unintended effect Reference 
Canola Over-expression of phytoene-
synthase 
Multiple metabolic changes 
(tocopherol, chlorophyll, fatty acids, 
phytoene) 
SHEWMAKER et al. 
(1999) 
Potato Expression of yeast invertase Reduced glycoalkaloid content (-37 to 
-48 %) 
ENGEL et al. (1998) 
Potato Expression of soybean glycinin Increased glycoalkaloid content (+16 
to 88 %) 
HASHIMOTO et al. 
(1999) 
Rice 
Expression of soybean glycinin 
Impaired carbohydrate transport in 
the phloem 
Increased vitamin B6 content (+50 %) 
DUECK et al. (1998) 
 
MOMMA et al. (1999) 
Rice Expression of provitamin A 
biosynthetic pathway 
Formation of unexpected carotenoid 
derivatives (ß-carotene, lutein, 
zeaxanthin) 
YE et al. (2000) 
Wheat Expression of glucose oxidase Phytotoxicity MURRAY et al. (1999) 
Wheat Expression of phosphatidyl 
serine synthase 
Necrotic lesions DELHAIZE et al. (1999) 
 
Although many surveys have proven substantial equivalence between GM foods and 
their conventional parental or near isogenic lines (reviewed by FLACHOWSKY, 2005) in 
some studies unintended side effects due to genetic engineering breeding (see Table 7) 
were observed. By expressing glucose oxidase in wheat MURRAY et al. (1999) found 
reduced fungal infection as expected but the plant exhibited also phytotoxicity. 
HASHIMOTO et al. (1999) observed increased glycoalkaloid contents in transgenic 
potatoes due to insertion of soybean glycinin. In general, the concept of substantial 
equivalence works well for evaluating “first generation” crops. However, the application 
for “second generation” crops with an intended modification of one or more nutritional 
characteristics is difficult. For these plants investigating nutritional equivalence in animal 
feeding trials may be a useful alternative or additional part of safety considerations 
(AUMAITRE et al., 2002; FLACHOWSKY, 2005). 
 
2.2.3 Dietary and physiological effects of genetically modified plants 
investigated by measuring conventional traits in feeding trials 
According to FAO/WHO (2000), animal testing may be considered necessary if the 
characterization of the GM food indicates that available data are insufficient for a 
thorough safety assessment. As mentioned above, this might particularly be the case for 
“second generation” crops. In addition, compositional analyses provide the basis for the 
safety assessment of new crops but they should be considered only as part of the overall 
LITERATURE REVIEW 
 
20
nutritional assessment as they give limited information on the bioavailability of nutrients 
(ILSI, 2004).  
Nevertheless, the key element of investigating nutritional equivalence in feeding studies 
is consistent with the concept of substantial equivalence. The condition of animals fed 
with GM crops needs to be compared to animals fed with a food/feed derived from a 
suitable comparator. This in turn might be difficult to obtain regarding foods/feeds with 
intentionally changed nutritional composition (ILSI, 2004). 
Within the recent years many feeding trials with GM ingredients have been carried out 
using conventionally measured traits (e.g. digestibility of nutrients, weight gain, general 
health and performance characteristics and blood chemistry). These studies were 
conducted with several species like mice, rats, rabbits, cattle, broilers, pigs etc. Most of 
them did not exhibit health risks for the ingesting organism. Detailed overviews are given 
by FLACHOWSKY (2005), FLACHOWSKY et al. (2007) and EFSA (2008). 
FLACHOWSKY et al. (2007) conclude that in general, genetically modified plants without 
substantial changes in their composition do not significantly differ in their nutritional value 
from those of their nearest isogenic varieties and do not affect health of the organism 
that ingested the plant. Including very recent studies most surveys prove that the tested 
GM crops are as safe and nutritious as their non-GM counterparts (some examples are 
given in Table 8) though it has to be taken into account that the parameters which were 
investigated vary between the different studies.  
However, few findings report on physiological effects of GM plants when ingested by 
animals in feeding trials or in cell culture experiments. FENTON et al. (1999) argued for 
greater care before incorporating plant lectins into GM foods because they found that 
snowdrop lectin binds to human white blood cells. A very controversial study of EWEN & 
PUSZTAI (1999) revealed trophic effects of GM potatoes expressing a snowdrop lectin 
on rats’ intestines. PRESCOTT et al. (2005) observed an altered immunogenicity of GM 
peas in mice. MALATESTA et al. (2002) found an influence of GM soybean on zymogen 
synthesis in pancreatic acinar cells of mice. SÉRALINI et al. (2007) detected signs of 
hepatorenal toxicity when re-analyzing a data from a feeding study with GM maize in 
rats. They concluded that longer experiments were essential in order to indicate the real 
nature and extent of the possible pathology and that from the specific study the GM corn 
could not be regarded as a safe product. Results from SAGSTADT et al. (2007) 
suggested that a specific GM maize line might induce significant changes in white blood 
cell populations in fish which are associated with an immune response. 
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Table 8: Examples of feeding studies with GM plants investigating conventionally measured 
parameters  
GM plant Investigated parameters Animal Result Authors 
Glyphosate 
tolerant 
soybeans 
Plant: Crude nutrient & antinutrient  
composition 
Animal: Growth, feed conversion (R, C, 
B), fillet composition (C), milk production 
& composition (D) 
Rat (R), 
Broiler (B), 
Catfish (C), 
Dairy cows 
(D) 
	 
HAMMOND et al. 
(1996) 
Glyphosate 
tolerant 
soybeans 
Animal: Growth, food intake, organ 
weights of liver and spleen, 
histopathology of several organs, IgE & 
EgG antibodies in sera 
Rat 	 
TESHIMA et al. 
(2000) 
Glyphosate 
tolerant 
maize 
Plant: Crude nutrients, amino acid & fatty 
acid profile, sugar, starch 
Animal: N-digestibility, PER, NPU 
Rat 	 
CHRENKOVA et 
al. (2002) 
Glyphosate 
tolerant 
soybeans 
Plant: Crude nutrients, amino acids, 
minerals 
Animal: Growth performance, carcass 
and organ yields 
Broiler 	 
MCNAUGHTON 
et al. (2007) 
Myristic 
acid-rich 
rapeseed 
Plant: Crude nutrients, amino acid, 
minerals 
Fatty acid profiles,  
Glucosinolate contents 
Animal: Digestibility, feeding value, feed 
intake, weight gain 
Back & intramuscular fat composition 
Pig 
 
	 
fatty acid profiles changed 
 of glucosinolate contents 
 
 of feed intake & weight 
gain  
BÖHME et al. 
(2007) 
Glufosinate 
tolerant 
sugar beets 
& maize  
Plant: Crude nutrients, amino acid & fatty 
acid profile, NDF-fraction 
Animal: digestibility, feeding value Pig, ruminant 	 
BÖHME et al. 
(2001) 
Glufosinatet
olerant 
maize  
Plant: Nutritional profile of diets, 
Animal: weight gain, feed 
intake/efficiency, hematology, clinical 
chemistry, coagulation urinalysis, organ 
weight and gross and microscopic 
pathology 
Rat 	 
MALLEY et al. 
(2007) 
Bt maize Plant: Crude nutrients, sugar, starch, 
non-starch polysaccharides, minerals, 
amino acid & fatty acid profile 
Animal: feeding value 
Pig 	 
REUTER et al. 
(2002) 
Bt maize Plant: Crude nutrients, amino acids, anti-
nutrients, secondary metabolites 
Animal: nutritional performance 
variables, hematology, clinical chemistry, 
coagulation & urinalysis, organ weights, 
gross & microscopic appearance of 
tissues 
Rat 	 
MACKENZIE et 
al. (2007) 
Bt maize 
(grain & 
silage) 
Plant: Crude nutrients, ADF, NDF, 
minerals, lignin, starch 
Animal: body weight, health parameters, 
milk production and composition, 
hematology, clinical chemistry 
Dairy cows 	 
FAUST et al. 
(2007) 
Bt maize 
 
 
Animal: Health performance, body 
weight, feed consumption, hematology, 
blood chemistry, urinalysis, organ 
weights, gross & microscopic appearance 
of tissues 
Rat 	 
HAMMOND et al. 
(2006) 
Bt maize 
 
Plant: Crude nutrients, starch, sugar, 
minerals, glycoalkaloids, protease 
inhibitor activity 
Animal: feed intake, body weight, feed 
efficiency, organ weights, blood chemistry
Rat 	 
EL SANHOTY et 
al. (2004) 
PER = protein efficiency ratio, NPU=net protein utilization; ADF = acid detergent fibre; NDF = neutral detergent fibre;             
 = reduction of specific content or parameter;  = increase of specific content or parameter; 	 = no changes observed 
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Although the observed changes might not be meaningful in terms of health concerns 
these results demonstrate the need for the use of sensitive methods or tools to ensure 
the safety. Moreover such outcomes have given rise to discussions about the adequacy 
of the currently used methods (KÖNIG et al., 2004; LIU-STRATTON et al., 2004) which 
usually belong to the target-based approaches. 
 
2.2.4 The use of target and non-target approaches in the physiological 
 characterization of genetically modified plants and animals ingesting 
 these feeds 
When characterizing GM foods or physiological effects caused by their ingestion, target- 
and non-target-based approaches can be followed. Targeted approaches are 
hypothesis driven and focus on gaining information about specific known macro- and 
micronutrients, toxic allergenic or bioactive compounds present in the GM crop. The 
spectrum of compounds is determined by information gained from analyses of 
conventionally bred crops (ILSI, 2004). However, these approaches have severe 
limitations with respect to unknown anti-nutrients and natural toxins especially in less 
well known crops (KUIPER et al., 2001). To increase the chances of detecting 
unintended effects due to the genetic modification of plants, profiling technologies (non-
target approaches) such as transcriptomics, proteomics and metabolomics have the 
potential to provide useful additional information and to broaden the extensiveness of 
comparative analyses. Profiling methods provide an open-ended broad view of the 
complex cellular metabolism of the organism. These non-targeted approaches may be of 
particular relevance for second-generation GM food crops e.g. which lead to enhanced 
nutritional profiles. They may not replace conventional analyses but could be useful to 
confirm and supplement other results (EFSA, 2006). LIU-STRATTON et al. (2004) 
suggested studying expression, proteome and metabolome profiles of genetically 
modified foods as well as of tissues from experiments with humans or animals that have 
ingested such foods and to compare them to the corresponding traditional food as a 
reference. A first application of expression profiling using microarray technology in 
analyzing physiological effects of GM crops was carried out successfully by NARASAKA 
et al. (2006). In their study they investigated the effect of GM wheat flour on gene 
expression in liver and intestine of rats and concluded that microarray technology could 
be applicable to the field of food safety analysis. KÖNIG et al. (2004) proposed the use 
of sets of genes as biomarkers for cells´ responses to toxins and allergens and points out 
an increasing sensitivity of test systems by using profiling methods. 
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2.3 Expression profiling methods - transcriptomics 
Several methods are widely used for transcript quantification: e.g. differential display, 
northern blotting, in situ hybridization and reverse transcription polymerase chain 
reaction (RT-PCR). Apart from RT-PCR the use of these methods is limited by their low 
sensitivity (BUSTIN, 2000). Moreover, they focus mostly on the analysis of few 
molecules whereas in functional genomics transcript levels are studied in a more global 
way, meaning that transcription of thousands of molecules can be monitored at the same 
time. This has become possible since the development of new high-throughput methods 
(HOCQUETTE et al., 2007). Commonly used and very powerful tools are the high-
density oligonucleotide and cDNA arrays (microarray; LOCKHART & WINZELER, 2000). 
 
2.3.1 Microarray analysis – a holistic profiling method 
The cornerstone for this technology was led by Stephen P.A. Fodor in the late 1980s 
who showed that peptides may be synthesized on small silicon chips by means of 
photolithographic synthesis. It became rapidly clear that this method might also be used 
to synthesize and fix short DNA fragments on silicon or glass chips (KUNZ et al., 2004). 
The term array refers to the regular arrangement of oligonucleotide (oligo array) or cDNA 
(cDNA array) representations (probes) of genes on a solid support (YE & DAY, 2003). 
cDNA probes are generally products of the polymerase chain reaction (PCR) generated 
from cDNA libraries or clone collections which are then spotted onto the glass slide or 
nylon membrane. For oligo arrays a different fabrication system is usually applied. These 
probes are synthesized in situ either by photolithography or by ink-yet technology. The 
advantage is an increased probe density on the array with the drawback that probe 
sequence length is restricted. Alternatively, pre-synthesized oligonucleotides can also be 
deposited onto glass slides (WATSON et al., 1998; SCHULZE & DOWNWARD, 2001).  
One of the first surveys using this microarray technology to study global gene expression 
was carried out by DERISI et al. (1996). Nowadays microarrays are becoming rapidly a 
fundamental tool in discovery-based genomic and biomedical research (WANG et al., 
2006). 
 
Aspects of experimental design and workflow of microarray experiments 
Before conducting a microarray experiment certain aspects have to be taken into 
consideration. Choosing an appropriate experimental design for the issue which is to be 
investigated can be challenging because it may have an impact on the results obtained. 
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The first decision to be made is which microarray system (cDNA or Oligo array) should 
be used. However, this question is mostly answered by the accessibility and cost of the 
array platform (scanner and other technical requirements) in the certain working field. 
Nevertheless, it can be mentioned that oligo arrays (35 – 80 bp) (CAUSTON et al., 
2003), as design for instance by the company Affymetrix, are potentially vulnerable to 
single base changes due to polymorphisms or sequencing errors in the original 
sequence used for oligonucleotide design. False mismatches may occur and result in an 
underestimation of gene expression (MAH et al., 2004). cDNA arrays, which are usually 
spotted chips with probe sequences ranging from 200 – 1500 bp, are less sensitive to 
single base pair exchanges because of probe sequence is longer. Nevertheless, they are 
more prone to cross-hybridizations (i.e. gene families) and may include latent non-
specific sequences (i.e. repetitive elements). Moreover, the printing process of cDNA 
arrays may cause variations in probe concentrations (MAH et al., 2004).  
A second point to be taken into consideration concerning the experimental design is the 
decision for one or two color arrays. On the one hand, two color approaches allow the 
direct comparison of sample pairs hybridized on the same array. In that way variability 
due to processing multiple microarrays per assay can be minimized and results 
theoretically in an increased sensitivity (BENDIXEN et al., 2005; PATTERSON et al., 
2006). On the other hand, it has been reported that fold change values obtained from two 
color experiments often have a systematic dependence on intensity, the so called 
intensity-dependant dye bias, which is mostly observed in low intensity signals 
(CAUSTON et al., 2003). Though certain normalization methods (e.g. Lowess: 
QUACKENBUSH, 2002) compensate for this (YANG et al., 2002b). One color designs 
avoid this problem and in general are advantageous because of a greater design 
simplicity and flexibility. Regarding reproducibility, sensitivity and accuracy PATTERSON 
et al. (2006) reported good consistency between the data from one and two color 
experiments. They noted that both approaches provide similar levels of biological insight. 
DE REYNIÈS et al. (2006) in contrast found that one color based experiments have a 
higher level of reproducibility. Taken altogether it can be resumed that both systems 
have advantages and disadvantages and the decision to use either one color or two 
color arrays will often be determined by cost, experimental design considerations and 
personal preference (PATTERSON et al., 2006).  
 
The basic steps of a two color microarray experiment are shown in Figure 4. First 
RNA is extracted and purified from tissues of interest and labeled with a fluorescent dye. 
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One of the most popular applications is to compare the gene expression levels of two 
different groups e.g. different conditions. Thus, the two samples are labeled either with 
two different dyes (two color array) and hybridized on the same array, or the samples are 
hybridized on two different arrays and labeled with the same dye (one color array). After 
hybridization of the labeled RNA to the arrays they are excited by laser and scanned at 
the appropriate wavelengths (channel) of fluorescent dye. Each signal in every cDNA 
element on the slide provides a measurement of the specific expression level of the 
corresponding gene (CAUSTON et al., 2003; BENDIXEN et al., 2005). Signals from the 
two samples being investigated can then be compared.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4:  Workflow of a gene expression 
experiment using a two color platform 
(modified from LANGE, 2004) 
 
 
Image processing and quality filtering of two color microarrays 
Regardless of the product or design used in the experiment, the arrays are scanned 
following hybridization and independent grey scale images are generated for each 
experimental variable which is investigated (CAUSTON et al., 2003). This is typically 
done by a 16-bit scanner which creates TIFF (Tagged Image File Format) images. These 
images contain various pixel measurements, which are averaged, for each spot (gene) 
on the array and have an output range of 216-1 = 65535 units per pixel (YANG et al., 
2002c). Thus a 16-bit tif image is obtained from each channel and each array, 
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respectively. These images are then transformed into data matrixes using image analysis 
software. Typically these matrixes include both spot and background intensities for every 
probe/spot on the array (BENDIXEN et al., 2005) in order to correct for background 
specific noise. Once expression is extracted, a quality filtering is carried out. As a first 
quality criterion, visual inspection of the generated image is done (CAUSTON et al., 
2003) and spots that look suspicious are manually flagged. Moreover, some image 
analysis software tools offer the choice to automatically flag spots with very low 
expression or low quality signal. Several parameters e.g. spot uniformity, signal to 
background ratio or spot shape regularity can be defined (DRAGHICI et al., 2003).  
 
    
Figure 5(A+B): Example of a boxplot (A) and a MA-plot (B) of microarray expression values 
 
Box-plots (see Figure 5A) show the mean of all raw log2 values for each array (mostly 
one color arrays). They can be used to identify and exclude outlier arrays of low quality. 
Generating MA-plots (see Figure 5B) by plotting the log-ratio “M” (the log to the ratio 
between the two “dye”-channels is a measure of relative expression) against the average 
intensity “A” for each spot, allows the detection of intensity dependant deviations of the 
log-ratios due to dye effects (BENDIXEN et al., 2005). 
 
Data pre-processing and normalization of two color microarrays 
A first pre-processing step is the background correction of the intensity signal. The idea 
behind is that the signal of a spot includes the fluorescence of the background due to 
unspecific binding and the fluorescence due to the labeled RNA. Consequently, in order 
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to obtain values proportional to the amount of RNA, the value of the background needs 
to be subtracted from intensity signal (DRAGHICI et al., 2003). Background values are 
mostly calculated from the area around the spot. The correction approach is therefore 
named local background correction. Sub-grid or global background correction are also 
used. They calculate the background from sub-grid sections or build the average across 
the whole array. Moreover, a filtering of hybridization intensities, which are only slightly 
above the background intensity, can be done because these spots are the most 
imprecisely measured and therefore most likely to be of poor or questionable quality. 
One possible approach is to exclude signals that differ from their background signal in 
less than x (usually a factor of 2 is used) standard deviations. As an alternative a fixed 
minimum intensity can be applied as threshold to exclude poor signals (CAUSTON et al., 
2003). 
A common step in data pre-processing is logarithmic transformation of either original 
intensity values or of the ratios (fold change factor between two experimental groups). 
The log transformation makes data more symmetrical especially the ratios and evens out 
highly skewed distributions. In addition it makes variation of intensities and ratios more 
independent of absolute magnitude and thus reduces the influence of single outliers with 
extreme intensities (SPEED, 2000).  
As a next step between-array and color (dye) normalization is performed. Normalization 
is done to adjust the intensity values for effects which arise from technological variation 
rather then from biological differences between the samples. Differences between arrays 
may be due to variation in print quality, differences in ambient conditions when the slides 
were processed or simply from changes in scanner settings (SMYTH & SPEED, 2003). 
This bias can be corrected for instance by global normalization which measures the 
mean of intensities for all genes of each array and calculates a scaling factor (between 
the arrays) to correct the individual ratios (YE & DAY, 2003; DRAGHICI et al., 2003). 
This simple scaling is based on the assumption that the total intensity on each array 
should be the same (BENDIXEN et al., 2005). For imbalances between the two dyes 
several approaches have been described e.g.: linear regression, log centering, Chens´ 
ratio statistics and rank invariant methods. However, none of these approaches takes 
into account systematic dependence of dye bias on intensity. Therefore, a locally 
weighted linear regression (lowess) analysis has been proposed to normalize for 
intensity-dependant effects in the log2(ratio) values (QUACKENBUSH, 2002; see Figure 
6). A brief description of lowess is given by GAROSI et al. (2005): “Lowess normalization 
uses locally weighted linear regression to smooth data. The smoothing process is
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considered local because each smoothed value is determined by neighboring data points 
defined within the span. The process is weighted because a regression weight function is 
defined for the data points contained within the span”. 
 
   
Figure 6(A+B): Analyzing two color microarrays. A: before normalization, B: after lowess 
normalization. (Source: http://www.umanitoba.ca/faculties/afs/plant_science/COURSES/bioinformatics 
/lec12/ lec12.2.html) 
 
Defining differentially expressed genes 
The purpose of most microarray experiments is to find genes which are differentially 
expressed between two or more experimental groups. Thus, the calculation of fold 
change factors (ratio) of the two intensity signals give a first hint which genes are 
differentially regulated. To define “differential expression” numerous methods are used in 
microarray experiments including (DRAGHICI, 2002): 
 
Fold change:   Any gene having a ratio above an arbitrary (often 2) threshold  
   between two experimental groups is defined as being differentially 
   expressed 
Unusual ratio: This method involves selecting genes for which the ratio of the 
   control and experiment values is a certain distance from the mean 
   control/experiment ratio (typically this distance is to be taken ± 2 
   standard deviation) 
Univariate statistics: This approach uses classical hypothesis testing e.g. t-test.  
ANOVA:  The idea behind defining differentially expressed genes by ANalysis 
   Of VAriance (ANOVA) is to build an explicit model about the  
   sources of variance that affect the measurements and use the data 
   to estimate the variance of each individual in the model. 
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SAM   The software SAM calculates a modified t-statistic (SAM score) for 
   each gene on the basis of changes in gene expression relative to 
   the standard deviation of repeated measurements. Significant  
   genes are those greater than the adjustable score. SAM also  
   includes a calculation of the False Discovery Rate based on  
   permutation of the measurements of each gene (TUSHER et al., 
   2001; BOOTH et al., 2004). 
When using hypothesis testing one needs to consider the fact that many genes are 
analyzed at one time. Therefore, when assuming significance at p  0.05 many false 
positive genes will appear being significantly different just by chance (e.g. 5 % out of 
10 000 genes = 500 significantly different genes just by chance). Thus, a correction for 
multiple testing has to be applied (MURPHY, 2002; DRAGHICI et al., 2003; GAROSI et 
al., 2005). Some correction approaches used in microarray studies, as for instance 
“Bonferroni”, control the familiy-wise error rate which is the probability of making false 
discoveries, or type I errors among all the hypotheses (false positive rate). Nevertheless, 
they are regarded as being too conservative for microarray experiments where usually 
thousands of tests are done (BENDER & LANGE, 1999; DRAGHICI et al., 2003). In their 
work, BENJAMINI & HOCHBERG (1995) introduced a new multiple-hypothesis testing 
error measure called False Discovery Rate (FDR). The FDR is the expected proportion 
of false positive findings among all rejected hypothesis. For example, by applying a False 
Discovery Rate of 5% as threshold in a microarray experiment, the largest subset of 
genes to be classified as differentially expressed, that has an expected percentage (5 %) 
of false positives, will be found (STOREY & TIBSHIRANI, 2003; DRAGHICI et al., 2003; 
WIT & MCCLURE, 2004). This approach is less stringent and more suitable for 
microarray data than e.g. “Bonferroni” procedure since the amount of estimated not 
differentially expressed genes is excluded from the correction procedure. A commonly 
used method to control the FDR and to correct for multiple testing was proposed by 
STOREY & TIBSHIRANI (2003). It calculates a corrected p-value described as q-value. 
For defining significantly differentially expressed genes a threshold of q  0.05 is often 
applied (ALLISON et al., 2006).  
 
Gene Ontology annotation - functional classification of differentially expressed 
genes 
The above described steps in microarray data analysis were focusing on the 
identification of differentially expressed genes that accompany alterations in 
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physiological state. However, in many cases the ultimate purpose of the gene expression 
experiment is to produce biological knowledge and to interpret the results biologically. 
Thus, the researcher needs to translate the list of differentially expressed genes into a 
better understanding of the biological phenomena underlying these changes.  
Extracting the important biological facts from results of such experiments is of crucial 
importance, but is difficult for experimental biologists. A first step can be the generation 
of a functional profile by using a systemized annotation vocabulary describing functional 
knowledge. This approach may help to detect coherent changes in the expression of 
groups of genes. The Gene Ontology (GO; THE GENE ONTOLOGY CONSORTIUM, 
2000) annotations are an example for systems that provide sets of terms describing 
biological entities organized in hierarchical structures. Lists of differentially expressed 
genes, as obtained from microarray experiments, can be associated with certain GO 
terms according to the biological function they perform or represent.  
The GO database provides ontologies to describe attributes of gene products in three 
non-overlapping domains of molecular biology (THE GENE ONTOLOGY 
CONSORTIUM, 2004): 
Molecular Function – describes activities such as catalytic or binding activities at the 
 molecular level 
Biological Process – describes biological goals accomplished by one or more ordered 
 assemblies of molecular function 
Cellular Component – describes locations at the levels of sub cellular structures and 
 macromolecular complexes 
A functional profile can be created by recognizing statistically enriched terms in GO 
annotated lists of differentially expressed genes (DRAGHICI et al., 2003; ZHOU & SU, 
2007). It enables the scientist to identify physiological alterations in terms of pathways 
rather than changes in single genes. Software, web servers and methods which have 
been developed for this purpose are summarized by KHATRI & DR
HICI (2005) and by 
KIM et al. (2007). 
 
2.3.2 Quantitative measurement of transcript level with real-time RT-PCR 
Quantitative real-time polymerase chain reaction (PCR) is a technique that was 
developed at the beginning of the 1990s. This technology combines DNA amplification 
and the detection and quantification of the accumulated product. During PCR each DNA 
molecule becomes a target template for synthesis of its own new complementary copy 
within one cycle. To facilitate the reaction a DNA polymerase enzyme and sequence 
LITERATURE REVIEW 
 
31
specific oligonucleotides (primers) are needed. Moreover, a precisely set temperature 
regime is applied to enable the primer annealing, elongation and denaturation within 
each cycle.  
During the log linear phase the accumulation of the PCR product can be measured via 
fluorescent dyes which bind to the PCR product. The emitted fluorescent signal 
correlates with the amount of target DNA produced and increased during every cycle. 
The number of amplification cycles required to obtain a particular amount of DNA 
molecules is registered and the initial amount of DNA template can be calculated 
(TICHOPAD, 2003; HIGUCHI, 1993; KUBISTA et al., 2006). For quantification of PCR 
product generally two approaches are used: absolute and relative quantification. The 
absolute quantification is based on a standard curve of the corresponding PCR product 
or plasmid with known concentration. Relative quantification relates the measured 
quantity to another “non-regulated” housekeeping gene (PFAFFL, 2004). Relative 
quantification is also often used to normalize the quantification results in order to correct 
for variance among the samples in the starting amount of the template. 
For labeling several fluorescent dyes or probes can be used. A commonly used dye is 
SYBR Green I which binds to any dsDNA available in the reaction tube (MORRISON et 
al., 1998). Molecular beacons (TYAGI & KRAMER, 1996) or TaqMan-probes (HOLLAND 
et al., 1991) in contrast are target sequence specific oligonucleotides which are bound to 
a fluorescent dye. 
Real-time PCR is also frequently applied to quantify gene expression or more precisely 
mRNA amount in target samples. Because mRNA cannot be used as template, it is 
reversely transcribed into cDNA, typically by using a poly(dT)-primers and then followed 
by its exponential amplification in a PCR reaction. The method is referred to as real-time 
RT-PCR. It can be either carried out in one assay or it can be done in two separate 
steps: reverse transcription and PCR reaction. The advantage of the two step approach 
is the generation of a stable cDNA pool that can be stored and used several times 
(BUSTIN, 2000). 
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3 MATERIALS AND METHODS 
3.1 Materials 
All feeding experiments were conducted and supervised by the research group 
“nutritional physiology” of the Research Institute for the Biology of Farm Animals. 
 
Animals 
The effect of feeding a genetically modified feed additive, more precisely a recombinant 
baculovirus, on gene expression was studied in a first feeding experiment with rats (see 
Table 9). In a second experiment the impact of a feeding of two different genetically 
modified potatoes, was examined (see Table 10).  
For both feeding experiments Wistar rats were purchased from Charles River 
Laboratories (Germany), which weighed about 100 g at the beginning of the experiment. 
They were housed individually under standardized humidity (60 ± 5 %) and temperature 
(21.5 ± 1 °C) in metabolism cages with a 12/12 hours light regime.  
 
Experimental groups 
Table 9: Experimental groups used in the feeding experiment with recombinant baculovirus 
Experimental groups wtBV rBV-VP60 
Diet Commercial basic diet + 15 % lyophilized potatoes 
Commercial basic diet + 
15 % lyophilized potatoes 
Feed additive Wildtype baculovirus Transgenic baculovirus 
Inserted gene - VP60 
Animals / group 6 7 
 
Table 10: Experimental groups used in the feeding experiment with recombinant potatoes 
Experimental groups wtAlb rAlb-VP60 rAlb-nptII 
Diet Semi-synthetic diet Semi-synthetic diet Semi-synthetic diet 
Feed additive Conventional potato Transgenic potato Transgenic potato 
Inserted gene - VP60, CtxB, nptII nptII 
Animals / group 8 8 8 
 
Tissues 
Samples were obtained from the liver (left lateral hepatic lobe), the spleen (cranial) and 
from small intestine epithelium (jejunum). The Liver was analyzed because of its central 
role in metabolism especially in nutrient conversion and storage. The spleen was 
selected due to its involvement in immune related processes, which should be 
considered when a potential bioactivity of the transgenic feed additive cannot be 
excluded. By investigating expression in small intestine epithelium it was intended to gain 
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insight into impacts taking place during nutrient resorption processes which are of 
specific relevance when studying effects of specific feeds.  
 
3.1.1 Feeding experiment with rats fed recombinant baculovirus 
Diets and experimental conditions 
For the experiment the rats were divided into two groups (wtBV and rBV-VP60; see 
Table 9). A commercial basic diet (ALTROMIN® Standard-Diet 1310) supplemented with 
15 % lyophilized potatoes was fed to both groups. All animals received 10 g feed per 
100 g body weight and per day. In addition, both groups received 20 ml solution of an 
additive consisting of corresponding amounts (approximately 106.0 TCID 50 per ml) of 
lyophilized and ethylenimin-inactivated baculovirus. The baculovirus additives were fed 
on days 0, 2, 4 and 21, 23, 25. The wtBV group was fed a non-transgenic wildtype 
baculovirus and the rBV-VP60 group was given the recombinant rBV-VP60 (~1 μg 
VP60/ml) which was propagated and handled according to HAMMER (2006). VP60 is the 
major structural protein of a calicivirus that causes the rabbit hemorrhagic disease (RHD; 
PARRA & PRIETO, 1990; OHLINGER et al., 1993). The VP60 expressing baculovirus 
rBV-VP60 was proven to induce production of the VP60 antigen and by this means 
protection against RHD virus (SCHIRRMEIER et al., 1997, 2000; KADEN et al., 1998). 
The VP60 baculovirus additive was obtained from the Friedrich-Loeffler-Institute on 
Riems (Institute of Diagnostic Virology). Both diets were isoenergetic and isonitrogenous 
and the rats had free access to the food and water. The experiment was conducted over 
a period of 42 days. In the following the feed additives will be named equally as the 
feeding groups (rBV-VP60, wtBV). 
 
Tissue collection 
At the end (day 42) of the experiment animals were exsanguinated under inhalant 
isofluran (IsoFlo®) anesthesia, 12 hours after the last food intake, to measure gene 
expression with minimized interference by food intake. Tissue samples of the liver, the 
spleen and of small intestine epithelium were collected, immediately frozen in liquid 
nitrogen and stored at -80 °C until isolation of RNA. 
 
3.1.2 Feeding experiment with rats fed recombinant potatoes 
Diets and experimental conditions 
Three feeding groups (see Table 10 wtAlb, rAlb-VP60, rAlb-nptII) were used for the 
experiment. A half-synthetic basis diet was fed. Casein was given as main protein source 
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(supplying around 85 % of the total protein offered). The amount of potatoes was 
calculated to supply about 15 % of the protein in the diet (see Table 11, Table 12, Table 
13). rAlb-VP60 group was fed a transgenic potato of the cultivar Albatros with the 
inserted genes VP60, CtxB and nptII. rAlb-nptII group was given a transgenic Albatros 
potato where only the nptII gene had been introduced. wtAlb group received the non-
transgenic near-isogenic potato of the cultivar Albatros. Per 100 g body weight and day, 
10 g feed were offered which comprised 150 mg N/100 g body weight.  
The nptII gene codes for an aminoglycoside phosphotransferase conferring resistance to 
antibiotics such as kanamycin, neomycin or paromomycin etc. and is used as a selection 
marker in genetically modified plants (EFSA, 2008). CtxB is the non-toxic B subunit of 
cholera toxin and has adjuvant action by stimulating mucosal and other immune 
responses (CZERKINSKY et al., 1989; HOLMGREN et al., 1993). The non-transgenic 
conventional potatoes were provided by NORIKA GmbH (Groß Luesewitz, Germany). 
Transgenic tubers were obtained from the University of Rostock (Faculty for Agricultural 
and Environmental Sciences, Agrobiotechnology and Applied Research in Bio- and 
Gene-Technology). VP60 protein presence could not be detected (see Table 14) with 
ELISA but mRNA expression was shown (MIKSCHOWSKY, personal communication).  
 
Table 11: Composition of semi-synthetic diet fed to rats in g/kg DM (JANCZYK, personal 
communication) 
Feeding groups wtAlb rAlb-VP60 rAlb-nptII 
Corn starch 79 68 79 
N-free mixture* 700 700 700 
Casein** 85 85 85 
Potato 136 147 136 
*N-free mixture consisted of 18.5% cellulose, 37.1% sugar, 14.8% oil, 7.4% vitamins (Vitamin A – 750 IE, B1- 1 mg, B2 – 1 mg, 
B6 – 0.5 mg, B12 – 0.5 mg, C – 1 mg, D3 – 25 IE. E – 2.5 mg, K3 – 0.1 mg, Panthotenic acid – 1 mg, Nicotine acid amide – 2.5 
mg, Choline hydrochloride – 100 mg, Folic acid – 0.1 mg, Biotin – 0.01 mg, Inositol – 12.5 mg, p-Aminobenzoic acid – 5 mg, 
fulfilled ad. 1 g with wheat starch). 14.8% minerals (CaCO3 - 6.86%, Ca-citrate – 30.83%, CaHPO4·H20 – 11.28, K2HPO4 – 
21.88, KCl – 12.47%, NaCl – 7.71%, MgSO4 – 3.83%, MgCO3 – 3.52%, Fe-Ill ammoncitrate – 1.53%, MnSO4·H2O – 0.02%, 
CnS04·H20 – 0.0078%, KJ - 0.0041%, NaF – 0.051%, AlNH4(S04)2·12 H20 – 0.009%, ZnCO3 – 0.006%) and 7.4% wheat 
starch; corn starch was added to obtain 100%.  
**3% methionine was added 
 
Table 12: Nutrient composition of potatoes used in feeding experiments (JANCZYK, personal 
communication) 
Parameter wtAlb rAlb-VP60 rAlb-nptII 
DM (%) 93.02 93.20 93.13 
cA (%DM) 3.74 3.57 3.73 
cP (%DM) 8.12 7.58 8.18 
cF (%DM) 2.23 2.26 2.50 
EE (%DM) 0.28 0.26 0.26 
NfE (%DM) 85.63 86.33 85.33 
Starch (%) 77.40 77.51 Not analyzed 
DM: dry matter; cA: crude ash; cP: crude protein; cF: crude fiber; EE: ether extract; NfE: nitrogen free extract 
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Table 13: Amino acid profile of potatoes used in feeding experiments (JANCZYK et al., 2007 and 
personal communication) 
Amino acids (g/16 g N) wtAlb rAlb-VP60 rAlb-nptII 
asparagine 7.13 15.71 14.95 
threonine 4.35 3.84 3.84 
serine 4.67 3.57 3.5 
glutamic acid 16.14 10.39 10.92 
glycine 1.79 3.08 3.06 
alanine 3.31 3.23 3.14 
valine 4.84 4.14 4.14 
isoleucine 4.24 3.18 3.2 
leucine 8.06 5.79 5.74 
tyrosine 3.03 1.77 1.51 
phenylalanine 3.91 3.73 3.76 
histidine 2.21 1.53 1.58 
lysine 7.36 5.12 5.18 
arginine 2.92 4.05 4.26 
proline 7.06 3.95 3.44 
cysteine 1.56 1.58 1.61 
methionine 1.18 1.22 1.26 
tryptphan 0.83 0.91 1.11 
 
All diets were isoenergetic and isonitrogenous and were fed once a day (at 8.00 a.m.). 
Water was provided ad libitum. Free access to food was allowed from 8.00 to 20.00. The 
experiment was conducted over a period of 14 days.  
In the following the feed components will be named equally as the feeding groups (rAlb-
VP60, rAlb-nptII, wtAlb). 
 
Table 14: Content of VP60, CtxB and NPTII in freeze-dried potato tuber material, prepared for feeding 
experiments according to MIKSCHOWSKY (personal communication) 
Parameters wtAlb rAlb-VP60 rAlb-nptII 
VP60 μg/mg TSP - not detectable - 
CtxB μg/mg TSP - not detectable - 
NPTII μg/mg TSP - 0.03 ± 0.01 0.05 ± 0.00 
 
Tissue collection 
After 14 days animals were exsanguinated and slaughtered as described above. Tissue 
samples of the liver, the spleen and of small intestine epithelium were collected, 
immediately frozen in liquid nitrogen and stored at -80 °C until isolation of RNA. 
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3.2 Methods 
3.2.1 RNA isolation and quantification 
As a first step frozen tissues of spleen, liver and small intestine epithelium were ground 
with a mortar in liquid nitrogen to avoid unfreezing and degradation of RNA. Extraction of 
total RNA was done with the RNeasy Mini Kit® (Qiagen, Hilden). DEPC-treated water, 
RNase-free reagents and vessels were used for all isolation and processing steps. 
According to manufacturers´ instructions 30 mg tissue powder were mixed with 1.5 ml 
RLT lysis buffer and homogenized with the “Ultra TurraxT25® basic” (11 000 - 24 000 
rpm). The lysate was then centrifuged at 10 000 rpm for 30 min and the supernatant was 
removed by pipetting and transferred into a new microcentrifuge tube with 1.5 ml ethanol 
(70%) to clear the lysate. After mixing the solution it was transferred to an RNeasy spin 
column, placed in a 2 ml collection tube and centrifuged for 15 sec at 10.000 rpm. The 
flow-through was discarded. RNA was now bound to the membrane of the spin columns 
and was washed with RW1 washing buffer. A DNAse I digestion (Qiagen, Hilden) was 
performed on the membrane for 1 hour at 37 °C. After an additional washing with RW1 
and RPE buffers, the columns were centrifuged (10.000 rpm for 30 sec) to dryness. As 
an ultimate step RNA could then be eluted in about 30 μl RNAse-free water by 
centrifugating at 10.000 rpm. Total RNA was stored at -80 °C. 
Concentration and purity of the RNA were determined with a NanoDrop® ND-1000 
spectrophotometer (NanoDrop technologies Ltd, USA) by measuring the optical density 
of each sample at 230, 260 and 280 nm. The 260/280 and 260/230 (protein-
contamination-value) ratios should be above 1.8 to ensure high purity of RNA. The 
quality of the RNA was further confirmed by gel electrophoresis on a 2.2 M formaldehyde 
gel. On the gel, the bands of the 18S and 28S rRNA band should be clearly visible. To 
control fragment sizes, the Alu I Maker was used. 
 
3.2.2 Microarray hybridization 
For genome wide expression profiling the MWG “rat 10K array” (MWG Biotech AG, 
Ebersberg) was used, which allows the detection of expression levels of 9802 
transcripts. 5787 probes/spots of the array were annotated to known geneIDs 
(http://www.ncbi.nlm.nih.gov/sites/entrez and http://rgd.mcw.edu/genes/). Additional 
probes could not be assigned to any known genes. They represented mostly ESTs from 
an in-house MWG EST-sequencing project. Probes consisted of 50mer oligonucleotides. 
A dual labeling system was used. For DNA chip hybridization the samples of control 
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group and test group were pooled and labeled with Cy3 (control group) and Cy5 (test 
group) dyes, respectively and co-hybridized on the same array. Each hybridization was 
carried out in triplicate. Probe preparation and chip hybridization were carried out 
essentially according to manufacturers´ protocol (MWG, 2002).  
 
3.2.2.1 First and second strand synthesis 
Synthesis of first strand cDNA was performed with “cDNA Synthesis System®” (Roche, 
Mannheim, Germany), the corresponding AMV Reverse Transcriptase and Oligo[(dT)24-
T7promotor]65 primers using 15 μg of pooled total RNA. Primer annealing was done at 
70 °C for 10 min. For synthesis reaction 19 μl master mix were added to the RNA and 
the solution was incubated for 60 min at 42 °C. 
 
Master mix:  5 x Reverse Transcription buffer    8 μl 
   0.1 M DDT       4 μl 
   AMV Reverse Transcriptase    2 μl 
   RNase Inhibitor (25U/μl)     1 μl 
   dNTP Mix (10 mM each nucleotide)   4 μl 
 
Second strand synthesis was done at 16 °C for 2 hours using 110 μl of the reaction mix. 
 
Reaction mix:  5 x second strand buffer     30  μl 
   dNTP mix (10 mM each nucleotide)   1.5 μl 
   second strand enzyme mix     6.5 μl 
   RNase-free water      72  μl 
 
Moreover T4 DNA polymerase was added for removing overhangs (16 °C for 5 min). 
This reaction was stopped with 17 μl EDTA and remaining RNA was eliminated with 
1.5 μl RNase I (37 °C for 30 min). Protein contamination was cleared with 5 μl of 
Proteinase K (37 °C for 30 min) and dsDNA was dried in a vacuum concentrator. 
 
3.2.2.2 cRNA synthesis, labeling and fragmentation 
After these steps dsDNA was transcribed into cRNA with a T7 transcription and during 
this step Cy3-UTPs or Cy5-UTPs were incorporated into the newly synthesized cRNA 
(MEGAscriptTM T7 Kit®, Ambion). 20 μl of the reaction mix was added to the dried 
dsDNA and incubated at 37 °C for at least 4 hours. 
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Reaction mix:  10 x reaction buffer      2 μl 
   ATP/CTP/GTP-mix stock solution (25 mM each)  6 μl 
   U-nucleotide stock solution (50 mM)   2 μl 
   RNase-free water      1 μl 
   Enzyme mix, incl. T7 RNA polymerase   4 μl 
   Cy3-UTP or Cy5-UTP (5 mM)    5 μl 
 
Labeled cRNA was purified and fragmented with 5 x fragmentation buffer (12 μl, 
incubation at 94 °C for 15 min). After an additional purification step the labeled cRNA of 
both groups was merged, dried and used for hybridization. 
 
3.2.2.3 Hybridization of cRNA on the rat array 
The labeled cRNA was re-dissolved in 35 μl hybridization buffer, heated for 3 min at 
94 °C and immediately placed on ice. The hybridization mix was pipetted onto the array, 
covered with a cover slip and sealed with rubber cement. The arrays were placed for 
incubation in a dark, humid chamber at 42 °C for 16 – 24 hours. After hybridization, the 
arrays were washed for 5 min in washing solutions A, B, and C (A: 2 x SSC, 0.1 % SDS; 
B: 1 x SSC; C: 0.5 x SSC) at 32 °C to remove unspecifically bound molecules. After 
washing, arrays were centrifuged to dryness.  
 
Hybridization buffer:  Na-Phosphate (1 M, pH 8.0)   50   μl 
    Formamide (99.8 %)     500 μl 
    20 x SSC      300 μl  
    50 x Denhardts Solution    100 μl 
    10 % SDS       50  μl 
 
3.2.3 Microarray data analysis 
3.2.3.1 Image processing 
Cyanine-3 and Cyanine-5 fluorescence can be detected using a confocal scanning 
instrument. With two tuned lasers, Cyanine dyes were excited at appropriate 
wavelengths (Cy5: 651 nm; Cy3: 552 nm). After drying, all slides were scanned 
immediately (428TM Scanner®; Affymetrix, Inc., Santa Clara, USA). Scans were done at 
various photo multiplier tube (PMT) settings (gains), above and below saturation of the 
most intense fluorescent spots on each array. The images were saved as TIFF files. 
Files for Cy3 and the corresponding Cy5 scans were produced. The images were then 
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transformed into data matrixes using Imagene™ 5 software (BioDiscovery Inc., Los 
Angeles, USA). These matrices included both spot and background intensities in order to 
be able to correct for background specific noise. 
 
3.2.3.2 Quality filtering and data pre-processing 
Moreover, a first visual quality inspection was carried out to check for major 
contamination (e.g. dirt or dust) on the image and to manually flag the affected area. 
Additionally, Imagene™ 5 offers the choice to automatically flag spots according to 
several quality criteria: 
 Bad quality spots (shape irregularity, contamination, offset from expected position) 
 Empty spots 
 Negative spots (background > signal) 
 Weak spots: if for some spots this ratio 
 
 
 
 
 appeared to be lower than the threshold “two”, the spot was flagged.  
 
Data was further processed with MAVI Pro 2.6.0 software (MWG Biotech AG, 
Ebersberg). The software intends to increase the dynamic range, while at the same time 
avoiding saturation problems. This was achieved by linear regression analysis on the 
intensity data of the images from three different scanner PMT gain settings. MAVI also 
subtracted unspecific background signals and corrected intensity signals could be 
exported for further analyses. 
Moreover a fixed minimum intensity threshold of  150 (as recommended by MWG, 
personal comment) in both experimental groups was applied to exclude signals of poor 
or questionable performance. 
 
3.2.3.3 Normalization 
For further data analysis GeneSight 3.5 (Biodiscovery Inc., Los Angeles, USA) and TIGR 
MeV 4.0 (http://www.tm4.org/mev.html; SAEED et al., 2003) software were used. Firstly, 
a logarithmic transformation of intensity values was accomplished. Then color (dye) 
normalization was performed. Normalization was done to adjust the intensity values for 
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effects which are due to technological variation i.e. dye bias. This bias can be corrected 
using various normalization methods. Several of them were tested in 4.1.1: 
 Global normalization (QUACKENBUSH, 2002) 
 Linear regression (FINKELSTEIN, 2002) 
 Log centering (CAUSTON, 2003) 
 Chens` ratio statistic (CHEN et al., 1997) 
 Lowess (QUACKENBUSH, 2002) 
 
For subsequent analysis lowess (locally weighted linear regression) normalization was 
applied. MA-plots were drawn with “R” software (GENTLEMAN et al., 2003; 
http://www.bioconductor.org/) using the following formula: 
 
M = log2(Cy5) - log2(Cy3)        and      A = 0.5 * (log2 (Cy5) + log2 (Cy3))  
 
A lowess curve was created using the “lowess.smooth” command. Correlation analysis 
was done with “cor.test” command both included in “R” software. 
 
3.2.3.4 Statistical analysis 
Single gene analysis: To identify genes which are significantly differentially regulated a 
t-test was carried out (TIGR MeV 4.0; SAEED et al., 2003). P-values were then adjusted 
for high numbers of expected false positives. This was done by correcting the False 
Discovery Rate using the concept of STOREY & TIBSHIRANI (2003). For the ordered p-
values the corresponding q-values (= corrected p-values) were calculated using the 
software QVALUE (http://genomics. princeton.edu/storeylab/qvalue/) which has 
implemented the above mentioned statistical concept. A threshold of q  0.05 was 
applied to define significantly differentially expressed genes (DEGs) between two feeding 
groups for experiments described in 4.3. Moreover a fold change/ratio was calculated 
and fold changes of  1.5 were considered as relevant and thus used as an additional 
filter for defining expression changes between the feeding groups. 
 
Fold change  =  log2 (intensity Cy5-signal) – log2 (intensity Cy3-signal) 
 
Threshold-based enrichment analysis of functional GO processes: Based on Gene 
Ontology (GO) database (http://www.geneontology.org), DEGs were functionally 
assigned to biological processes in which they play a role. Processes with a significantly 
increased number of associated DEGs were defined using the EASE Score (ES  0.05) 
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as implemented in the DAVID software (http://david.abcc.ncifcrf.gov/home.jsp). The 
software calculates the over-representation of DEGs within a GO category (gene set) 
with respect to the total number of genes assayed and annotated within the classification 
system. The EASE Score is a conservative adjustment of the fisher exact probability, 
taking into account the over-estimation of processes assigned with only few genes 
(HOSACK et al., 2003). Not for all genes a functional annotation was available. Thus, for 
the identification of diet-affected biological processes only GO annotated molecules 
could be included. Starting point of this approach is a pre-defined threshold-based list of 
DEGs. In the following this approach is referred to as individual gene analysis (IGA). 
 
Threshold-free gene set analysis of functional GO processes (GSA): For applying a 
threshold-free gene set analysis, the software tool GAZER (http://expressome.kobic.re.kr 
/GAzer/index. faces; KIM et al., 2007) was employed. This tool identifies significantly 
altered gene set categories based on GO annotation and uses all available ranking 
statistics (e.g. p-values, fold changes) without pre-selection according to a certain 
threshold. As recommended for small sample sizes, fold changes were chosen as 
ranking statistics and a z-test (PAGE algorithm; KIM & VOLSKY, 2005) was selected as 
statistical test. 
 
3.2.4 Real-time RT-PCR 
3.2.4.1 Primer design  
To obtain quantitative real-time measurements of mRNA expression of several selected 
DEGs a real-time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) was 
carried out with the LightCylcer® 2.0 (Roche Diagnostics) system. Using Primer3 
software (http://frodo.wi.mit.edu/; ROZEN & SKALETSKY, 2000) sequence specific 
primers of 100 – 250 bp length were designed for the selected genes from the 
corresponding cDNA sequence in NCBI database (http://www.ncbi.nlm.nih.gov/sites/ 
entrez). Primers used within this work are given in Table 15.  
As a first step primers were tested in a PCR reaction and checked in gel electrophoresis 
in order to examine the temperature at which they were annealing best. Moreover, a 
PCR product for creation of a standard curve was produced and concentration of PCR 
product was determined with the Nano Drop® instrument (Nanodrop Technologies, 
Delaware, USA). PCR was performed according to the following PCR protocol with 2.5 μl 
cDNA template (containing 2 μg) and within 40 cycles:  
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Master mix  H2O     36 μl 
   10 x PCR buffer   5 μl 
   dNTPs (each, 10mM)  1 μl 
   Forward primer (10 pmol/μl) 1 μl 
   Reverse primer (10 pmol/μl) 1 μl 
   Taq Polymerase   0.5 μl 
 
For measuring mRNA level of specific molecules with real-time RT-PCR the 
corresponding RNA Pools of the microarray assay were used.  
 
3.2.4.2 LightCycler®-PCR Protocol 
Synthesis of cDNA (reverse transcribed RNA) was performed with M-MLV reverse 
transcriptase (Promega, Mannheim, Germany) and Oligo(dT)12 primers using 2 μg of 
total RNA. The RNA was dissolved in 6 μl water, 2 μl primers (100 μM) were added and 
the tubes were incubated at 70 °C for 5 min for primer annealing. 17 μl of master mix 
were added and reverse transcription was carried out at 42 °C for 1 hour with and 
additional step at 95 °C (5 min) to destroy the enzyme and stop transcription process. 
 
Master mix:  H2O      5.4    μl 
   5 x MMLV RT-buffer   5.0    μl  
   dNTPs (each, 10mM)  1.25  μl 
   RNasin (25 U/μl)    0.60  μl  
   M-MLV reverse transcriptase 1.0    μl  
 
A cDNA yield of 80 ng/μl was assumed. cDNA was frozen at -20°C until further use in 
real-time RT-PCR assay.  
Real-time RT-PCR was carried out in the LightCycler instrument according to 
manufacturers´ recommendation and an optimized protocol essentially as described by 
SCHWERIN et al. (2002). For LightCycler reactions, a master mix of the following 
reaction components was prepared using the LightCylcer-FastStart DNA Sybr Green 1 
kit: 
 
Master mix:  H2O      10.6 μl 
   MgCl       2.4   μl  
   Forward primer (10 pmol/μl)  1.5   μl  
   Reverse primer (10 pmol/μl)  1.5   μl  
   Enzyme Mix     2.0   μl  
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Samples of 18 μl of LightCycler master mix were filled in the LightCycler glass capillaries 
and 10 ng of reverse transcribed RNA, dissolved in 2 μl water, was added as PCR 
template. A protocol with 45 cycles was applied. Based on the melting curve analysis of 
the PCR products, a fluorescence acquisition temperature (see Table 15) was estimated 
and included in the amplification cycle program. High-temperature fluorescence 
acquisition melts unspecific PCR products, eliminates the non-specific fluorescence 
signal derived from primer dimers, and ensures an accurate quantification of only the 
desired specific sequence.  
For all the assays a standard curve was generated using DNA standard dilutions (102, 
103, 104, 105 and 106 copies) of the corresponding PCR product. The standard curve was 
used for calculation of transcript copies per 10 ng total mRNA. Fluorescence signals, 
which were recorded on-line during amplification, were subsequently analyzed using the 
“Second Derivative Maximum” method of the LightCycler data analysis software. The 
copy number of the housekeeping gene Gapdh was measured to normalize for equal 
RNA amounts. The mRNA abundance was analyzed in triplicate. 
 
3.2.4.3 Statistical analysis 
The average mRNA expression level (copies/10 ng total mRNA) of the selected DEGs 
was determined for the corresponding test and control groups of the feeding 
experiments. Differences between the experimental groups were assigned with t-test 
(SAS®, 2002). Significance was assumed at p  0.05. 
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Table 15: Primers and corresponding reaction conditions used for real-time RT-PCR amplification 
Gene 
symbola 
Accession 
No. Primer sequences (5´-3´) AT
b[°C] Length of PCR product [bp] FT
c [°C] 
Acox2 for cagcagcagaaactccttcc 
Acox2 rev 
NM_145770 
aaacgtggccttcataccag 
63 165 85 
Add2 for gcttcctccatgaacttctcc 
Add2 rev 
NM_012491 
gtcctgctccttgctcactc 
60 189 87 
Alad for ctggatatggtgcaggaggt 
Alad rev 
NM_012899 
agctggggtgcaaagtaggt 
61 197 88 
Cebpb for caagctgagcgacgagtaca 
Cebpb rev 
NM_024125 
cagctgctccaccttcttct 
63 157 90 
Cpa1 for cagctcctgctctaccccta 
Cpa1 rev 
NM_016998 
gtacttgatgccctggctgt 
65 198 85 
Ctrb1 for caaatacaatgccctcaagacc 
Ctrb1 rev 
NM_012536 
caggagtggaagtggaacaga 
65 245 89 
Ela1 for catctgctccagctcctctt 
Ela1 rev 
NM_012552 
gtgaagactgtgggcttcct 
60 204 87 
F3 for gctgggaactgtggagtttg 
F3 rev 
NM_013057 
cctgggcaacctagtgtctt 
63 200 83 
Fbp1 for gtctgttttgatcccctcga 
Fbp1 rev 
NM_012558 
tccagcatgaagcagttgac 
60 218 85 
Flt1 for gacgtgtggtcctacggagt 
Flt1 rev 
NM_019306 
tttctttggggtctttgtgc 
65 190 84 
Gapdh for catggccttccgtgttccta 
Gapdh rev 
NM_017008 
cccagcatcaaaggtggaag 
65 205 86 
Gp5 for agggaccttgaccaaaacct 
Gp5 rev 
NM_012795 
cgcgataaatccaacacctt 
63 134 81 
Hsd17b2 for cctcttatcggtgtcctgct 
Hsd17b2 rev 
NM_024391 
cgctcagagcagtttttcct 
55 219 86 
Pap1 for actccatgaccccactcttg 
Pap1 rev 
NM_053289 
tgacaagctgccacagaatc 
60 136 82 
Pc for caagcctacctgcacattcc 
Pc rev 
NM_012744 
tccaccttgtctcccatctt 
58 182 86 
Pemt for tccagagtgaccacatttcc 
Pemt rev 
NM_013003 
ttcaaacaggagagcaacca 
63 159 87 
Pla2g1b for tcctcatcgacaacccctac 
Pla2g1b rev 
NM_031585 
acggcatagacaggaagtgg 
60 217 86 
Pnlip for aaccttacttccagggcaca 
Pnlip rev 
NM_013161 
gtcaacgatttgggaaagga 
60 206 83 
Prkaa2 for caccaccggtctctgtcttt 
Prkaa2 rev 
NM_023991 
ggccagatttctgtgtttcc 
55 155 83 
Rara for ccctacgccttcttctttcc 
Rara rev 
AJ002940 
agggctgggcactatctctt 
60 159 87 
aAcox2: acyl-Coenzyme A oxidase 2, branched chain; Add2: adducin 2 (beta); Alad: aminolevulinate, delta-, 
dehydratase;.Cebpb: CCAAT/enhancer binding protein, beta; Cpa1: carboxypeptidase A1; Ela1: elastase 1, pancreatic; F3: 
coagulation factor III; Fbp1: fructose-1,6-biphosphatase 1; Flt1: FMS-like tyrosine kinase 1; Gapdh: glyceraldehyde-3-phosphate 
dehydrogenase; Gp5: glycoprotein 5, platelet; Hsd17b2: hydroxysteroid (17-beta) dehydrogenase 2; Pap1: pancreatitis-
associated protein; Pc: Pyruvate carboxylase; Pemt: phosphatidylethanolamine N-methyltransferase; Pla2g1b: phospholipase 
A2, group IB; Pnlip: pancreatic lipase; Prkaa2: protein kinase, AMP-activated, alpha 2 catal. subunit; Rara: retinoic acid 
receptor, alpha 
bannealing temperature; cfluorescence acquisition temperature 
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4 RESULTS 
4.1 Pre-screening of different microarray analysis parameters to select an 
appropriate analysis approach for subsequent investigations 
Gene expression profiling was done in the liver, the spleen and in small intestine 
epithelium of rats fed a diet including the genetically modified (GM) feed additive rBV-
VP60 (VP60 expressing baculovirus). Expression profiles were compared to rats fed a 
non-GM additive (wtBV). For expression studies the “10K rat oligonucleotide array”, 
representing about 10 000 transcripts of the rat genome, was used. As a prerequisite for 
further studies, a pre-screening of different analysis parameter settings was performed in 
order to select an appropriate analysis approach for the identification of diet effects. This 
was done because microarray data evaluation includes many different steps of data 
processing and analysis and it is known that they can have a profound impact on the 
results and even on the conclusion drawn of them.  
 
4.1.1 Trimming of low quality and low intensity signals and normalization of 
 dye specific bias 
As a first step of microarray data analysis a background correction of the intensity signals 
was performed. This step corrects for most background noise. MA-plots of all arrays 
were drawn in order to evaluate the need for further filtering due to low quality signals 
and to study the influence of different dyes on the data (dye bias). The latter was 
necessary because the experiment was based on a two color platform where the two 
experimental groups were labeled with different dyes (Cy3, Cy5) which have different 
physical properties and incorporation rates. MA-plots show the log ratio between each 
intensity signal of the two experimental groups and its log geometric mean. As can be 
seen from array signals presented in Figure 7A, the variability among the fold changes 
was high at low intensities as it was likewise observed in all other arrays (for Figure 7 a 
single array from liver tissue was chosen at random to give an example). This could be 
caused by low quality signals due to a weak signal intensity arising from low transcript 
levels that may be masked or biased by noise (non-specific hybridization). Consequently, 
a further filtering was performed. Signals with a distance of  2 SD (standard deviations) 
to the respective background value were excluded. Moreover, a fixed minimum intensity 
( 150 as recommended by MWG, personal communication) in both experimental groups 
was applied as quality criterion in order to remove signals of poor or questionable 
performance.  
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Figure 7(A-F): Fold changes of transcript levels measured in the liver of rats (fold change between 
animals fed the rBV-VP60 (Cy5) and the wtBV (Cy3) diet). A: background corrected, un-normalized 
data without quality filtering; B: quality filtered and background corrected data, globally normalized; C: 
quality filtered and background corrected data, normalized with linear regression method; D: quality 
filtered and background corrected data, normalized with log centering method; E: quality filtered and 
background corrected data, normalized with Chens´ ratio statistic method; F: quality filtered and 
background corrected data, normalized with lowess method. 
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The effect of the proposed data trimming as well as the influence of a global 
normalization on the distribution of fold changes can be seen from Figure 7B. Global 
normalization adjusts the mean over all genes as to be equal between the two groups 
(Cy3-labelled and Cy5-labelled). The quality filtering did successfully exclude low 
intensity and possibly unreliable signals. Though, a distinct intensity-dependant dye bias 
could not be diminished. The filtering had no effect on the “banana-like” shape of the plot 
as visualized by adding a smooth curve (green line) computed with the lowess function 
(locally weighted regression). Consequently other common normalization methods were 
tested on the dataset: 
 Linear regression  
 Log centering  
 Chens´ ratio statistic 
 Lowess 
Linear regression, log centering, Chens´ ratio statistics did likewise not compensate for 
the intensity-dependant bias (see Figure 7C-E). Best results were obtained using lowess 
normalization which uses locally weighted linear regression to smooth the data. Figure 
7F shows an appropriate dye bias smoothing of the expression fold changes which can 
be seen from the good agreement of the green lowess curve and the red “zero” line. This 
tendency was generally observed in all other arrays processed within this study, 
regardless of the array or tissue that was analyzed (data not shown). In consequence 
lowess normalization was used for any further experiments. 
 
4.1.2 Application of False Discovery Rate correction and fold change thresholds 
In this section of the study it was investigated whether and how the use of varying 
thresholds for defining significant expression changes can influence the number of 
differentially expressed genes (DEG). In addition, it was analyzed how threshold choice 
affected the pattern of identified diet-affected biological processes, which were based on 
a significant enrichment of associated DEGs. 
First, a t-test was performed and p-values were computed. Second, the False Discovery 
Rate (FDR) was corrected to adjust for multiple testing and the corresponding q-values 
were calculated. DEGs were defined based on different significance thresholds. 
Significance was assumed for q-values  0.2 / 0.1 / 0.05 and for p-value  0.05 and 
resulting numbers of DEGs were compared. Besides, the use of a minimum FC (Fold 
Change) in combination with a q  0.05 was tested. The FC filter was set to FC  1.5 / 2. 
The results were also compared to a variant without FC criterion. 
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4.1.2.1 Effects of threshold choice on the number of differentially expressed 
genes  
Table 16 shows the number of analyzed signals (= genes) after pre-processing the data 
which comprises genes that had detectable signals and that passed the quality criteria. 
From the spleen 8800, from the liver 9320 and from small intestine epithelium 8339 
signals were included in further analyses. Results varied between the three tissues. 2377 
(spleen), 2754 (liver) and 1608 (small intestine epithelium) genes, respectively were 
differentially expressed with a p-value  0.05. As outlined in chapter 1 the high amount of 
tests carried out simultaneously led to a very high number of expected false positives. 
440 (19 %) out of the 2377 significant DEGs in the spleen are expected to be false 
positives (liver: 466 = 17 %; small intestine epithelium: 417 = 26 %). Even when applying 
a very stringent p-value threshold ( 0.001) a large proportion, namely 9 out of 41 DEGs 
in the spleen and 9 out of 43 DEGs in the liver would expected to be false positive (false 
positives in small intestine epithelium: 8 out of 10). These results emphasize the need for 
a multiple testing correction as described above. 
 
Table 16: Number of expressed, differentially expressed (p-value  0.05) and expected false positive 
genes in the liver, the spleen and in small intestine epithelium of rats fed rBV-VP60 in comparison to 
rats fed wtBV. 
Tissue Number of analyzed genes 
Number differentially 
expressed genes1 
(100%) 
Expected false positives  
Liver 9320 2754 466 (17%) 
Spleen 8800 2377 440 (19%) 
Small intestine 
epithelium 8339 1608 417 (26%) 
1 p-value  0.05 
 
q-value threshold 
A FDR correction was applied and DEGs were now defined according to different q-value 
thresholds (q  0.2, q  0.1, and q  0.05). When assuming significance at q  0.05, a 
stringency that is commonly used in microarray studies, the number of DEGs was 
reduced in comparison to the DEG list without FDR correction (compare Table 16 and 
Table 17). In the liver only a slight reduction from 2754 to 2620 was observed. The other 
tissues revealed a more distinct effect. In the spleen the number of DEGs dropped from 
2377 to 917 and in small intestine epithelium from 1608 to 10. Loosening threshold 
stringency (e.g. q-value  0.1) led to a distinctively higher number of DEGs which 
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exceeded the results of gene selection without a multiple testing correction. In agreement 
with the results in Table 16, the liver seemed to be affected the most by the diet in that 
the number of DEGs was largest in this tissue; not matter which stringency level of the 
threshold was chosen. 
 
Table 17: Number of differentially expressed genes identified at different “False Discovery Rate” 
(FDR) thresholds in the liver, the spleen and in small intestine epithelium of rats fed rBV-VP60 in 
comparison to rats fed wtBV. 
Tissue 
q-value 
threshold 
(FDR) 
Number of differentially 
expressed genes 
(100%) 
Expected false positives 
among the differentially 
expressed genes 
     q  0.2                  7759                   1552 (20%) 
     q  0.1                  5241                   524 (10%) Liver 
     q  0.05                  2620                   131 (5%) 
     q  0.2                  6241                   1248 (20%) 
     q  0.1                  3667                   337 (10%) Spleen 
     q  0.05                  917                   46 (5%) 
     q  0.2                  4560                   912 (20%) 
     q  0.1                  355                   35 (10%) 
Small 
intestine 
epithelium      q  0.05                  10                   1 (5%) 
 
Referring to the tissues spleen and liver, a conservative threshold of q  0.05 appeared 
to be most reliable for the present data. The availability of only few replicates (n = 3) and 
thus a low statistical power may produce high false positive rates. It was intended to 
reduce the number of expected false positives amongst the DEGs to an acceptable and 
commonly applied level of significance. In consequence, a q  0.05 was used to define 
significant changes in gene expression for continuative investigations as described in 
4.1.2.3 and 4.3 (see appendix Table 34, Table 35 and Table 36: entire list of DEGs). 
 
Fold change filter in combination with a q  0.05 
When applying fold change filters of  1.5 or  2 to the list of significant DEGs defined 
with a q  0.05, the number of DEGs was reduced considerably in all examined tissues. 
In the liver 6 % (see Table 18) of the significant DEGs remained when filtering with a FC 
 1.5. A FC filter of  2 even reduced the amount of DEGs to 1 %. In the spleen a FC 
filter application diminished the number of DEGs to 17 % (FC  1.5) and 5 % (FC  2). In 
small intestine epithelium only very few genes had a q  0.05. A FC filter reduced the 
amount of DEGs to two (FC  1.5) and one gene (FC  2). 
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Table 18: Number of differentially expressed genes identified with different “fold change” (FC) filters in 
the tissues liver, spleen and in small intestine epithelium of rats fed rBV-VP60 in comparison to rats 
fed wtBV. 
Tissue Fold change filter1 Number of differentially expressed genes2 
             No FC              2620 (100%) 
             FC  1.5              149 (6%) Liver 
             FC  2              24 (1%) 
             No FC              917 (100%) 
             FC  1.5              157 (17%) Spleen 
             FC  2              49 (5%) 
             No FC              10 (100%) 
             FC  1.5              2 (20%) 
Small 
intestine 
epithelium              FC  2              1 (10%) 
1fold change (rBV-VP60 group/wtBV group);   2only genes with q  0.05 were included 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8(A-C): Frequency of expression fold 
changes between rats fed rBV-VP60 and rats 
fed wtBV as measured in the liver (A), the 
spleen (B) and in small intestine epithelium (C). 
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From Figure 8(A–C) it becomes clear that the frequency of high fold changes (i.e.  2) 
was very low, thus applying such a stringent filter might be not appropriate for this data. 
Moderate FC filters of  1.5 are probably more suitable in the present case and were 
regarded as most appropriate for further investigations within this study (4.1.2.3 and 
4.3). Moreover, it can be seen that small intestine epithelium had the least expression 
changes between the two groups and small fold changes, respectively. 
 
4.1.2.2 Effects of threshold choice on biological processes, exhibiting a 
significant enrichment of differentially expressed genes 
Results of 4.1.2.1 had shown that using different significance thresholds or fold change 
filters can have a profound influence on the number of differentially expressed genes. 
Whether the varying lists of DEGs also impact on the pattern of diet-affected biological 
processes, was additionally tested. 
To define affected diet-biological processes the DEGs were annotated to biological 
processes in which they are known to be involved. This was done using gene ontology 
(GO) database (http://www. geneontology.org/). GO annotation was not available for the 
entire number of genes/probes represented on the “10K rat oligo array”. On the one 
hand, this is due to a lack of functional knowledge meaning that for many genes the 
specific function is simply not known yet. On the other hand, it is by reason that a 
considerable amount of the probes, presented on the array, were deduced from EST 
(expressed sequence tag) sequences. ESTs are sequences known to be expressed but 
are not yet annotated to genes. Thus, it was not possible to assign a GO annotation for 
these ESTs (GO annotated genes on array 4217 out of 9802). Nevertheless, in the liver 
4022 out of 9320, in the spleen 3738 out of 8800 and in small intestine epithelium 3600 
out of 8339 probes/genes could be GO annotated and associated to biological processes 
in which they play a role. For the remaining genes no GO annotation was available and 
they were consequently excluded from further GO analysis. For defining a significant 
enrichment of DEGs within a biological process an enrichment score (EASE Score) was 
calculated and significance was assumed for an EASE Score of  0.05. Findings from 
liver tissue were chosen as example and are presented in Table 19. Results from spleen 
and small intestine epithelium are given in Table 27 and Table 29 (appendix). 
 
q-value threshold 
Table 19 shows, that the decision whether to apply a FDR correction or not and which 
stringency (q  0.2 / 0.1 / 0.05) to use can strongly influence the results. In liver tissue 
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only few processes (e.g. “nucleic acid metabolism”, “regulation of Wnt receptor signaling 
pathway”) showed partial consistency, with respect to significance, when applying 
different thresholds. In general the pattern of significant processes varied strongly and 
non-predictably with the number of DEGs included in the analysis. Comparable results 
were observed in the spleen and in small intestine epithelium (see Table 27 and Table 
29, appendix). Highest agreement in the liver was observed between applying no FDR 
correction and a q  0.05; which is due to the similar quantities of DEGs annotated to the 
specific processes and to comparable lengths of DEG lists (see row: All). 
 
Table 19: Influence of an application of different “False Discovery Rate” (FDR) thresholds on identified 
biological processes exhibiting a significantly increased number of differentially expressed genes. 
Different gene expression refers to the liver of rats fed rBV-VP60 in comparison with rats fed wtBV. 
Grey color marks significantly affected biological processes with ES  0.05. 
Number of differentially expressed GO annotated 
genes 
p  0.05 q  0.2 q  0.1 q  0.05 
Liver 
 
Biological process  
(GO term) 
Number of GO 
annotated 
genes on the 
array n1 ES2 n1 ES2 n1 ES2 n1 ES2 
Nucleic acid metabolism 760 248 0.05 628 0.01 441 0.08 239 0.04 
Regulation of Wnt receptor 
      signaling pathway 14 9 0.03 12 0.67 10 0.35 9 0.02 
Macromolecule catabolism 124 47 0.05 99 0.56 75 0.20 45 0.06 
Spermatid development 16 11 0.01 14 0.56 12 0.21 9 0.06 
Aldehyde metabolism 11 8 0.02 10 0.59 10 0.07 7 0.06 
Germ cell development 19 12 0.01 18 0.21 17 0.01 10 0.06 
Epidermis morphogenesis 13 7 0.16 12 0.47 12 0.03 6 0.31 
Transport 1120 339 0.44 915 0.01 650 0.03 329 0.30 
Organelle organization and 
      biogenesis 275 86 0.38 237 0.00 160 0.23 80 0.51 
DNA repair 50 17 0.43 46 0.03 30 0.42 16 0.47 
Sensory perception of 
smell 50 13 0.86 46 0.03 30 0.42 13 0.81 
All 4022 1205  3183  2234  1153  
1 n = number of differentially expressed genes in process 
2 ES = calculated EASE Score based on modified Fishers´ exact test; significance was assumed at ES  0.05 
 
Some processes, e.g. “regulation of Wnt receptor signaling pathway”, did not exhibit 
significance at lower stringencies (q  0.1) but did meet the criteria at a more stringent 
threshold (q  0.05) although the number of significant genes in process was nearly the 
same (10 vs. 9). It would be expected that with larger DEG lists as obtained e.g. at a 
q  0.1, the number of significant processes would be larger as well and would diminish 
but overlap along with raising threshold stringency and a reduced number of DEGs. As to 
be seen from Table 19 the results are different. Less processes appeared to be 
significant with an increased stringencies but the agreement of processes was very 
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low or not existent. For calculating whether a process is significantly affected by a diet, 
the following question is generally asked (e.g. “regulation of Wnt receptor signaling 
pathway” at q  0.1 and q  0.05): 
 
Are e.g. 10 out of 2234 or 9 out of 1153 genes significantly more than 
14 out of 4022 genes, or is it just random chance? 
* the process “regulation of Wnt receptor signaling pathway” had an EASE Score  0.05  
 
This example shows that the ratio between DEGs within the process and all DEGs 
increased with a more stringent q-value (0.004 vs. 0.008). The ratio between all genes 
within the process and the entire list of analyzed genes, which was used as reference, 
remained the same (0.003). Thus, the calculated EASE Score changed and the process 
that was not significant at a q  0.1 became significant at a q  0.05. This was due to the 
distinctively modified “n” of the complete DEG list at the particular threshold, whereas the 
number of DEGs in a specific process did hardly change. Genes of “regulation of Wnt 
receptor signaling pathway” tended to have high q-values, the distribution was not even.  
 
Fold change filter in combination with a q-value  0.05 
In addition to selecting DEGs by FDR criterion (q  0.05), FC filters were applied and the 
impact on the biological interpretation was likewise investigated. The number of 
significantly diet-affected processes in the liver of rats was reduced to zero with a FC 
filter  2 and q  0.05 (see Table 20) due to a drastically reduced list of DEGs (compare 
Table 18). When filtering with a FC  1.5, “nucleic acid metabolism” was the only 
category that was significant in agreement with results when no FC filter was applied. 
The fact that threshold choice and significance are not linked linearly and that results 
varied non-predictably with the number of DEGs gives reason to the assumption that the 
distribution of FCs is likewise not even between the DEGs in process and all DEGs. 
Besides, a filter of FC  2 seemed to be very stringent. In the spleen only one and in the 
liver and in small intestine epithelium no biological processes had EASE Scores  0.05 
(see Table 20 and Table 28). This is in agreement with results from 4.1.2.1 where it was 
shown that the frequency of high fold changes ( 2) was very low in the data used within 
this work (Figure 8A-C). Thus, setting a FC filter of  2 strongly reduced the DEG list and 
accordingly the number of biological processes with a significant enrichment of DEGs.
q  0.1 q  0.05* q  0.1 and  q  0.05 
DEGs in process / all DEGs DEGs in process / all DEGs all genes in process / all genes 
10 / 2234  =  0.004 9 / 1153  =  0.008 14 out of 4022 =  0.003 
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Table 20: Influence of an application of different fold change filters (no FC filter; FC  1.5; FC  2) on 
the identified biological processes exhibiting a significant over-representation of differentially 
expressed genes. Different gene expression refers to the liver of rats fed rBV-VP60 in comparison to 
rats fed wtBV and to DEGs with q  0.05. Grey color marks significantly affected biological processes 
with ES  0.05. 
Number of differentially expressed GO 
annotated genes 
no FC FC  1.5 FC  2 
Liver 
 
 
Biological process (GO term) 
 
Number of GO 
annotated genes 
on the array 
n1 ES2 n1 ES2 n1 ES2 
Regulation of Wnt receptor  
    Signaling pathway 14 9 0.02 - - - - 
Nucleic acid metabolism 760 239 0.04 25 0.01 - - 
Metanephros development 18 6 0.62 4 0.01 1 1.00 
Positive regulation of metabolism 173 51 0.50 10 0.01 - - 
Regulation of cellular metabolism 566 174 0.15 21 0.01 1 1.00 
Kidney development 22 6 0.80 4 0.01 1 1.00 
Intracellular signaling cascade 495 142 0.55 17 0.04 2 0.82 
Alcohol metabolism 164 54 0.16 8 0.05 1 1.00 
All 4022 1153  83  14  
1 n = number of differentially expressed genes in process 
2 ES = calculated EASE Score based on modified Fishers´ exact test; significance was assumed at ES  0.05 
 
4.1.2.3 Regulation of genes involved in biological processes, exhibiting a 
significant enrichment of differentially expressed genes 
In the spleen and the liver significant expression changes were monitored when applying 
selected threshold settings. Biological processes presented in Table 20 and Table 28 
(see appendix) with q  0.05 and FC  1.5 were regarded as being affected by the rBV-
VP60 diet. Small intestine epithelium did not exhibit any significant effects on that 
condition. Regulation of genes involved in these diet-affected biological processes is 
given in Figure 9, Figure 10(A-B) and Figure 11(A-D). In the spleen an enrichment of 
DEGs was observed in lipid catabolism. Four of the five associated genes had a 
decreased expression level in rBV-VP60 group compared to wtBV group (see Figure 9). 
One gene had a increased expression. In liver several biological processes including  
 nucleic acid metabolism 
 metanephros and kidney development (comprises two processes) 
 intracellular signaling cascade 
 alcohol metabolism 
 regulation of cellular metabolism 
 positive regulation of metabolism 
were significantly affected by the diet.  
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Figure 9: Regulation of differentially expressed genes as 
revealed by microarray technology. Genes are involved in 
lipid catabolism, a diet-affected biological process (GO 
annotation) that was identified in the spleen of rats fed 
rBV-VP60 compared to wtBV group. (Abbreviations: Pnlip: 
pancreatic lipase; Grn: granulin; Pla2g1b: phospholipase 
A2, group IB, pancreas; Pnliprp1: pancreatic lipase related 
protein 1; Pnliprp2: pancreatic lipase-related protein 2) 
 
 
 
 
 
       
 
Figure 10(A-B): Regulation of differentially expressed genes involved in several diet-affected biological 
processes (GO annotation) as revealed by microarray technology. Different expression refers to the 
liver of rats fed rBV-VP60 compared to wtBV group. (Abbreviations: Sds: serine dehydratase; 
Onecut1: one cut domain, family member 1; Pkm2: pyruvate kinase, muscle; Pdx1: pancreatic and 
duodenal homeobox 1; Ppap2a: phosphatidic acid phosphatase 2a; Atf4: activating transcription factor 
4; Pdk2: pyruvate dehydrogenase kinase, isoenzyme 2; Fabp5: fatty acid binding protein 5, epidermal; 
Mapk10: mitogen activated protein kinase 10; Spag5: sperm associated antigen 5; Adcy4: adenylate 
cyclase 4; Prkcz: protein kinase C, zeta; Vsnl1: visinin-like 1; Ret: ret proto-oncogene; Adra1a: 
adrenergic receptor, alpha 1a; Freq: frequenin homolog; Sstr1: somatostatin receptor 1; Ccne: cyclin 
E1; Grm5: glutamate receptor, metabotropic 5; Rap2a: RAS related protein 2a; Arrb1: arrestin, beta 1; 
Cfl1: cofilin 1, non-muscle; Agt: angiotensinogen (serpin peptidase inhibitor, clade A, member 8); 
Cap1: CAP, adenylate cyclase-associated protein 1). 
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Figure 11(A-D): Regulation of differentially expressed genes involved in several diet-affected biological 
processes (GO annotation) as revealed by microarray technology. Different expression refers to the 
liver of rats fed rBV-VP60 compared to wtBV group. (Abbreviations: Agt: angiotensinogen (serpin 
peptidase inhibitor, clade A, member 8); Rara: retinoic acid receptor, alpha; Ret: ret proto-oncogene; 
Lama5: laminin, alpha 5; Adcy4: adenylate cyclase 4; Aqp2: aquaporin 2; Znf354a: zinc finger protein 
354A; Hoxc4: homeo box C4; Prnp: prion protein; Crem: cAMP responsive element modulator; Grm5: 
glutamate receptor, metabotropic 5; Onecut1: one cut domain, family member 1; Pdx1: pancreatic and 
duodenal homeobox 1; Arrb1: arrestin, beta 1; Pkm2: pyruvate kinase, muscle; Slc28a2: solute carrier 
family 28 (sodium-coupled nucleoside transporter), member 2; Nln: neurolysin (metallopeptidase M3 
family) ; Nfil3: nuclear factor, interleukin 3 regulated; Prol2: proline-rich nuclear receptor coactivator 1; 
Atf4: activating transcription factor 4; Pet1: Pet1; Tcf4: transcription factor 4; Ccne: cyclin E1; Tcf1: 
HNF1 homeobox A; Cfl1: cofilin 1, non-muscle; Klf15: Kruppel-like factor 15; Hsp86: heat shock 
protein 90, alpha (cytosolic), class A member 1; Pdgfrb: platelet derived growth factor receptor, beta 
polypeptide). 
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All molecules involved in “alcohol metabolism” had a reduced expression level after 
feeding rBV-VP60 in comparison to the wtBV fed rats (see Figure 10A). Genes playing a 
role in “intracellular signaling cascade”, in “metanephros and kidney development”, in 
“nucleic acid metabolism” and in “regulation of cellular metabolism” showed a 
predominant down-regulation in rBV-VP60 group (Figure 10B + Figure 11(A, B, D). 
Molecules attributed to the GO process “positive regulation of metabolism” were both 
down- and up-regulated after feeding the GM feed additive (see Figure 11C). 
 
4.2 Comparison of microarray and real-time RT-PCR measurements 
In addition to the DNA chip hybridization measurements (microarray), gene expression of 
several randomly selected molecules was determined by using real-time RT-PCR – a 
method that is often used to validate microarray findings. These genes were chosen from 
the microarray experiment described in 4.1 and had revealed significant expression 
changes (q  0.05 and FC  1.5) in the tissues liver or spleen (see Table 21). Transcript 
levels of the housekeeping gene Gapdh (glyceraldehyde-3-phosphate dehydrogenase) 
were measured in the spleen and the liver in order to normalize for equal RNA amounts 
(see Figure 12). As to be expected, Gapdh did not show significant differences between 
the two feeding groups when analyzed with t-test. It could be used for normalization in 
further analyses. 
 
 
 
Figure 12: Transcript level of housekeeping gene Gapdh (Glyceraldehyde-3-phosphate dehydro-
genase) measured via real-time RT-PCR in the spleen and the liver of rats fed either a wtBV or a rBV-
VP60 feed additive (n = 3). 
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Figure 13(A-H): Transcript levels of selected molecules (A: carboxypeptidase A; B: phospholipase A2, 
group IB; C: chymotrypsinogen B1; D: pancreatic lipase; E: elastase 1, pancreatic; F: adducin 2 (beta); 
G: glycoprotein 5, platelet; H: coagulation factor III) measured via real-time RT-PCR in the spleen of 
rats fed either a wtBV or an rBV-VP60 feed additive (n = 3). 
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In general real-time RT-PCR results were in agreement with the results of the microarray 
study. Most studied genes that had shown significant expression differences between the 
feeding groups in microarray investigations also exhibited significant differences in real-
time RT-PCR approach. In spleen five genes (Ela1: elastase 1, pancreatic; Pla2g1b: 
phospholipase A2, group IB; Pnlip: pancreatic lipase; Ctrb1: Chymotrypsinogen B1; 
Cpa1: carboxypeptidase A1) were down-regulated in rBV-VP60 group (see Figure 13A-
H) and significance of the difference was proven in real-time RT-PCR approach. One 
gene (Add2: adducin 2 (beta) was significantly up-regulated in rBV-VP60 group when 
studied by real-time RT-PCR as well as by chip hybridization. Direction of regulation 
coincided with results obtained from microarray study. For two genes (Gp5: glycoprotein 
5, platelet; F3: coagulation factor III) significant differences in transcript level could not be 
proved by real-time RT-PCR although it was demonstrated using microarray technology. 
In the liver both genes (Rara: retinoic acid receptor, alpha; Cebpb: CCAAT/enhancer 
binding protein (C/EBP), beta) investigated by real-time RT-PCR showed a down-
regulation in rBV-VP60 group compared to wtBV group; as it was likewise observed with 
microarray approach (see Figure 14A+B). Moreover significance of these differences 
could be proved. 
 
                 
Figure 14(A+B): Transcript levels of selected molecules (A: retinoic acid receptor, alpha; B: 
CCAAT/enhancer binding protein (C/EBP), beta) measured via real-time RT-PCR in the liver of rats 
fed either the wtBV or the rBV-VP60 feed additive (n = 3). 
 
 
Correlation of expression values between microarray and real-time RT-PCR 
measurements was high (r = 0.72) and significant (p-value= 0.0004, see Figure 15) with 
a confidence interval (95 %) of 0.40 – 0.88. 
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Figure 15: Correlation between expression 
values measured with real-time RT-PCR and 
microarray technology. Measurements of both 
groups (wtBV and rBV-VP60) and of tissues 
spleen and liver are included and comprise the 
following genes: Ela1: elastase 1, pancreatic; 
Pla2g1b: phospholipase A2, group IB; Pnlip: 
pancreatic lipase; Ctrb1: Chymotrypsinogen B1; 
Cpa1: carboxy-peptidase A1; Add2: adducin 2 
(beta); Rara: retinoic acid receptor, alpha; 
Cebpb: CCAAT/enhancer binding protein 
(C/EBP), beta; Gp5: glycoprotein 5, platelet; F3: 
coagulation factor III. 
 
 
 
 
Table 21: Selected differentially expressed genes identified by microarray technology in rats fed rBV-
VP60 compared to rats fed wtBV  
Tissue Gene Fold change q-value 
Pnlip -1.10 0.03 
Pla2g1b -1.11 0.05 
Ctrb -0.67 0.05 
Cpa1 -0.77 0.05 
Ela1 -1.07 0.00 
Add2 0.78 0.03 
Gp5 -0.94 0.05 
Spleen 
F3 -0.61 0.03 
Rara -0.61 0.04 
Liver 
Cebp -0.71 0.03 
 
 
4.3 Characterization of physiological effects of genetically modified potatoes 
in rats using expression profiling  
The aim of the present part of the study was to characterize the potential physiological 
effects of two specific feed components on the animal organism by means of expression 
profiling. The components consisted of two different genetically modified potato lines 
(rAlb-VP60 and rAlb-nptII). For this purpose a feeding experiment with laboratory rats 
was carried out and a comparative gene expression study using a “rat 10k oligo array” 
was conducted. This technology was shown to be useful for detecting diet-related 
physiological changes in rats in 4.1. Expression was studied in the spleen, the liver and 
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in small intestine epithelium of rats which ingested the genetically modified material.  
For defining significant expression differences between the two feeding groups, a q-value 
of  0.05 was accepted according to results of 4.1.2. Moreover, a fold change filter was 
applied and set to FC  1.5 since the histograms of the fold change distribution had 
shown a very low occurrence of high FCs (see Figure 23A+B and Figure 24, appendix). 
 
4.3.1 Comparative expression analyses in the spleen, the liver and in small 
 intestine epithelium of rats fed recombinant rAlb-VP60 potatoes  
rAlb-VP60 was one of the transgenic potatoes that were studied regarding their influence 
on animals’ expression profile and therewith on physiology. Expression profiles of the 
rAlb-VP60 fed rats were then compared to profiles of animals that were given the non-
transgenic near-isogenic line of these potatoes (wtAlb). rAlb-VP60 line expresses VP60 
(capsid protein of RHD virus, which is able to induce immunity) and CtxB (Cholera toxin 
subunit B, which is known to have adjuvant activity). Additionally nptII, a marker gene 
used for plant selection (nptII confers resistance to antibiotics e.g. canamycin), is 
produced. Effects on physiology of the animals which ingested this feed component can 
possibly be caused by altered composition or nutrient value of the potatoes due to 
transgenesis or may occur due to a potential bioactivity of the “foreign” genes.  
 
4.3.1.1 Identification of differentially expressed genes in rats fed rAlb-VP60 
potatoes 
From the microarray analysis 7021 (spleen), 8058 (liver) and 8398 (small intestine 
epithelium) evaluable signals were obtained (total probes/genes on array: 9802). These 
signals had passed quality filtering and could be included in further statistical analysis 
(see Figure 16A).  
Microarray analysis revealed a significantly altered gene expression pattern between rats 
fed rAlb-VP60 and rats fed wtAlb. Distinct changes were observed in the spleen and in 
small intestine epithelium whereas only minor changes were found in the liver. The 
number of significant differentially expressed genes varied widely between the tissues. In 
the spleen 117 genes succeeded the significance criteria (see Figure 16B). 30 genes 
showed an elevated transcript level and 87 genes were down-regulated in rAlb-VP60 
group in comparison to wtAlb group. In the liver two genes showed significant expression 
differences; one gene was up-regulated and one gene was down-regulated. In small 
intestine epithelium 27 DEGs were found, whereof 13 genes had an increased and 14 a 
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decreased level expression (see appendix Table 30, Table 31 and Table 32: list of all 
differentially expressed genes). 
 
        
Figure 16(A+B): A: Number of genes on the microarray and number of genes included in statistical 
analysis. B: number of differentially expressed genes which had a q  0.05 and passed an additional 
FC filter of  1.5. Data is referring to the comparative gene expression profiling in different tissues of 
rats fed the rAlb-VP60 compared to rats fed the wtAlb potato. 
 
4.3.1.2 Identification of biological processes with a significant enrichment of 
differentially expressed genes in rats fed rAlb-VP60 potatoes 
As reported in 4.3.1.1, gene expression in the spleen and in small intestine epithelium 
differed significantly between the two feeding groups rAlb-VP60 and wtAlb. DEGs from 
these tissues were used for further identification of diet-affected biological processes. 
The amount of only two DEGs as observed in the liver does not meet the requirements of 
statistical analysis for identifying GO annotation-based physiological effects. These 
genes were therefore excluded from further analysis. A GO annotation was available for 
67 of the 117 DEGs in the spleen. Out of 27 DEGs found in small intestine epithelium 
nine could be annotated based on the GO database.  
In the spleen the GM diet had a significant impact on rats’ physiology. An over-
representation of DEGs in several biological processes was demonstrated by means of 
an EASE score ( 0.05, see Table 22). For condensed illustration in figures, several 
biological processes shown in Table 22 were abstracted because they are represented 
by the same genes and are functionally very closely related. In the following “lipid 
catabolism” embodies genes playing a role in “lipid catabolism” and “membrane lipid 
catabolism”. The term “pigment/porphyrin metabolism” summarizes genes of 
“porphyrin biosynthesis”, “pigment biosynthesis”, “heme metabolism”, “porphyrin 
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metabolism”, “pigment metabolism” and “pigmentation”. “Macromolecule catabolism” as 
well as “proteolysis and peptidolysis” associated genes are included in “protein 
catabolism”. Genes of GO process “catabolism” are also represented by the terms “lipid 
catabolism” and “protein catabolism”. This process was therefore not separately 
displayed as figure. 
As shown in Figure 17(A, B, D, E)), the application of rAlb-VP60 diet caused mainly a 
significant down-regulation of genes associated with ”developmental processes”, “protein 
catabolism”, “digestion” and “lipid catabolism” in the spleen of rats. In contrast, a diet-
associated up-regulation of gene expression was mainly to be found in genes related to 
“pigment/porphyrin metabolism” (see Figure 17C). Genes playing a role in 
“developmental processes” showed primarily a reduced transcription level in the rAlb-
VP60 feeding group, though up-regulation of some molecules was observed.  
In small intestine epithelium only minor but nevertheless significant diet-related changes 
were observed. rAlb-VP60 feeding led to a down-regulation of two genes playing a role in 
“acute phase response” (see Table 23). 
 
Table 22: Biological processes exhibiting significantly increased numbers of differentially expressed 
genes, as revealed by microarray technology. Different expression refers to the spleen of rats fed rAlb-
VP60 potatoes in comparison with wtAlb group. Significance of expression changes was assumed for 
q  0.05 and a FC  1.5 was accepted. Significant over-representation of differentially expressed 
genes in biological processes was defined by means of an EASE Score  0.05. 
Number of differentially expressed GO 
annotated genes 
Spleen 
Biological process  
(GO term) 
Number of GO 
annotated genes 
in process n1 ES2 
Lipid catabolism 31 7 0.00 
Digestion 13 5 0.00 
Catabolism 253 17 0.00 
Protein catabolism 168 10 0.02 
Proteolysis and peptidolysis 164 10 0.01 
Macromolecule catabolism 171 10 0.02 
Development 402 17 0.02 
Heme biosynthesis 5 3 0.01 
Membrane lipid catabolism 5 3 0.01 
Pigment biosynthesis 6 3 0.01 
Porphyrin biosynthesis 6 3 0.01 
Heme metabolism 7 3 0.01 
Porphyrin metabolism 8 3 0.01 
Pigment metabolism 9 3 0.02 
Pigmentation 9 3 0.02 
All 2781 67  
1 n = number of differentially expressed genes in process 
2 ES = calculated EASE Score based on modified Fishers exact test; significance is assigned at ES  0.05 
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Figure 17(A-E): Regulation of differentially expressed genes, involved in several diet-affected 
biological processes (GO annotation) as revealed by microarray technology. Different expression 
refers to the spleen of rats fed rAlb-VP60 potatoes in comparison to wtAlb group. (Abbreviations: 
Chrd: chordin; Pou3f3: POU domain, class 3, transcription factor 3; Rara: retinoic acid receptor, alpha; 
Lgl1: cysteine-rich secretory protein LCCL domain containing 2; Add2: adducin 2 (beta); Cebpa: 
CCAAT/enhancer binding protein (C/EBP), alpha; Cacna1a: calcium channel alpha 1A; Sox10: SRY-
box containing gene 10; Flt1: FMS-like tyrosine kinase 1; Limk1: LIM domain kinase 1; Dcamkl1: 
doublecortin-like kinase 1; Csx: NK2 transcription factor related, locus 5; Adora1: adenosine A1 
receptor; Fut9: ucosyltransferase 9; Urod: uroporphyrinogen decarboxylase; Usp22: ubiquitin specific 
peptidase 22; Cpb1: carboxypeptidase B1; Cpa1: carboxypeptidase A1; Ela1: elastase 1, pancreatic; 
Ela2: elastase 2A; Ctrl: chymotrypsin-like; Ctrb1: chymotrypsinogen B1; Prss1: protease, serine, 1 
(trypsin 1); preprotryps. IV: preprotrypsinogen IV; cationic tryps.: cationic trypsinogen; Alad: 
aminolevulinate, delta-, dehydratase; Hmbs: hydroxymethylbilane synthase; Clps: colipase, 
pancreatic; Pnlip: pancreatic lipase; Pnliprp1: pancreatic lipase related protein 1; Pnliprp2: pancreatic 
lipase related protein 2; Cel: carboxyl ester lipase; Pla2g1b: phospholipase A2, group IB; Plcb2: 
phospholipase C, beta 2). 
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Table 23: Biological process exhibiting significantly increased number of differentially expressed 
genes, as revealed by microarray technology. Different expression refers to small intestine epithelium 
of rats fed rAlb-VP60 potatoes in comparison to wtAlb group. For defining significant gene expression 
changes, a q of  0.05 and a FC  1.5 was accepted. Significant over-representation of differentially 
expressed genes in biological processes was defined by means of an EASE Score  0.05. 
Number of differentially expressed GO 
annotated genes 
Small intestine epithelium 
Biological process  
(GO term 
Number of GO 
annotated genes in 
process n1 ES2 
Acute phase response 15 2 0.04 
All 3366 9  
1 n = number of differentially expressed genes in process 
2 ES = calculated EASE Score based on modified Fishers’ exact test; significance is assigned at ES  0.05 
 
 
4.3.1.3 Quantitative gene expression analysis of selected genes using real-time 
RT-PCR 
Eight DEGs found in the spleen (see Figure 17A-D and Table 30) and one DEG found in 
small intestine epithelium (see Table 32), representing significant biological processes as 
described in 4.3.1.2, were selected. Transcript levels were determined using real-time 
RT-PCR in order to underline results of the microarray study. Results are shown in 
Figure 18(A-I).  
In agreement with microarray results, two genes playing a role in “lipid catabolism” 
(Pla2g1b, Pnlip) and three genes, which are associated with “protein catabolism” (Cpa1, 
Ela1 and Ctrb1, that is also associated with “digestion”), showed a significant (p  0.05) 
down-regulation in rAlb-VP60 feeding group. The biological GO process “development” 
was represented by the molecules Rara and Flt1 which equally exhibited a significant 
down-regulation and thus confirmed microarray results. Alad (“pigment/porphyrin 
metabolism”; “development”) revealed a significantly increased expression level in real-
time RT-PCR analysis as well as in microarray examination. Expression of Pap1, an 
“acute phase response” related gene, was reduced in small intestine epithelium of rAlb-
VP60 feeding group. Significant differences were demonstrated with real-time RT-PCR 
and with microarray technology. 
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Figure 18 (A-I): Transcript level of selected genes (A: pancreatic lipase; B: phospholipase A2, group 
IB; C: carboxypeptidase A1; D: elastase 1, pancreatic; E: Chymotrypsinogen B1; F: aminolevulinate, 
delta-, dehydratase; G: retinoic acid receptor, alpha; H: FMS-like tyrosine kinase 1; I: pancreatitis-
associated protein) measured via real-time RT-PCR in the spleen (A-H) and in small intestine 
epithelium (I) of rats fed either wtAlb or rAlb-VP60 potatoes (n = 3). 
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4.3.2 Comparative expression analysis in the spleen, the liver and in small 
 intestine epithelium of rats fed rAlb-nptII potatoes 
In a further experiment, the physiological effects of feeding recombinant rAlb-nptII 
potatoes were investigated. Expression profiles were compared to the corresponding 
control group that was given the near-isogenic non-GM potatoes (wtAlb). The transgenic 
tubers fed in this experiment were only expressing the nptII marker gene, but no VP60, 
CtxB or any other additional molecules. This marker is solely used for selecting plants 
that have successfully integrated the “foreign” DNA sequence of interest. It has no 
intended trait-improving effect on the plant. By investigating physiological effects of these 
potatoes it was intended to be able to identify effects that are caused due nptII gene 
insertion. The NPTII protein has no known bioactivity but its integration into the plant 
genome can possibly lead to an unexpectedly altered plant composition or nutritional 
value. Likewise to 4.3.1 this transgenic potato was fed to rats and gene expression was 
studied in the tissues spleen, liver and in small intestine epithelium. 
 
4.3.2.1 Identification of differentially expressed genes in rats fed rAlb-nptII 
potatoes 
The microarray investigations revealed 6707 (spleen), 6083 (liver) and 5959 (small 
intestine epithelium) signals, respectively that passed quality checking and could be 
further analyzed (see Figure 19A). Low quality signals (see 4.1.1) were not included in 
advanced data evaluation.  
        
Figure 19(A+B): A: Number of genes on the microarray and number of genes included in statistical 
analysis. B: number of differentially expressed genes which had a q-value  0.05 and passed an 
additional FC filter of  1.5. Data is referring to the comparative gene expression profiling in different 
tissues of rats fed rAlb-nptII compared to rats fed wtAlb potato. 
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Only in the liver significant effects of rAlb-nptII feeding on gene expression in rats were 
observed. 205 genes were differentially expressed when compared to the expression 
level of wtAlb fed rats (see Figure 19B). 127 of these molecules had a higher transcript 
level in rAlb-nptII fed animals compared to the wtAlb group. 78 genes were down-
regulated after rAlb-nptII feeding (see appendix Table 33: list of all differentially 
expressed genes in the liver). In the spleen and in small intestine epithelium no gene 
showed significant expression differences between the two feeding groups. 
 
4.3.2.2 Identification of biological processes with a significant enrichment of 
differentially expressed genes in rats fed rAlb-nptII potatoes 
For an identification of diet-affected biological processes DEGs found in the liver could 
be used because the remaining tissues did not exhibit significant effects. 123 out of the 
205 DEGs could be GO annotated and thus be included in the further analysis.  
By means of a GO analysis several biological processes with a significant enrichment of 
DEGs were identified. Feeding of rAlb-nptII potatoes led to significant changes in 
expression level of genes involved in “electron transport”, “lipid metabolism” and several 
“monosaccharide” and “alcohol metabolism”-related processes (see Table 24) in 
comparison to wtAlb potato feeding. “Monosaccharide biosynthesis”, “gluconeogenesis”, 
“hexose biosynthesis”, “alcohol biosynthesis” and “alcohol metabolism” will be referred to 
as “alcohol/monosaccharide metabolism” in that they are functionally very closely 
related according to the GO annotation structure and comprise the same genes. 
 
Table 24: Biological processes exhibiting significantly increased numbers of differentially expressed 
genes, as revealed by microarray technology. Different expression refers to the liver of rats fed rAlb-
nptII potatoes in comparison to wtAlb group. For defining significant gene expression changes a q-
value of  0.05 and a FC  1.5 was accepted. Significant over-representation of differentially 
expressed genes in biological processes was defined by means of an EASE Score  0.05. 
Number of differentially expressed GO 
annotated genes 
Liver 
Biological process  
(GO term 
Number of GO 
annotated genes 
in process n1 ES2 
Electron transport 116 16 0.00 
Lipid metabolism 174 16 0.02 
Monosaccharide biosynthesis 5 3 0.02 
Gluconeogenesis 5 3 0.02 
Hexose biosynthesis 5 3 0.02 
Alcohol biosynthesis 5 3 0.02 
Alcohol metabolism 88 9 0.05 
All 2570 123  
1 n = number of differentially expressed genes in process 
2 ES = calculated EASE Score based on modified Fishers´ exact test; significance is assigned at ES  0.05 
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As shown in Figure 20(A-C) nearly all genes, involved in “electron transport”, 
“alcohol/monosaccharide metabolism” as well as “lipid metabolism”, exhibited an up-
regulation of gene expression in the rAlb-nptII group in comparison to the wtAlb group. 
Only few genes showed a down-regulation. 
 
       
 
 
 
 
Figure 20(A-C): Regulation of differentially 
expressed genes involved in several diet-affected 
biological processes (GO annotation), as revealed 
by microarray technology. Different expression 
refers to the liver of rats fed rAlb-nptII potatoes in 
comparison to wtAlb group. (Abbreviations: Sardh: 
sarcosine dehydrogenase; CYP3A11: cytochrome 
P450, family 3, subfamily a, polypeptide 11; Cyp27: 
cytochrome P450, family 27, subfamily a, 
polypeptide 1; Cyp2f1: cytochrome P450, family 2, 
subfamily f, polypeptide 4; Cyba: cytochrome b-245, 
alpha polypeptide; Gulo: gulonolactone (L-) 
oxidase; Acads: acyl-Coenzyme A dehydrogenase, 
short chain; Egfr: epidermal growth factor receptor; 
Mipp65: NADH dehydrogenase (ubiquinone) 
flavoprotein 3-like; Ptgis: prostaglandin I2 
(prostacyclin) synthase; Grp58: protein disulfide isomerase associated 3; Nr1h3: nuclear receptor 
subfamily 1, group H, member 3; Txn2: thioredoxin 2; Acox2: acyl-Coenzyme A oxidase 2, branched 
chain; Cyp4b1: cytochrome P450, family 4, subfamily b, polypeptide 1; Cat: catalase; Aldoa: aldolase 
A; Fbp1: fructose-1,6- biphosphatase 1; Pc: pyruvate carboxylase; Sord: sorbitol dehydrogenase; 
Prkaa2: protein kinase, AMP-activated, alpha 2 catalytic subunit; Tpi1: triosephosphate isomerase 1; 
G6pt1: solute carrier family 37 (glucose-6-phosphate transporter), member 4; Khk: ketohexokinase; 
Gyk: glycerol kinase; Pemt: phosphatidylethanolamine N-methyltransferase; Hsd17b2: hydroxysteroid 
(17-beta) dehydrogenase 2; Psap: prosaposin; Hnf4a: hepatic nuclear factor 4, alpha; Plcb2: 
phospholipase C, beta 2; Prdx6: peroxiredoxin 6; Echs1: enoyl Coenzyme A hydratase, short chain, 1, 
mitochondrial; Dri42: phosphatidic acid phosphatase type 2B; Hsd17b4: hydroxysteroid (17-beta) 
dehydrogenase 4). 
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4.3.2.3 Quantitative gene expression analysis of selected molecules using real-
time RT-PCR 
In addition to the microarray investigations, real-time RT-PCR was used to determine 
transcription levels of six selected molecules in the liver of rats fed rAlb-nptII or wtAlb 
potatoes. For these molecules a significant expression change was observed in 
microarray analysis (see Figure 20A-C or Table 33) and they are known to be involved in 
the biological processes “electron transport” (Acox2), “lipid metabolism” (Pemt, Hsd17b2, 
Prkaa2) and “alcohol/monosaccharide metabolism” (Fbp1, Pc, Prkaa2). These processes 
were identified as being diet-affected in 4.3.2.2. Transcript levels detected via real-time 
RT-PCR were partly consistent with microarray results (see Figure 21). A significant (p  
0.05) increase of expression levels in rAlb-nptII fed rats was shown for the molecules 
Acox2 and Hsd17b2.  
 
 
Figure 21(A-F): Transcript level of selected genes (A: acyl-Coenzyme A oxidase 2, branched chain; B: 
phosphatidylethanolamine N-methyltransferase; C: hydroxysteroid (17-beta) dehydrogenase 2; D: 
protein kinase, AMP-activated, alpha 2 catalytic subunit; E: fructose-1,6- biphosphatase 1; F: Pyruvate 
carboxylase) measured via real-time RT-PCR in liver of rats fed rAlb-nptII or wtAlb potatoes (n = 3). 
RESULTS 
 
71
For the four remaining genes Pemt, Prkaa2, Fbp1 and PC no significant expression 
changes between the two feeding groups were observed, although this was shown using 
microarray technology. 
 
4.4 Comparative analysis of physiological effects observed in rats fed rBV-
VP60 and in rats fed rAlb-VP60 components 
Results (i.e. lists of DEGs) obtained from comparative expression profiling in different 
tissues of rats fed the VP60 potatoes (rAlb-VP60 vs. wtAlb) were compared with DEGs 
identified in the experiment with rats fed VP60 baculovirus additive (rBV-VP60 vs. wtBV). 
Both investigations (4.3 and 4.1.2.3) had revealed physiological changes due to a 
feeding of the particular transgenic dietary component. Though, an interpretation of the 
results of rAlb-VP60 experiment remained difficult because it could not be concluded 
whether the observed effects were due to the foreign genes (VP60/CtxB/nptII) or due to 
compositional alterations or changes in the nutritional value of the potatoes. Thus, a 
cross-comparison of DEGs and significantly affected biological processes identified in 
the two experiments should facilitate a further interpretation of the findings. The only 
concordant feed component given to the rats in both feeding trials (rBV-VP60 and rAlb-
VP60) was the VP60 molecule. VP60 was expressed by the potato tubers as well as by 
the baculovirus expression system. Consequently, coinciding findings might be attributed 
to the bioactive or immunogenic properties of VP60. 
 
In the spleen the transcript levels of 13 molecules were found to be significantly affected 
by feeding rAlb-VP60 as well as by feeding rBV-VP60 (see Figure 22). These genes 
showed a down-regulation in both groups (rAlb-VP60 and rBV-VP60) when comparing 
them to the corresponding control group (wtAlb and wtBV); though the effects observed 
in the rAlb-VP60 group were generally stronger. Functionally these genes are mainly 
associated with “lipid catabolism” (Clps, Pnlip, Pnliprp1, Pnliprp2, Pla2g1b) and “protein 
catabolism” (Cpb1, Ctrb1, Cpa1, Ela1, Ela2, Ctrl). Consequently in both investigations 
“lipid catabolism” had a significant enrichment of DEGs and was identified as being 
affected by the GM diets (rAlb-VP60 and rBV-VP60). “Protein catabolism” did show a 
significant over-representation of DEGs in rats fed the rAlb-VP60 potatoes but not in rBV-
VP60 group, although genes associated with this process were congruently down-
regulated (Figure 22). Further agreements of results from the tissues liver or small 
intestine epithelium were not detected. 
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Figure 22: Regulation of significantly differentially expressed genes identified in the spleen of rats fed 
rAlb-VP60 (test group) potatoes as well as in the spleen of rats fed rBV-VP60 (test group). Difference 
in gene expression refers to a comparison with the corresponding non-GM control group (wtAlb or 
wtBV). 
 
4.5 Comparative analysis of physiological effects observed in rats fed rAlb-
VP60 and in rats fed rAlb-nptII components 
A further cross-comparison of DEGs identified in the liver of animals fed rAlb-VP60 
(experiment: rAlb-VP60 vs. wtAlb) and animals fed rAlb-nptII (experiment: rAlb-nptII vs. 
wtAlb) did not reveal any consistent results. In this case the coincident component was 
the nptII gene which was expressed in rAlb-VP60 as well as in rAlb-nptII potatoes.  
 
4.6 Comparison of diet-affected biological processes identified with either 
individual gene analysis or gene set analysis 
Commonly a two-step approach is used to identify treatment-affected processes. First, 
expression measurements between two groups are compared. Lists of altered genes are 
defined from significance or cut-off thresholds (IGA: individual gene analysis); as it was 
done in foregoing presented results. In a second step, these DEG lists are then 
compared to biologically defined gene sets (e.g. GO processes) and an enrichment of 
DEGs in specific processes is assessed. The strong dependency of such approaches on 
threshold parameter-settings has been demonstrated in 4.1.2. Thus, part of the data was 
re-analyzed with a more recently suggested analysis method (PAGE algorithm) which 
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belongs to the “gene set analysis” (GSA) approaches. IGA and GSA results were 
compared. The term GSA summarizes several methods which also focus on gene sets 
but use for instance ranked FCs or q-values of all genes analyzed, without limitation to 
threshold-based lists. For small sample sizes of less than five, the use of fold changes 
rather than t-statistics or other parameters is recommended. Consequently, the entire 
lists of fold changes were used as measurement of expression difference between the 
GM (rAlb-VP60 or rAlb-nptII) and the non-GM (wtAlb) feeding group and explored in 
GAZER (GSA-tool). 
 
Table 25: Comparison of significant biological processes (GO) identified with either individual gene 
analysis (IGA) or with gene set analysis (GSA) in the spleen and in small intestine epithelium of rats 
fed rAlb-VP60 potatoes compared to rats fed wtAlb. X refers to significance (q  0.05) of the process. 
Tissue Significant biological processes IGA GSA 
Lipid catabolism X X 
Digestion X X 
Protein catabolism X  
Pigment/porphyrin metabolism X  
Development X  
Spleen 
Lymph gland development  X 
Acute phase response X  
Protein biosynthesis  X 
Ribosome biogenesis  X 
Ubiquitin-dependent prot. Catab./ Ubiquitin cycle  X 
RNA processing  X 
Small intestine 
epithelium 
DNA replication  X 
 
 
Re-analyzing expression data from the spleen and from small intestine epithelium using 
GSA revealed a significant effect of the rAlb-VP60 diet on several biological processes 
(see Table 25). In the spleen “lipid catabolism”, “digestion” and “lymph gland 
development” exhibited a significant enrichment of up- or down-regulated genes. These 
results are partly in agreement with results from IGA analysis. Processes “lipid 
catabolism” and “digestion” exhibit significance in both analysis approaches. 
Nevertheless some categories e.g. “protein catabolism” and “pigment/porphyrin 
metabolism” or “lymph gland development” did not coincide. In small intestine epithelium 
no consistency between the results of both analyses was observed. With the IGA 
approach, only “acute phase response” revealed a diet effect whereas with GSA analysis 
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“protein biosynthesis”, “ribosome biogenesis”, “ubiquitin related processes”, “RNA 
processing”  and “DNA replication” were identified. 
In a comparative gene expression study in the liver of rats fed rAlb-nptII and wtAlb only 
“lipid biosynthesis” was identified as diet-affected when using GSA (see Table 26). In 
contrast IGA approach had shown effects in “electron transport”, “alcohol/ 
monosaccharide metabolism” and “lipid metabolism”. However, some consistency can be 
concluded in that “lipid metabolism” and “lipid biosynthesis” are closely related and 
comprise to some extent the same molecules. 
 
Table 26: Comparison of significant biological processes (GO) identified with either individual gene 
analysis (IGA) or with gene set analysis (GSA) in the liver of rats fed rAlb-nptII potatoes compared to 
rats fed wtAlb. X refers to significance (q  0.05) of the process. 
Tissue Significant biological processes IGA GSA 
Lipid metabolism X  
Lipid biosynthesis  X 
Electron transport X  
Liver 
Alcohol/monosaccharide metabolism X  
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5 DISCUSSION 
The present study was conducted to evaluate the sensitivity and adequacy of expression 
profiling for the characterization of potential physiological side effects of genetically 
modified (GM) feed components. The application of this method for studying such effects 
of GM feeds in animal feeding trials could be promising since sensitivity of conventional 
methods has been criticized recently. Within the scope of this work, effects of several 
specific GM components on rats’ physiology were investigated. For this purpose feeding 
experiments with laboratory rats were conducted and a comparative expression profiling 
was done using microarray technology in the tissues liver, spleen and in small intestine 
epithelium. The GM feed components consisted either of recombinant potatoes with the 
inserted genes VP60, CtxB and nptII (rAlb-VP60) or of recombinant potatoes that had 
introduced only the nptII gene (rAlb-nptII). Expression profiles of animals fed these 
potatoes were compared to profiles of rats fed the corresponding non-transgenic near-
isogenic potatoes (wtAlb). In order to identify VP60-specific effects, expression was also 
investigated after feeding an additive of inactivated, recombinant baculovirus with the 
inserted gene VP60 (rBV-VP60). The profiles were then compared to rats fed the 
corresponding additive consisting of wildtype baculovirus (wtBV). Based on the identified 
differentially expressed genes (DEG) and on their gene ontology (GO) annotation, 
biological processes with a significantly enrichment of associated DEGs were identified 
in order to characterize physiological alterations in response to these specific GM feeds 
and GM feed additives. 
 
5.1 Application of different analysis parameter settings in microarray 
experiments conducted for the identification of diet effects  
As a pre-requisite for reliable results and interpretation of microarray investigations, data 
pre-processing steps as well as different thresholds for defining gene expression 
differences were evaluated regarding their appropriateness for the present study. This 
pre-study was based on the feeding experiment with the rBV-VP60 and its corresponding 
wildtype (wtBV) additive. 
 
Data pre-processing and normalization 
Generally, a considerable proportion of typical microarray data sets is composed of 
signals with low intensities that cause variability or impair of reproducibility due to their 
low transcript levels. These signals may be masked or biased by noise and non-specific 
DISCUSSION 
 
76
hybridization, respectively (BILBAN et al., 2002). In the present study analogue findings, 
namely strong noise at low intensity levels, emphasized the need for removing data with 
a low signal to noise ratio. The applied quality filtering eliminated most of the potentially 
unreliable signals. Such filtering has been discussed in literature and is often applied 
(EPSTEIN et al., 2001; LEUNG & CAVALIERI, 2003; CAUSTON et al., 2003). In 
contrast, GAO et al. (2003) point out that weak signals do contain valuable information 
and should be kept for further analysis. Thus, by correcting for noise, a loss of 
information is always accepted. Nevertheless, DRAGHICI et al. (2006) state that today’s 
technology might still be insufficient to detect relevant changes in low abundance genes, 
such as transcription factors.  
However, quality filtering does not adjust for a bias which occurs in two-color 
approaches. Normalization procedures are applied to correct for a dye bias due to 
differences related to incorporation and detection of the two dyes. Out of the five 
algorithms tested in this work, only lowess normalization did adjust satisfactorily, not only 
for general dye bias, but also for intensity-dependant dye differences and thus seemed to 
be the most appropriate. The use of the lowess algorithm has been proposed by various 
authors as for instance by QUACKENBUSH (2002) or YANG et al. (2002a). 
Nevertheless, there has also been criticism. According to SANCHEZ-CABO et al. (2003) 
lowess is not suitable for “low-density” microarray experiments though this is kind of 
consequential because lowess, like other normalization methods as well, is based on the 
assumption that most of the genes do no differ in their expression between the 
experimental groups. Besides, the authors report a poor reproducibility of replicated 
measurements after lowess correction and propose the use of self normalization. 
However, within the range of given design options and accessible analysis software tools 
and therewith the available normalization algorithms, lowess still performed best for the 
data used within this work. 
 
Effect of threshold choice on the number of differentially expressed genes and on 
the biological processes with a significant enrichment of DEGs 
The application of varying thresholds for defining significant gene expression differences 
was evaluated as a further parameter. The identification of differentially expressed genes 
is a crucial step in microarray data analysis as it determines strongly the following 
biological interpretation. In the data used within this study, the application of solely a t-
test with an assumed significance at a p  0.05 led to high false positive rates. This is 
due to the large amount of tests carried out in such microarray analyses. Between 17 % 
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and 26 % expected false positives were observed among the significant differentially 
expressed genes. It became clear that a correction for multiple testing was essential. 
There is consensus about the use of a False Discovery Rate (FDR) correction as an 
alternative to conventional correction approaches for multiple-testing (ALLISON et al., 
2006). However, the decision about the stringency of the threshold, above which gene 
expression of two groups is defined as significantly different, is left of course to the 
scientist. A threshold of q  0.05 (FDR  5 %) is commonly used and suggested for 
instance by authors of the EADGENE network (JAFRÈZIC et al., 2007). Nevertheless, in 
some studies less stringent q-values of  0.1 or  0.2 were applied (RUIZ-
BALLESTEROS et al., 2005; ZHU et al., 2005; PONSUKSILI et al. 2007).  
Referring to the present investigations the use of varying thresholds (q  0.05 / 0.1 / 0.2) 
indicated a strong impact of threshold choice on the number of identified DEGs and thus 
on the biological conclusion drawn from the experiment. The application of a FDR 
correction and the use of a threshold of q  0.05 reduced the number of DEGs in 
comparison to the DEG list obtained without FDR correction (p  0.05). 95 % of genes 
remained significant in the liver despite this stringent q-value threshold. In small intestine 
epithelium only 1 % of the genes exceeded the FDR threshold. This diversity is attributed 
to a different distribution of p-values in these tissues. A high occurrence of small p-
values, as observed in the liver, results in a higher number of genes with q-values below 
the threshold. In small intestine epithelium in contrast, a lesser amount of small p-values 
was found. Consequently, the estimated fraction of truly nulls (not differentially 
expressed) - the key parameter that determines FDR characteristics - was higher 
(PAWITAN et al., 2005). As a result, very few genes with small q-values arose. When 
applying lower stringencies (q  0.1 or 0.2), increased numbers of DEGs were found. 
They were exceeding in most cases the amount of DEGs after t-test without FDR 
correction. Nevertheless, is has to be kept in mind that a q  0.2 means that the 
expected rate of false positives among the DEGs is raised to 20 %.  
 
DEG lists, as determined by different threshold levels, were used for the identification of 
significantly diet-affected biological processes. A biological process was regarded as 
being influenced by the diet when a significant enrichment of associated DEGs was 
demonstrated. It was shown that the size of the DEG input list considerably influenced 
the output. Increased proportions of expected false positives due to less stringent 
thresholds led to varying results with respect to the enriched biological processes. For 
instance, in the liver the pattern of significant biological processes changed completely 
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when raising the q-value threshold applied to the DEG list from q  0.05 to q  0.1. No 
overlapping processes were found. Moreover, the relationship between threshold choice 
and significance of the processes did neither seem to be linear nor predictable. This 
effect may be due to the possible non-linearity of the ratio between the total number of 
identified DEGs and the number of DEGs belonging to a specific process. PAN et al. 
(2005) showed similar effects in their study. Their work was related to the identification of 
DEGs that comprise “gene sets” which are then associated with tumor types and 
functional categories. With varying thresholds they produced gene sets of different sizes 
and exhibited strong effects on the identification of functional categories. 
These results emphasize that caution that has to be taken when choosing the threshold 
as it strongly influences the biological conclusion. The general aim of gene selection is 
clearly to identify a list of DEGs as accurately as possible (CHEN et al., 2007b). 
Nevertheless, choice of threshold stringency should depend on the objective of the 
experiment (CHEN et al., 2007a). An optimal threshold that at the same time minimizes 
both false positives and false negatives does not exist. Threshold choice will always be a 
compromise. When intending to select few candidate genes for instance, procedures 
with few false positives might be desirable. For pathway analysis a certain size of DEG 
list is requisite. Thus, more relaxed parameters, at the prices of higher a FDR, could 
possibly be applied. 
For the data used within this work it was concluded that a FDR threshold of q  0.05 was 
most appropriate because it was aimed for a high reliability of the results. The fact that 
only few replicates (n = 3) were available supported this decision. WEI et al. (2004) 
pointed out that a small number of replicates, resulting in low statistical power for 
detecting differentially expressed genes, may produce high false positive rates. The 
application of less stringent thresholds (q  0.1 / 0.2) and consequently higher numbers 
of expected false positives might be more suitable for experimental designs that allow a 
higher statistical power.  
 
As an additional criterion to define DEGs the application of a fold change (FC) filter was 
tested in combination with a q-value ranking. According to ALLISON et al. (2006), fold 
differences are a reasonable measure of effect size. In the history of microarray studies 
they were the first method used to evaluate whether genes differed in their expression 
level. Today it is common to apply fold change (FC) filters to a gene list that has passed 
the p-value or q-value thresholds and use this approach for DEG identification; as it was 
suggested by the Microarray Quality Control Consortium (MAQC Consortium, 2006). SHI 
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et al. (2004) mentioned that gene lists obtained by fold change ranking performed well 
since they found a large overlap when comparing data produced with different microarray 
platforms. They argue that this overlap was reasonable a surrogate for assessing the 
accuracy of microarray data. According to CHEN et al. (2007a) fold change rankings for 
producing gene lists provide better ranking than t-statistics when the sample size is 
small. GUO et al. (2006) also showed a higher reproducibility of results generated by fold 
change ranking than those obtained by t-test. Nevertheless, using solely a FC is not 
advisable, as it does not account for variance (MURPHY et al., 2002; CHEN et al., 
2007a). The choice of applicable filter stringencies is again left to the investigator, but 
according to QUACKENBUSH et al. (2001) most studies have used a cut-off of two-fold 
increase or decrease in measured expression level. Nevertheless, fold differences of 1.3 
(BOOTH et al., 2004) and 1.5 (HAN et al., 2006) can also be found in literature.  
Therefore, the effect of different FC filters (without, FC  1.5 and FC  2.0) on the 
number of identified DEGs and ultimately on significantly affected biological processes, 
was studied as an additional parameter. The combined application of a q  0.05 and a 
fold change thresholds (FC  1.5, FC  2.0) in data analysis did significantly reduce the 
number of DEGs in all tissues in comparison to the DEG lists obtained without FC filter.  
The resulting DEG lists were used to identify diet-affected biological processes with a 
significant enrichment of associated DEGs. These analyses resulted in a similar 
conclusion as above. The use of varying fold change filters produced diverse results. 
Consistency between the information obtained at changing FC levels - when referring to 
diet-affected biological processes - was low. Nevertheless, it became clear that a FC 
filter of  2 was probably too stringent as no significant biological process was identified 
due to a low frequency of high fold changes and consequently an extremely reduced 
number of DEGs. BEN-SHAUL et al. (2005) argues that the organisms’ reaction could 
involve smaller adjustments of large gene sets, rather than extreme changes in fewer 
genes which would be disregarded by a very conservative fold change cut-off. Again, the 
decision whether to apply a fold change filter and which stringency to use, has to be 
taken in the context of the experiment. For this study a FC of  1.5 was regarded as most 
appropriate. A FC of  2 was excluded for the above mentioned reasons. Skipping a fold 
change cut-off seemed to produce high numbers of false positives as indicated by the 
large amount of DEGs that remained at all FDR levels. In studies with the aim of 
discovering “high response” genes, a higher FC filter might be more suitable. 
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5.2 Characterization of physiological effects of genetically modified feed 
components in rats 
In addition to the methodological investigation discussed in 5.1, a further aim of the study 
was to investigate unintended physiological effects of an ingestion of specific genetically 
modified potatoes in feeding experiments with rats.  
 
Physiological effects of a feeding of rAlb-VP60 potatoes 
The effect of an oral intake of the rAlb-VP60 potatoes on gene expression was studied 
and compared to a feeding of its near-isogenic non-GM potato (wtAlb). Gene expression 
profiling in rats fed the rAlb-VP60 potatoes revealed significant expression differences 
mainly in the spleen and slight changes in small intestine epithelium. Hepatic gene 
expression seemed to be un-affected by the diet. In the spleen several biological 
processes exhibited a significant enrichment of DEGs. The transcription level of genes 
associated with “lipid” (e.g. Pnlip, Pla2g1b) and “protein catabolism” (e.g. Ela1, Ctrb1, 
Cpa1) were mainly down-regulated, whereas genes of “pigment/porphyrin metabolism” 
(e.g. Alad, Urod) showed a significant up-regulation in animals fed rAlb-VP60 compared 
to wtAlb group. Expression of molecules involved in different “developmental processes” 
had both an elevated (e.g. Urod, Alad) and reduced (e.g. Flt1, Add2) expression level. In 
small intestine epithelium few genes related to acute phase response (e.g. Pap1) 
showed significant down-regulation in response to rAlb-VP60. In addition to the 
microarray measurements, transcription levels of several genes were determined using 
quantitative real-time RT-PCR. The recorded expression of the molecules Pnlip, 
Pla2g1b, Cpa1, Ctrb1, Ela1, Alad, Rara, Flt1 and Pap1, representing the different diet-
affected biological processes, correlated well with microarray results. The good 
correlation underlines the reliability and importance of the results. 
Particularly the down-regulation of genes involved in proteolysis and lipolysis indicate 
reduced catabolic activities in the spleen of rats fed the rAlb-VP60 potatoes. Molecular 
causes for these expression changes are difficult to explain. Effects on physiology of the 
animals which ingested this potato can possibly be caused by altered nutrient 
composition or nutrient value of the potatoes due to transgenesis. Such effects may 
occur as a result of genetic rearrangements, gene disruption or sequence changes as a 
consequence of the recombination event (ILSI, 2007) or could be caused by somaclonal 
variation or pleiotropic effects of the newly introduced gene (MOHAN JAIN, 2001; 
SHEPARD, 2006). Though, the potential bioactivity of the introduced genes, especially 
VP60, may also have affected rats’ physiology. 
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For coming up to the question whether an altered nutrient profile or the bioactivity of the 
introduced genes caused the observed changes some issues have to be taken into 
account. According to JANCZYK et al. (2007), who investigated nutritional parameters of 
the rAlb-VP60 and the wtAlb potatoes, most contents of crude nutrients did not differ 
between the two potato lines, though slight changes in protein content were detected 
(wtAlb: 8.12 %DM; rAlb-VP60: 7.58 %DM). Moreover, they showed that parameters 
recorded in the animals, as for instance nitrogen balance and other protein 
value/digestibility traits, remained mainly equal between the feeding groups. 
Nevertheless, contents of several amino acids (e.g. asparagine, glycine, glutamic acid, 
leucine) differed explicitly between the two lines. Besides, the digestibility quotients of 
these amino acids showed significant changes. These alterations can be implicated with 
the reported expression changes since it is known that amino acids can act as dietary 
signals and thereby influence transcription (KIMBALL & JEFFERSON, 2004). 
Expression differences in rats that were related to proteolytic processes could also point 
at physiological effects that were caused by variation in amino acid profiles or protein 
content of the GM potatoes. Alad for instance is discussed to be a critical factor for the 
inhibition of protein degradation via the proteasome (GUO et al., 1994). It was up-
regulated after rAlb-VP60 feeding and acts in this way correspondingly to the down-
regulated catabolic molecules of protein metabolism. However, only 15 % of the protein 
was offered via the potatoes and all diets were isonitrogenous. Thus it can be argued 
whether this amount is enough to cause distinctive effects. Besides, an extensive 
analysis of classical parameters was carried out by JANCZYK et al. (2007) in the same 
animals. Neither, growth, blood, serum parameters nor histopathological investigations 
revealed any diet effects. But still, a possible implication of variations in the metabolic 
profile of the potato cannot be excluded. Compositional alterations, which have possibly 
not been detected with the methods used in this work, should be considered. 
A possible involvement of the VP60/CtxB molecules in the observed expression changes 
appears comprehensible, when looking at results of small intestine epithelium where 
acute phase molecules showed a significant down-regulation in rAlb-VP60 fed rats. In 
addition, several DEGs identified in the major immune relevant organ spleen, can be 
implicated in immune processes or the preservation of normal cell function. Some 
enzymes, including pancreatic lipase (Pnlip), are known to be involved in the induction of 
macrophages to produce the pro-inflammatory cytokine TNF-alpha (JAFFRAY et al., 
2000; ORDAS et al., 2007). Besides, Pla2g1b and Ctrb1 have been associated with 
immune relevant functions (WANG et al., 1998; KOSHIKAWA et al., 1998; MANDAL et
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 al., 2001; PERRIN-COCON et al., 2004). Rara is involved in transcriptional regulation, 
but anti-apoptotic properties against oxidative stress induced apoptosis may be an 
additional function of this molecule (HEGELE et al., 2001; XU et al., 2002). In addition, 
Flt1 is suggested to be a useful marker for monocyte-macrophages in humans 
(SAWANO et al., 2001). Furthermore, FOLCH-PUY et al. (2006) speculated that Pap1 
could play a similar role to that of IL-10 in epithelial cells. However, most of these 
molecules were down-regulated and it remains unclear why the antigen VP60 or the 
adjuvant CtxB should induce a down-regulation of immune related molecules rather than 
an up-regulation.  
It should be also mentioned that a VP60 molecule was proven to induce IgG production 
when expressed in baculovirus and administered to rats via intramuscular injections. In 
contrast, when determining IgG production after an oral application of the VP60 
baculovirus or the rAlb-VP60 potato, no antibodies could be detected in a feeding study 
with rabbits (HAMMER et al., 2006). This could be explained with the biological active 
concentration of VP60 that is needed to induce an immune reaction. The amount of 
VP60 might have been too low after passing the gastrointestinal tract of the animals. In 
fact, VP60 could not be detected in the rAlb-VP60 tubers with the applied methods 
(MIKSCHOWSKY, personal communication) although expression was proven. These 
last-mentioned findings in turn argue against a VP60 involvement in the expression 
changes. Though it is not clear whether gene mRNA expression profiling might be more 
sensitive and able to detect slight responses of the organism, which are not reflected by 
a major IgG production and are consequently not sensed with ELISA techniques. 
 
Physiological effects of a feeding of rAlb-nptII potatoes 
To gain more insight into expression modifications that are most likely caused by an 
unexpected altered plant composition without interfering effects that have to be ascribed 
to the immunogenic properties of the VP60/CtxB molecules, a further GM potato was 
studied in a feeding experiment with rats. A potential bioactivity of nptII cannot be 
completely excluded but has never been proven. Moreover, FUCHS et al. (1993) and 
EFSA (2008) concluded that the ingestion of genetically engineered plants, which are 
expressing the nptII protein, do not pose safety concerns.  
Nevertheless, in the present study it was shown that a feeding of potatoes, which are 
solely expressing the nptII marker gene, did change gene expression in rats in 
comparison to wtAlb fed animals. However, in this case the liver, the most important 
organ for nutrient metabolism, was the only affected organ. A significant enrichment of 
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mostly up-regulated DEGs was observed in GO processes “electron transport”, “lipid 
metabolism” and “alcohol/monosaccharide metabolism”. Microarray results of six 
selected molecules partly correlated with findings of real-time RT-PCR measurements. A 
significant increase of expression levels in rAlb-VP60 fed rats was shown for the 
molecules Acox2 (electron transport) and Hsd17b2 (lipid metabolism). For the four 
remaining genes Pemt, Prkaa2, Fbp1 and PC, which were associated with “lipid 
metabolism” (Pemt, Prkaa2) and “alcohol/monosaccharide metabolism” (Fbp1, Pc, 
Prkaa2), no significant expression changes between the feeding groups were observed 
via real-time RT-PCR; although this was proven using microarray technology. 
Especially the up-regulation of genes associated with alcohol/monosaccharide 
metabolism, which are also involved in general energy equilibrium, and an up-regulation 
of lipid metabolism related genes indicate a higher hepatic metabolic activity in rats fed 
the rAlb-nptII potatoes. Acox2 for instance is part of GO processes “electron transport” 
and “lipid metabolism” and encodes for the acyl-Coenzyme A oxidase 2. Acyl-CoA 
oxidases are known to be involved in fatty acid oxidation (LI et al., 2006). Hsd17b2 is 
involved in steroid synthesis. Steroid hormones in turn are known to play a role in lipid 
metabolism and to be influenced by dietary fat intake (ACOSTA, 2001; GROMADZKA-
OSTROWSKA et al., 2002; LIN et al., 2006). The up-regulation of molecules like Fbp1, 
Pc and Prkaa2 demonstrates implications with energy providing processes since these 
molecules are playing a role in gluconeogenesis and in regulation of energy metabolism 
(VELEZ & DONKIN, 2005; VAN POELJE et al., 2006; TOSCA et al., 2008). Moreover, 
the transcription of several cytochrome P450 molecules was affected. Cytochromes 
P450 are associated with xenobiotic metabolism but literature also suggests a function in 
the regulation of steroid hormones (MEYER, 2007; GEHLHAUS et al., 2007). These 
facts underline the interaction between the organisms` response and diet composition or 
nutrient supply and could hint at a physiological reaction towards the observed 
alterations in the nutrient profile of the two potato lines.  
Therefore rAlb-nptII potatoes were also screened for alterations in macro nutrients. In 
addition, classical parameters of digestibility and health were studied in the rats which 
ingested these plants. Macro-nutrients did not differ between the non-GM and the GM 
line. However, distinctive changes in amino acid profile (e.g. serine, glutamic acid, 
leucine, lysine, proline) were observed; likewise to the modification monitored in rAlb-
VP60 potatoes. Consequently also digestibility of these amino acids was altered when 
measured in rats. General health parameters like growth, blood chemistry and 
histopathological examination of the animals did not reveal any differences or negative
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effects of the GM potato feeding when comparing it to the wtAlb feeding group 
(JANCZYK, personal communication). Again, only 15 % of the protein source was 
supplied by the potato. This may seem little especially because there was no protein 
restriction. Both, the wtAlb and the rAlb-nptII diet were isonitrogenous and isoenergetic. 
But as discussed before, some amino acids have been shown to be significantly involved 
in the regulation of gene expression (JOUSSE et al., 2000; KIMBALL & JEFFERSON, 
2004). An altered amino acid profile of the plant could consequently result in expression 
changes as monitored in the animal. 
 
Feeding of rBV-VP60, rAlb-VP60 and rAlb-nptII – agreement of results 
Interestingly the results of the expression profiling discussed above are partly consistent 
with results of the pre-study (rBV-VP60/wtBV feeding experiment). An enrichment of 
differentially expressed genes of “lipid catabolism” was recorded consistently in spleen. 
Most genes of “lipid catabolism” were down-regulated when feeding the rBV-VP60 
additive as well as when feeding the rAlb-VP60 potato. Similar findings were observed 
for several genes involved in “protein catabolism”. Overlapping significant molecules 
were down-regulated after rBV-VP60 and rAlb-VP60 feeding although this process was 
only significant in the rAlb-VP60 feeding study. Thus, some of our findings have to be 
ascribed most likely to the VP60 molecule for the reason that it was the only identical 
component in both feeding trials. However, some results did not coincide (e.g. 
“development” or “pigment/porphyrin metabolism” appeared only after rAlb-VP60 
feeding) and therefore provide indication that not all changes can be explained by a 
potential bioactivity of the VP60 molecule. Though, it has to be kept in mind that 
conditions were not equal between these two experiments. Alternatively, these 
differences could be also attributed to the variation in nutrient profile between the 
recombinant and the non-GM potato line or could be assigned to the CtxB molecule or to 
interacting and combined effects of several causative factors. A potential bioactivity of 
the nptII molecule does not seem likely because no corresponding results were observed 
when comparing DEGs identified in the liver of animals fed rAlb-VP60 and rAlb-nptII 
although both potatoes expressed the nptII molecule. 
 
5.3 The application of threshold-based and threshold-free approaches for the 
identification of diet-affected biological processes 
Results discussed in 5.1 show some drawbacks of “classical” threshold-based, “two-
step” approaches (IGA: individual gene analysis; definition according to NAM & KIMI, 
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2008) for functional interpretation of genome-scale experiments. Besides, these kinds of 
analyses have been criticized since they are based on the assumption that biological 
relevant changes involve a high number of transcripts showing strong expression 
differences above defined thresholds. However, this might not always be the case. 
Moderate but meaningful expression changes could be discarded by a strict cut-off-
based approach. Interacting affected genes may be modified concertedly but without any 
member undergoing extreme modulations (KIM & VOLSKY, 2004; BEN-SHAUL et al., 
2005). DOPAZO (2006) criticizes the massive loss of information because a large 
number of false negatives is accepted in order to preserve a low fraction of false 
positives. More recently suggested analysis methods, which are summarized under the 
term gene set analysis (GSA; NAM & KIM, 2008), focus on so called gene sets (e.g. GO 
biological processes can be used to define gene sets) but use the ranked phenotype 
association information (e.g. q-values, FC etc.) of all analyzed genes; without constraint 
to threshold-based lists (JIANG & GENTLEMAN, 2007). The basic principle is to test the 
over- or under-expression of sets of functionally related genes by studying their relative 
position across a list of genes ranked by differential expression. That means a gene set 
is most likely related to the treatment/phenotype when its attributed genes tend to be 
ranked at the top end of the list (AL-SHAHROUR et al., 2007). 
Because of the mentioned shortcomings of threshold-based approaches, the data from 
the feeding experiments with GM potatoes was re-analyzed with a GSA algorithm 
(PAGE; KIM et al. 2005) and results were compared. According to the recommendations 
of KIM et al. (2007) for experiments with a small sample size, fold changes were used to 
define expression changes between the feeding groups. Although a very different 
concept was applied, parts of the results were in agreement. In the spleen of rats fed GM 
potatoes (rAlb-VP60) “lipid catabolism” and “digestion” were significantly affected by the 
diet and identified with both approaches. In the liver (rAlb-nptII) coincident results were 
observed as well, when regarding lipid metabolisms and lipid biosynthesis as strongly 
related categories. In small intestine epithelium, a tissue where applying the IGA 
approach only resulted in one significant process, GSA seemed to be advantageous; 
several processes could be identified. This is probably due to the low frequency of high 
FCs which was extreme in this tissue. These are obviously the cases where GSA 
performs better than IGA. In contrast, in the spleen IGA exhibited more processes. 
“Protein catabolism” did not appear in GSA though it has to be mentioned that most 
genes of this category were also involved in “digestion”. Pigment/porphyrin metabolism 
however did not emerge at all in GSA results. In liver “electron transport” and 
“alcohol/monosaccharide metabolism” were ignored with GSA.  
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It was concluded that in experiments/tissues where only slight changes are observed or 
expected, GSA might be a valuable approach and obviously performs better than IGA, 
though this is not conclusive. However, a general advantage of GSA could not be 
reasoned from these results, although the superiority of this new approach was 
demonstrated in literature e.g. by SUBRAMANIAN et al. (2005) or AL-SHAHROUR et al. 
(2005). In some cases “classical” IGA approaches might be more valuable in that they 
tend to find more processes in datasets with higher FCs. Though, the strong dependency 
of the results on the threshold remains a problem. RAGHAVAN et al. (2006) reported 
similar findings. They found that, depending on the distribution of the p-values, in some 
cases the IGA approach was superior to threshold-free approaches. They point out that 
distribution-based statistics (GSA) tend to check for a broad range of alternatives and 
consequently their sensitivity gets diluted for the specific alternatives of interest. But a 
suffering from the cut-offs applied in IGA approaches and the yield of different results 
depending on the thresholds was also mentioned. DAMIAN & GORFINE (2004) also 
criticize GSA and indicate situations when using GSA will ignore genes with highest 
values solely due to the size of the selected gene set. Since there has been criticism 
about both approaches it seems advisable to adapt the functional analysis to the 
particular experiment.  
However, both approaches seemed to be applicable to identify diet-affected biological 
processes. Depending on the data one or the other approach was more informative. Both 
should be tested and the one that gives the more interpretable results could be chosen. 
Nevertheless, for the present study both approaches were valuable as they showed 
overlapping findings which may be regarded as indication for the correctness of the 
results.  
 
5.4 The use of expression profiling in the safety assessment of genetically 
modified plants 
The present findings demonstrate that unintended changes in terms of a modified 
nutrient composition in the plant may occur and can affect physiology of animals 
ingesting such foods. Moreover, the impact of the introduced gene and its produced 
protein on the organism cannot always be predicted. This emphasizes the need for a 
holistic safety assessment when applying genetically modified foods or food additives to 
animals or humans. Classical parameters (e.g. blood chemistry, nutritional parameters) 
studied in rats by JANCZYK et al. (2007 and personal communication) did not show any 
effect of the diet on the animals’ physiology. In contrast, gene expression profiling 
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revealed effects although interpretation of the results remained difficult and effects could 
not be explained thoroughly from this study. As pointed out in 2.2.3 so far only very few 
indications for unintended effects of feeding genetically modified plants to animals were 
found. Detailed overviews are given by FLACHOWSKY et al. (2005, 2007) and EFSA 
(2008). In general they conclude, that genetically modified plants without substantial 
changes in their composition do not significantly differ in their nutritional value from those 
of their nearest isogenic varieties and do not have negative physiological effects on the 
organism that ingested the plant. Consequently, the present results may raise the 
question whether the classical approaches used until now are adequate and sensitive 
enough to detect possible effects. As shown in this study expression profiling methods, 
which are among the so called non-target approaches, provide a great sensitivity. 
NARASAKA et al. (2006) proposed and proved the usefulness of such techniques in the 
field of food safety. LIU-STRATTON et al. (2004) also suggests studying expression, 
proteomic and metabolomic profiles of tissues from experiments with humans or animals 
which have ingested such foods and to compare it to the corresponding traditional food 
as a reference for a complete safety assessment. Nevertheless, for a meaningful 
interpretation of expression results in animals’ tissues an extensive knowledge about 
alterations in nutrient profiles of the GM plants is essential. Thus, the implementation of 
expression and metabolic profiling in the characterization of the plants should perhaps be 
the first step towards a global safety assessment of GM plant and was likewise proposed 
by several authors e.g. KUIPER et al. (2001), CELLINI et al. (2004), METZDORF et al. 
(2006) and EFSA (2008). 
Some limitations of microarray approaches should also be considered. Although the 
microarray used within this work comprised expression information for about 10 000 
transcripts, only about 50 % of the probe IDs could be annotated to known genes and 
only these genes provide useful information. Nevertheless, this technology is a fast 
developing field and annotation information improves quickly. The same difficulties were 
encountered in functional assignment of genes, which is still far from being complete but 
likewise developing rapidly. Furthermore, it has to be kept in mind that there are no 
known critical values for expression signals which could be used to define dangerous 
health effects; as it may be done for instance with blood chemistry parameters. 
Expression studies should only be seen as a screening method to provide an open-
ended broad view of complex cellular reactions. They may not replace conventional 
analyses but could be useful to confirm and supplement other results and give indication 
whether further and more complete classical analyses are needed. In that way they 
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present a very valuable tool which could also be applicable in the field of food or feed 
safety. 
 
5.5 Agreement of real-time RT-PCR and microarray results 
In the course of evaluating different approaches for the analysis of microarray data, a 
comparison of expression measurements done by real-time RT-PCR and by microarray 
was performed. Expression values measured with real-time RT-PCR in the spleen and 
the liver of rats fed either rBV-VP60 or wtBV did significantly correlate with microarray 
results (r = 0.72, p = 0.0004). Eight out of 10 molecules, which revealed significance in 
the microarray analysis, did also show significant expression differences with the real-
time RT-PCR approach. These results are comparable to the correlations observed in 
other studies and may prove the reliability of the present microarray findings. RAJEEVAN 
et al. (2001a,b) for instance confirmed 71 % of the genes, which were significant with 
microarray approach, by real-time RT-PCR. MOREY et al. (2006) proved a significant 
correlation between microarray and real-time RT-PCR results of 0.7. In a further feeding 
experiment with rAlb-VP60 potatoes, 100 % confirmation of significance of the 
expression differences obtained from the two methods was shown in the spleen and in 
small intestine epithelium. In contrast, when assessing significant differences of single 
molecules in the liver of rats fed rAlb-nptII by real-time RT-PCR, some disagreements 
between real-time RT-PCR and microarray results were observed.  
The reasons for disagreements are manifold and widely discussed in literature. WANG et 
al. (2006) reported for instance a decrease in the overall accuracy of significance 
detection at low expression levels. This could be a reason for the lack of differential 
expression detection in two molecules (F3, Gp5) of rBV-VP60/wtBV experiment; both 
genes had a very low expression level (< 100) in real-time RT-PCR. ETIENNE et al. 
(2004) demonstrated the best agreement for genes with moderate expression levels 
indicating that high transcriptions levels, which are close to saturation point, can also be 
problematic. Fbp1 and Pemt which were identified in the rAlb-nptII/wtAlb experiment 
revealed a relatively high expression rate that could have introduce a bias into the 
measurement. In addition, Fbp1 and Pc (rAlb-nptII/wtAlb experiment) had FCs just above 
1.5. According to DALLAS et al. (2005) this is a critical threshold. Below this threshold 
decreased correlations for expression differences have to be expected.  
Another important factor influencing consistency could be the intense data processing 
and modification/correction steps especially in microarray analysis (MOREY et al., 2006). 
DALLAS et al. (2005) mention that different strategies in oligo probe and primer design 
DISCUSSION 
 
89
could attribute to the poor correlation because different subsets of alternative transcripts 
or alternative cross-hybridizing transcripts may be recognized. Moreover, microarray 
probes are usually 3´-based. This may not be the case for real-time RT-PCR primers. 
Thus, it seems comprehensible that ETIENNE et al. (2004) found a good agreement for 
genes with PCR primers located close to the microarray probes. In the present study 
microarray probe sequences were unfortunately not available. Consequently, a possible 
distance between microarray probe and PCR primer might have introduced some bias 
into the measurements. In addition, gene specific variation due to the different 
hybridization kinetics, which are associated with the two technologies, and misleading 
results due to errors in GeneBank sequence data or probe set annotations have to be 
considered (DALLAS et al., 2005). 
Most of the discussed points might be effectual for the reported disagreement in the 
present study though it is difficult to elucidate the actual cause. Moreover, it is not clear 
whether to believe in real-time RT-PCR results or in microarray values since the true 
expression level is unknown (ROCKETT & HELLMANN, 2004); even if it is widely 
accepted that real-time RT-PCR constitutes the “gold standard”. However, expression 
levels of microarrays undergo normalization procedures which rely on the assumption 
that the majority of genes are not differentially expressed. Therefore many expression 
values can be included in normalization and correction procedures to make up for 
technical variability. In real-time RT-PCR only a single gene is investigated and 
correction methods solely rely on the use of housekeeping genes.  
Moreover, microarray measurements are often based on multiple probe sets, which 
distributed within the gene sequence, thus the sensitivity of the measurement might be 
higher. In contrast real-time RT-PCR relies only on one primer pair and covers only a 
very limited sequence segment. ROCKETT & HELLMANN (2004) mention that all 
techniques used to analyze biological systems suffer some kind of bias and state that 
with regard to these aspects the “gold standard” status might appear arguable. ALLISON 
et al. (2006) question the general accepted need for real-time RT-PCR validation of 
microarray studies and conclude that it stems more from tradition than careful thought. 
Taking these arguments into account the present microarray measurements are not 
interpreted as false positive findings. In contrast, since both techniques are known to 
have drawbacks the results are still regarded as valuable. 
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6 SUMMARY 
The aim of the present work was to evaluate sensitivity and adequacy of comparative 
gene expression profiling using microarray technology in the characterization of 
unexpected physiological side effects caused by a feeding of genetically modified (GM) 
feed components. This was studied in feeding experiments with laboratory rats which 
were fed different kinds of diets containing genetically modified potatoes or genetically 
modified baculovirus. The GM potatoes were either expressing the viral antigen VP60 
and the nptII gene (rAlb-VP60) or solely nptII (rAlb-nptII). VP60 can induce an immune 
response against the Rabbit Hemorrhagic Disease Virus; the nptII gene transfers 
antibiotic resistance, which is needed for plant selection. Another genetically modified 
dietary component was made of inactivated, recombinant baculovirus, which also 
expressed the VP60 gene (rBV-VP60). Expression profiles obtained from the spleen, the 
liver and from small intestine epithelium of the rats were compared to profiles of animals 
fed a near-isogenic non-GM potato (wtAlb) or wildtype baculovirus (wtBV) additive. 
Differentially expressed genes were then classified, according to their function, into 
biological processes in order to characterize the effect of the feed components or 
additives on the organisms’ physiology. 
 
As a prerequisite for these expression studies, a pre-screening of different data analysis 
parameters was accomplished to select an appropriate analysis approach. This is crucial 
since microarray data evaluation includes many steps of data processing and analysis 
which can have a profound impact on the results and on the conclusions drawn from 
them. In this work the application of a False Discovery Rate threshold and a fold change 
filter with different stringencies was tested. The number of differentially expressed genes 
as well as the identified diet-affected biological processes varied considerably with 
changing threshold stringencies. This underlines the importance of setting thresholds 
carefully with respect to the aim of the study and the specific context of the experiment. 
As a result it was concluded that for the data, used within this work, a stringent False 
Discovery Rate level of  5 % would be most appropriate since a high reliability was 
aimed. A moderate fold change filter of  1.5 was evaluated as being adequate. 
 
Threshold-free approaches can be considered as an alternative to such threshold-based 
analyses as they avoid the above mentioned strong dependency of the results on 
threshold choice. The application of a so called “gene set analysis” was tested on parts 
of the same data. This method identifies diet-affected biological processes by using 
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ranked lists, containing fold changes or FDR values of all analyzed genes, without 
constraint to any threshold. The analyses revealed results which were partially coinciding 
with the threshold-based findings. In addition, it was reasoned that in cases with only 
small expression changes, the gene set analysis performed better. Though, a general 
superiority could not be concluded from the present findings. 
 
The investigation of physiological effects caused by an ingestion of specific genetically 
modified potatoes revealed significant effects on gene expression. A feeding of rAlb-
VP60 potatoes caused expression changes mainly in the spleen of rats compared to 
expression profiles of animals fed the corresponding wtAlb potato. The differentially 
expressed genes were for instance associated with “lipid and protein catabolism” and 
showed a prior down-regulation in the rAlb-VP60 feeding group. Similar results, found in 
rats fed the rBV-VP60 additive, indicate at least a partial involvement of the VP60 
molecule in expression changes. Nevertheless, some results did not correspond 
between the two feeding experiments (rAlb-VP60/wtAlb and rBV-VP60/wtBV). These 
disagreements could point to an additional influence of some variations in the nutrient 
profile of the used genetically modified potato. A feeding of rAlb-nptII potatoes caused an 
up-regulation of several genes in the liver which are known to play a role for instance in 
“lipid” and “alcohol/monosaccharide metabolism” and suggest an increased metabolic 
activity in this organ. Since the nptII molecule has no known bioactivity these changes 
are probably attributed to alterations in the potato composition due to genetic 
modification and/or somaclonal variation. 
 
In conclusion, the feeding of different GM dietary components did significantly affect 
gene expression in several organs of rats. According to these results, effects that have to 
be ascribed to the VP60 molecule as well as to an altered nutrient composition or 
nutrient value of the potatoes may occur. Though, classical nutrition parameters did not 
indicate any physiological impact of the diet. Moreover, it has been shown that 
expression profiling approaches provide great sensitivity in monitoring physiological 
reactions of an organism to such diets. They could therefore be a valuable supplement of 
conventional methods used in safety assessments of GM foods or feeds.  
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7 ZUSAMMENFASSUNG 
In der vorliegenden Arbeit wurden Untersuchungen zur Sensitivität und Eignung von 
vergleichendem „Genexpressionsprofiling“ für die Charakterisierung unerwarteter 
physiologischer Effekte, bedingt durch eine Verfütterung genetisch veränderter (GV) 
Futterzusätze, durchgeführt. In Fütterungsexperimenten wurden Laborratten 
unterschiedliche Futterzusätze, bestehend aus genetisch veränderten Kartoffeln oder 
Bakuloviren, verabreicht. Die GV Kartoffeln exprimierten entweder das virale Antigen 
VP60 und das Gen nptII (rAlb-VP60) oder ausschließlich nptII (rAlb-nptII). VP60 kann 
eine Immunität gegenüber der hämorrhagischen Kaninchen-Krankheit induzieren; nptII 
vermittelt Antibiotika-Resistenz, die für die Pflanzenselektion notwendig ist. Ein weiterer 
Futterzusatz bestand aus inaktivierten, rekombinanten Bakuloviren, die ebenfalls VP60 
exprimierten (rBV-VP60). Die Expressionsprofile wurden für unterschiedliche Gewebe 
(Milz, Leber, Dünndarmepithel) der Ratten erstellt und mit Profilen von Tieren verglichen, 
die den entsprechenden Futterzusatz aus Wildtyp-Kartoffel (wtAlb) bzw. Wildtyp-
Bakuloviren (wtBV) erhalten hatten. Different exprimierte Gene wurden dann, gemäß 
ihrer Funktion, biologischen Prozessen zugeordnet, um den Effekt der Futterzusätze auf 
physiologische Vorgänge im Organismus zu charakterisieren.  
 
Um einen geeigneten Ansatz für die Datenanalyse im Rahmen der 
Expressionsuntersuchungen zu ermitteln, bildeten Voruntersuchungen zur Stringenz 
verschiedener Auswertungs-Parameter die Vorraussetzung. Ein adäquater Ansatz ist 
unerlässlich, da die Microarray-Auswertung zahlreiche Schritte der Datenberarbeitung 
und -analyse beinhaltet. Diese können einen entscheidenden Einfluss auf die Ergebnisse 
und die daraus gezogenen Schlussfolgerungen haben. Im Rahmen dieser Arbeit wurden 
die Anwendung einer Korrektur der „False Discovery Rate“ (FDR: erwartete Rate von 
falsch Positiven unter den abgelehnten Hypothesen) und die Verwendung von Ratio-
Filtern mit unterschiedlichen Stringenzen untersucht. Die Anzahl different exprimierter 
Gene wie auch die identifizierten biologischen Prozesse variierten beträchtlich in 
Abhängigkeit von dem gewählten Grenzwert. Daraus wird die Notwendigkeit deutlich, 
diese Grenzwerte mit Bedacht in Hinblick auf das Ziel der Untersuchungen und unter 
Berücksichtigung spezifischer Versuchsbedingungen festzulegen. Für die vorliegenden 
Daten wurde ein stringentes FDR Niveau von  5 % als adäquat eingestuft, da eine hohe 
Verlässlichkeit der Ergebnisse angestrebt wurde. Für den Ratio-Filter wurde ein 
moderater Grenzwert von  1.5 als geeignet bewertet. 
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Als Alternative zu solchen grenzwert-basierten Vorgehensweisen können auch Ansätze 
in Betracht gezogen werden, die ganz auf die Anwendung von Grenzwerten verzichten 
und somit den Einfluss dieser Parameter auf die Ergebnisse vermeiden. Die Nutzung der 
sogenannten „genes set analysis“ wurde anhand eines Teils der vorliegenden Daten 
getestet. Diese Methode identifiziert diät-beeinflusste biologische Prozesse mittels einer 
Rangliste der Ratio- oder FDR-Werte aller analysierten Gene und verzichtet dabei auf 
jegliche Einschränkungen durch Grenzwerte. Aus den Untersuchungen ergaben sich 
Ergebnisse, die zum Teil mit denen des grenzwert-basierten Ansatzes übereinstimmten. 
Zudem wurde geschlussfolgert, dass bei zu erwartenden geringen Expressions-
unterschieden, die „genes set analysis“ geeigneter ist, obwohl eine generelle 
Überlegenheit aus den vorliegenden Untersuchungen nicht abgeleitet werden konnte. 
 
Physiologische Nebeneffekte einer Verabreichung spezifischer, genetisch veränderter 
Futterzusätze wurden mittels „Genexpressionsprofiling“ untersucht. Die Microarray 
Ergebnisse zeigten, dass die Verfütterung von rAlb-VP60 Kartoffeln im Vergleich zu 
einer Verfütterung von wtAlb Kartoffeln hauptsächlich in der Milz der Ratten zu 
signifikanten Expressionsunterschieden führte. Die different exprimierten Gene spielen 
unter anderem im Lipid- und im Proteinkatabolismus eine Rolle und zeigten vorrangig ein 
niedrigeres Expressionsniveau in der rAlb-VP60 Gruppe. Vergleichbare Ergebnisse 
wurden in rBV-VP60 gefütterten Ratten beobachtet und deuten auf eine zumindest 
partielle Beteiligung des VP60 Moleküls an den veränderten Expressionsmustern hin. 
Allerdings waren die Ergebnisse der beiden Experimente (rAlb-VP60/wtAlb und rBV-
VP60/wtBV) nur teilweise übereinstimmend. Diese Unterschiede könnten ein Indiz dafür 
sein, dass Veränderungen in der Nährstoffzusammensetzung der eingesetzten 
Kartoffellinie ebenfalls einen Einfluss hatten. Eine Verfütterung von Kartoffeln, die nur 
das nptII Markergen exprimierten, führte in der Leber zu einer Aufregulierung 
verschiedener Gene, die zum Beispiel im Lipid- und Alkohol/Monosaccharid-
metabolismus eine Rolle spielen und auf eine erhöhte Stoffwechselaktivität in diesem 
Organ hinweisen. Da es keine Kenntnisse über eine biologische Wirksamkeit des nptII 
Moleküls gibt, sind diese Veränderungen vermutlich auf Unterschiede in der 
Kartoffelzusammensetzung zurückzuführen 
 
Zusammenfassend ist festzustellen, dass die Verfütterung verschiedener GV 
Futterzusätze die Genexpression in einigen Organen von Ratten signifikant veränderte. 
Entsprechend dieser Ergebnisse können Effekte auftreten, die auf das VP60 Molekül, 
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eine veränderte Nährstoffzusammensetzung oder einen veränderten Nährwert 
zurückzuführen sind, obwohl klassische Ernährungsparameter nicht auf physiologische 
Auswirkungen der Diät hindeuteten. Weiterhin wurde gezeigt, dass 
„Genexpressionsprofiling“ eine genaue Erfassung von physiologischen Reaktionen eines 
Organismus gegenüber solchen Diäten ermöglicht. Im Rahmen von 
Sicherheitsuntersuchungen zu genetisch veränderter Nahrung oder Futtermitteln könnte 
dieser Ansatz eine wertvolle Ergänzung zu konventionellen Methoden darstellen. 
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9.1 Figures & Tables 
 
Table 27: Influence of applying different “False Discovery Rate” (FDR) thresholds on identified 
biological processes exhibiting a significantly increased number of differentially expressed genes. 
Different gene expression refers to the spleen of rats fed rBV-VP60 in comparison to rats fed wtBV. 
Grey color marks significantly affected biological processes with ES  0.05. 
Number of differentially expressed GO annotated 
genes 
p  0.05 q  0.2 q  0.1 q  0.05 
Spleen 
 
Biological process  
(GO term) 
 
Number of GO 
annotated 
genes on the 
array n1 ES2 n1 ES2 n1 ES2 n1 ES2 
Nucleic acid metabolism 719 216 0.03 513 0.05 326 0.01 58 0.08 
Central nervous system 
     development 103 38 0.03 71 0.60 46 0.34 7 0.69 
Aldehyde metabolism 10 7 0.03 8 0.61 8 0.06 2 0.50 
Hyperosmotic response 6 5 0.05 5 0.72 5 0.20 3 0.06 
DNA repair 51 19 0.12 44 0.01 25 0.24 5 0.44 
Establishment of cellular 
     localization 269 73 0.55 201 0.02 124 0.07 19 0.53 
Cellular localization 274 74 0.57 204 0.02 125 0.09 20 0.46 
Intracellular transport 265 72 0.54 197 0.03 122 0.08 19 0.50 
Secretory pathway 129 35 0.59 99 0.04 57 0.34 8 0.77 
Cell migration 146 39 0.63 111 0.04 64 0.35 15 0.10 
Organelle organization 
     and biogenesis 267 77 0.30 197 0.04 121 0.12 18 0.62 
Regulation of protein 
     metabolism 108 31 0.46 70 0.88 56 0.03 12 0.10 
Biopolymer metabolism 673 192 0.18 461 0.56 300 0.04 44 0.65 
Macromolecule 
     catabolism 119 36 0.30 87 0.21 60 0.04 10 0.40 
Response to salt stress 4 3 0.29 3 0.90 3 0.55 3 0.02 
Lipid catabolism 54 16 0.49 34 0.91 19 0.91 9 0.02 
Cellular lipid metabolism 265 67 0.80 187 0.30 102 0.88 27 0.03 
Glycerol ether 
     metabolism 12 6 0.20 11 0.22 7 0.37 4 0.04 
All 3738 1007  2562  1544  250  
1 n = number of differentially expressed genes in process 
2 ES = calculated EASE Score based on modified Fishers´ exact test; significance was assumed at ES  0.05 
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Table 28: Influence of applying different fold change filters (no FC filter; FC1.5; FC2) on identified 
biological processes exhibiting a significant over-representation of differentially expressed genes. 
Different gene expression refers to the spleen of rats fed rBV-VP60 in comparison to rats fed wtBV 
and to DEGs with q-values  0.05. Grey color marks significantly affected biological processes with ES 
 0.05. 
Number of differentially expressed GO annotated 
genes 
no FC FC  1.5 FC  2 
Spleen 
 
Biological process  
(GO term) 
 
Number of GO 
annotated 
genes on the 
array n1 ES2 n1 ES2 n1 ES2 
Lipid catabolism 54 9 0.02 5 0.03 4 0.01 
Cellular lipid metabolism 265 27 0.03 6 0.72 3 0.54 
Glycerol ether 
     metabolism 12 4 0.04 2 0.24 2 0.08 
Response to salt stress 4 3 0.02 1 1.00 - - 
All 3738 250  85  26  
1 n = number of differentially expressed genes in process 
2 ES = calculated EASE Score based on modified Fishers´ exact test; significance was assumed at ES  0.05 
 
 
Table 29: Influence of applying different “False Discovery Rate” (FDR) thresholds on identified 
biological processes exhibiting a significantly increased number of differentially expressed genes. 
Different gene expression refers to small intestine epithelium of rats fed rBV-VP60 in comparison to 
rats fed wtBV. Grey color marks significantly affected biological processes with ES  0.05. 
Number of differentially expressed GO annotated 
genes 
p  0.05 q  0.2 q  0.1 q  0.05 
Small intestine epithelium 
 
Biological process  
(GO term) 
 
Number of GO 
annotated 
genes on the 
array n1 ES2 n1 ES2 n1 ES2 n1 ES2 
Nucleic acid metabolism 697 166 0.02 385 0.21 39 0.16 2 0.58 
Fertilization  16 8 0.03 9 0.71 3 0.17 - - 
Ion transport 310 66 0.50 191 0.00 15 0.59 1 1.00 
Response to virus 13 2 0.95 13 0.00 - - - - 
Regulation of signal 
     transduction 123 34 0.06 81 0.01 9 0.21 1 1.00 
Transport 1003 206 0.66 569 0.01 45 0.72 3 0.31 
Lipid metabolism 306 69 0.29 182 0.02 14 0.68 - - 
Regulation of  
    biosynthesis 72 16 0.55 47 0.05 1 1.00 - - 
Regulation of cellular 
     metabolism 515 117 0.17 295 0.05 23 0.71 2 0.46 
All 3600 751  1932  169  5  
1 n = number of differentially expressed genes in process 
2 ES = calculated EASE Score based on modified Fishers´ exact test; significance was assumed at ES  0.05 
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Figure 23: Frequency of expression fold changes observed between rats fed rAlb-VP60 in comparison 
to rats fed wtBV (A: spleen; B: small intestine epithelium). 
 
 
 
Figure 24: Frequency of expression fold changes observed between rats fed rAlb-nptII in comparison 
to rats fed wtBV (liver). 
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iv 
entified in the spleen of rats fed rAlb-VP60 in comparison with wtAlb fed animals. 
change 
og2) 
q-value SD Description 
.72 0.03 0.08 cell division cycle control protein 2 cdc2a; cdc2 + 
0.95 0.03 0.14 thymidine phosphorylase 
0.70 0.03 0.01 chromosome 14 open reading frame 4 
1.42 0.02 0.12 phospholipase a2, group ib, pancreas pla2g1b; pancreatic a-2 
0.63 0.03 0.13 ragb ras-related, alternatively spliced gtpase b; gtp-binding protein 
1.18 0.03 0.20 EST 
0.74 0.03 0.12 truncated nociceptin receptor orl1 
0.76 0.00 0.02 pituitary tumor transforming gene protein pttg; tumor-transforming 1 pttg1 
1.02 0.04 0.33 ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit 
0.61 0.03 0.09 prostacyclin receptor 
1.57 0.04 0.35 adducin, beta add2; adducin 
1.97 0.03 0.42 fms-related tyrosine kinase 1 vascular endothelial growth factor 
0.60 0.03 0.09 phospholipase c beta 2 plcb2 
0.70 0.04 0.16 lim-domain containing, protein kinase limk1; limk-1 
1.66 0.02 0.17 carboxypeptidase a1 pancreatic cpa1; a precursor; preprocarboxypeptidase 
0.82 0.02 0.08 EST 
1.20 0.02 0.12 immunoglobulin gamma-2b immunoglobulin gamma-2b 
1.50 0.02 0.15 carboxypeptidase cpa2 
0.94 0.04 0.25 chordin 
0.95 0.03 0.14 aminolevulinate,delta-,dehydratase alad; delta-alad aa 1-330 
0.82 0.05 0.30 EST 
1.11 0.03 0.13 basigin 
0.82 0.02 0.04 adenosine a1 receptor adora1; 326 as 
0.62 0.02 0.06 nadh dehydrogenase, mitochondrial subunit 1 nd1 
0.96 0.04 0.28 EST 
1.65 0.03 0.29 neighbor of BRCA1 gene 1 
0.87 0.02 0.08 microsomal glutathione S-transferase 3 
0.61 0.04 0.20 endogenous retroviral family W 
0.62 0.05 0.07 transient receptor potential channel 4 beta-2 splice variant trpc4; trp4alpha 
0.88 0.03 0.09 macrophage inflammatory protein-1 alpha receptor gene loc57301 
0.91 0.03 0.14 s100 calcium-binding protein a9 calgranulin b s100a9; intracellular mrp14 
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1.11 0.02 0.09 double cortin and calcium/calmodulin-dependent protein kinase-li dcamkl1 
0.66 0.03 0.07 spindlin 1 
0.76 0.04 0.22 cyclic nucleotide phosphodiesterase 
0.94 0.03 0.12 preprocaldecrin; elastase iv 
2.59 0.03 0.40 trypsinogen 1 is 3rd base in codon; i trp1; ii; pancreatic trypsin prss1; prss2 
0.67 0.04 0.15 neurexin iii-alpha; 3 nrxn3 
0.72 0.03 0.13 EST 
0.80 0.05 0.31 calcium channel alpha-1 subunit rba-i; alpha 1a cacna1a 
1.31 0.02 0.12 trypsinogen ec 3.4.21.4 
0.90 0.03 0.19 fructose-6-phosphate 2-kinase/fructose-2,6-bisphosphatase rb2k1; rb2k2 
0.75 0.02 0.06 uroporphyrinogen decarboxylase 
0.70 0.02 0.03 2-alpha globin 2-alpha-1 globin; major alpha-hemoglobin 
.61 0.04 0.18 olfactory receptor; protein 
0.71 0.05 0.25 fucosyltransferase 9 alpha 1,3 fucosyltransferase fut9; alpha1,3 
0.63 0.04 0.17 putative olfactory receptor tpcr44 
0.71 0.03 0.11 core binding factor alpha 1 cbfa1 
0.91 0.03 0.17 transient receptor potential cation channel, subfamily C, member 4 asso. prot. 
1.34 0.03 0.18 small proline-rich protein spr 
1.58 0.02 0.15 chymotrypsin-like ctrl; chymopasin 
0.99 0.00 0.02 trypsin v a-form; b-form 
0.63 0.02 0.05 carbonic anhydrase 2 ca2; ii; dehydratase 
0.62 0.05 0.22 retinoid x receptor gamma rxrgamma 
0.88 0.04 0.26 syncollin; sip9 
1.24 0.02 0.11 integrin alpha e2 
0.66 0.03 0.09 testis ubiquitin specific processing protease; deubiquitinating enzyme ubp45 
0.67 0.03 0.14 gap junction membrane channel, protein alpha 4 connexin 37 gja4; cxn-37 
1.12 0.03 0.24 caat/enhancer-binding protein, dna-binding protein cebpa; c/ebp aa 1-358 
1.00 0.03 0.13 h-caldesmon 
0.70 0.04 0.16 EST 
1.52 0.03 0.29 serine incorporator 2 
1.95 0.03 0.35 shab-related delayed-rectifier k+ channel kv9.3 kcns3; potassium channel 
1.33 0.03 0.25 cd28 antigen cd28 
2.39 0.03 0.29 carboxypeptidase b cpb 
0.67 0.02 0.06 hydroxymethylbilane synthase hmbs; porphobilinogen deaminase; hemc 
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0.63 0.02 0.03 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 
1.09 0.04 0.25 solute carrier family 14, member 2 slc14a2; urea transporter ut4; ut-a3 
1.91 0.03 0.35 sry-box containing gene 10 sox10; protein 
0.62 0.03 0.08 rp59 protein rp59 
0.84 0.05 0.07 transmembrane emp24 protein transport domain containing 9 
0.78 0.03 0.17 late gestation lung protein 1 lgl1 
1.34 0.03 0.25 Rab40b, member RAS oncogene family 
0.74 0.05 0.26 chordin 
0.64 0.02 0.05 epithelial sodium channel, beta subunit renac 
1.55 0.02 0.12 pancreatic triglyceride lipase; pnlip 
1.03 0.04 0.06 pancreatic lipase-related protein 2 pnliprp2; lipase 
0.84 0.00 0.01 glycoprotein 330 lrp2; megalin 
0.96 0.03 0.17 cholesterol esterase pancreatic 
1.33 0.02 0.14 colipase pancreatic clps 
.61 0.05 0.20 EST 
1.93 0.03 0.20 pancreatic lipase related protein 1 pnliprp1; triacylglycerol 
0.84 0.03 0.18 homeodomain protein gbx2 gbx2 
1.32 0.02 0.13 EST 
0.86 0.03 0.10 cytidine 5'-triphosphate synthase 
1.03 0.03 0.21 serologically defined breast cancer antigen ny-br-16-like protein 
1.73 0.04 0.48 preprotrypsinogen iv aa -15 to 232 
0.64 0.05 0.26 histone 2b h2b 
.28 0.03 0.20 brain alpha-tropomyosin tmbr-1; tmbr-3 
0.62 0.05 0.21 adenylyl cyclase type ii; 2 adcy2 
0.67 0.04 0.16 CXXC finger 1 (PHD domain) 
0.63 0.03 0.09 gata-binding protein 1 globin transcription factor 1 gata1; gata-1 
0.95 0.03 0.20 creb-binding protein cbp 
1.01 0.04 0.30 interleukin-3 receptor beta-subunit ril-3r<beta> 
1.00 0.05 0.37 N-terminal asparagine amidase 
1.27 0.04 0.28 regulator of g-protein signaling 8 rgs8 
0.73 0.04 0.16 rh blood group protein; rhesus 
1.13 0.03 0.20 myotonic dystrophy kinase-related cdc42-binding kinase mrck-beta mrck-beta 
0.64 0.04 0.15 serine protease bsp2 
0.84 0.02 0.06 s100 calcium-binding protein a8 calgranulin a s100a8; intracellular mrp8 
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1.30 0.03 0.03 tulip 1 loc56785; 2 
0.93 0.02 0.09 RUN and FYVE domain containing 1 
1.03 0.03 0.13 ser-thr protein kinase related to the myotonic dystrophy protein kinase pk428 
0.66 0.03 0.11 potassium voltage gated channel, shab-related subfamily, member 1 kcnb1 
0.64 0.03 0.09 d6.1a protein 
1.60 0.04 0.43 furosemide-sensitive k-cl cotransporter kcc1; solute carrier family 12, member 4  
1.79 0.02 0.17 reading frame preproelastase ii; elastase precursor; 2, pancreatic ela2 
0.60 0.04 0.16 EST 
2.10 0.04 0.48 nk2 transcription factor related, locus 5 drosophila csx 
0.87 0.04 0.27 retinoic acid receptor alpha1 
0.87 0.05 0.35 brain-1 brn-1 protein brn-1 
0.63 0.05 0.24 transmembrane protein 10 
0.60 0.03 0.07 polo-like kinase isoform 
1.99 0.03 0.34 cytosolic peroxisome proliferator-induced acyl-coa thioesterase 
1.88 0.02 0.16 chymotrypsin b chyb; ctrb 
0.98 0.04 0.27 serine protease inhibitor, kanzal type 1/ trypsin inhibitor-like protein, pancreatic  
0.99 0.03 0.17 preproelastase i; elastase; 1 ela1 
0.70 0.04 0.23 factor 8-associated gene A 
entified in the liver of rats fed rAlb-VP60 in comparison with wtAlb fed animals. 
change 
og2) 
q-value SD Description 
0.62 0.00 0.02 zinc finger protein; kidney 1 kid1 
0.79 0.00 0.02 EST 
entified in small intestine epithelium of rats fed rAlb-VP60 in comparison with wtAlb fed animals. 
change 
og2) 
q-value SD Description 
.61 0.03 0.07 leukotriene c4 synthase ltc4s; ltc4 
0.63 0.04 0.12 organic anion transporting polypeptide 3 slc21a7; transporter protein 
0.63 0.03 0.10 chromosome 14 open reading frame 4 
.62 0.04 0.11 cubilin intrinsic factor-cobalamin receptor cubn; factor-b12 precursor 
.75 0.03 0.07 rtr4alpha1 tr4 
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viii 
.61 0.02 0.03 EST 
.04 0.03 0.14 phospholipase c beta 2 plcb2 
.69 0.02 0.04 hydroxysteroid sulfotransferase 
0.79 0.03 0.07 nemo like kinase 
0.65 0.04 0.13 EST 
0.87 0.04 0.16 sirtuin 5 (silent mating type information regulation 2 homolog) 5 
0.62 0.04 0.15 EST 
0.86 0.03 0.12 crp-ductin crpd; ebnerin 
0.71 0.02 0.03 transient receptor potential cation channel, subfamily C, member 4 asso.  protein 
0.67 0.05 0.20 pancreatitis associated protein iii papiii0; pancreatitis-associated papiii 
0.93 0.03 0.02 transmembrane emp24 protein transport domain containing 9 
0.82 0.02 0.04 fatty acid binding protein 6 bile acid-binding protein fabp6 
0.66 0.04 0.17 pleiotrophin heparine binding factor, hbnf, in the mouse ptn 
0.86 0.03 0.09 EST 
.89 0.02 0.05 brain alpha-tropomyosin tmbr-1; tmbr-3 
0.67 0.03 0.07 zona pellucida 2 glycoprotein zp2 
0.66 0.03 0.10 glutathione S-transferase A3 
0.82 0.05 0.28 EST 
0.92 0.04 0.18 pancreatitis-associated protein precursor pap; pancreatitis associated; 1 pap1 
1.03 0.02 0.07 cytosolic peroxisome proliferator-induced acyl-coa thioesterase; hydrolase rbach 
0.60 0.02 0.03 spectrin repeat containing, nuclear envelope 1 
entified in the liver of rats fed rAlb-nptII in comparison with wtAlb fed animals. 
change 
log2) 
q-value SD Description 
0.78 0.05 0.30 recoverin rcvrn 
0.61 0.03 0.12 second ltb4 receptor julf2 julf2; leukotriene b4 2 ltb4r2 
0.69 0.04 0.20 atp-dependent metalloprotease ftsh1 homolog meg-4; 
0.69 0.02 0.09 heat shock protein 90, alpha (cytosolic), class A member 1 
0.61 0.03 0.10 eukaryotic translation initiation factor 4 gamma, 3 
0.62 0.02 0.03 dopamine receptor d5 drd5; d1b 
0.65 0.05 0.29 calpastatin probably multiple splicing products cast 
0.69 0.02 0.04 nopp140 associated protein nap65 
0.98 0.03 0.24 claudin 1 cldn1; claudin-1 
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0.77 0.04 0.22 rab9, member ras oncogene family rab9; small gtp binding protein 
1.66 0.02 0.17 androsterone udp-glucuronosyltransferase ugt2b2 
0.60 0.03 0.12 angiotensinogen pat 
0.73 0.04 0.22 EST 
0.76 0.02 0.06 EST 
0.62 0.02 0.08 robo2 
0.77 0.03 0.16 rst transporter homolog 
0.83 0.03 0.14 vesicle-associated membrane protein 8 endobrevin vamp8 
0.90 0.02 0.07 acidic calcium-independent phospholipase a2 aipla2 
0.64 0.04 0.18 putative pheromone receptor v2r3 
0.86 0.04 0.22 acidic calcium-independent phospholipase a2 aipla2 
0.68 0.03 0.12 cytochrome p450, subfamily iif, polypeptide 1 cyp2f1; p4502f4 cyp4502f4 
0.75 0.05 0.10 camp-regulated guanine nucleotide exchange factor ii camp-gefii 
0.62 0.05 0.27 EST 
1.27 0.04 0.08 EST 
0.71 0.03 0.12 17-beta hydroxysteroid dehydrogenase type 2 hsd17b2 
0.71 0.02 0.04 EST 
0.81 0.02 0.05 EST 
0.67 0.04 0.19 stress activated protein kinase beta serk2 
0.91 0.00 0.03 betaine-homocysteine methyltransferase 2 
0.84 0.03 0.17 lipogenic protein s14 lpgp; spot 14 peptide 
0.85 0.04 0.06 EST 
0.70 0.03 0.11 eukaryotic translation initiation factor 4e binding protein 1 eif4ebp1 
0.75 0.02 0.06 hepsin hpn 
0.84 0.05 0.31 phospholipase c beta 2 plcb2 
0.63 0.05 0.06 acidic membrane protein of rat brain nap-22; basp1 
0.65 0.02 0.06 ketohexokinase khk 
0.72 0.02 0.06 brain lipid binding protein fabp7; fatty acid 
0.90 0.02 0.07 mipp65 protein mipp65 
0.60 0.02 0.07 cathepsin y 
1.10 0.02 0.10 acidic calcium-independent phospholipase a2 aipla2 
0.68 0.02 0.06 EST 
0.64 0.02 0.08 vitamin d 3 25-hydroxylase precursor cyp27 
0.75 0.03 0.11 EST 
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x 
0.85 0.02 0.06 EST 
0.61 0.03 0.15 syntaxin 5a stx5a; 5 
0.63 0.03 0.11 cytochrome p450, subfamily ivb, polypeptide 1 
0.62 0.04 0.19 aquaporin-pancreas and liver aqp8; aquaporin 8 
0.94 0.03 0.20 EST 
0.97 0.04 0.26 lck tyrosine kinase 
0.76 0.04 0.24 d site albumin promoter binding protein dbp; transcriptional activator 
0.87 0.02 0.06 Shwachman-Bodian-Diamond syndrome homolog (human) 
0.63 0.02 0.08 zinc finger protein 17 dzf17 
0.84 0.02 0.04 er transmembrane protein dri 42 
0.77 0.02 0.04 nadh dehydrogenase, mitochondrial subunit 1 nd1 
1.13 0.03 0.24 WNK lysine deficient protein kinase 4 
0.65 0.03 0.11 testosterone-6beta-hydroxylase 6 beta-a cyp3a2 
0.80 0.05 0.32 melanoma associated antigen (mutated) 1 
1.06 0.03 0.23 cyclin d1 ccnd1; rat 
0.63 0.04 0.22 type iii multi-pass transmembrane protein 
1.01 0.04 0.07 mitochondrial dicarboxylate carrier 
0.65 0.02 0.07 sorbitol dehydrogenase sord; l-iditol 2-dehydrogenase 
0.92 0.02 0.05 short chain acyl-coa dehydrogenase precursor ec 1.3.99.2 
0.77 0.02 0.06 nuclear receptor subfamily 1, group h, member 3 nr1h3; rld-1 
0.95 0.02 0.05 mitogen activated protein kinase kinase kinase 1 map3k1; map mekk1 
0.66 0.02 0.06 l-gulono-gamma-lactone oxidase precursor; gulo 
0.74 0.02 0.09 apolipoprotein e rapoe; apoe 
1.47 0.02 0.16 phosphatidylethanolamine n-methyltransferase pemt 
0.62 0.04 0.21 aspartyl-trna synthetase dars; drs1 
0.78 0.03 0.14 udp-glucuronosyltransferase ugt2b12 
0.69 0.04 0.22 leukemia viral v-raf-1 oncogene homolog 1 3611-msv raf1; raf protein 
1.27 0.04 0.38 17 beta-hydroxysteroid dehydrogenase type iv hsd iv 
0.94 0.02 0.08 ninjurin1 
0.88 0.02 0.10 microtubule-associated protein 6 mtap6; stop 
0.63 0.03 0.09 ferritin subunit h fth1; heavy chain; ferritin-h 
1.06 0.04 0.07 ATPase, H+ transporting, lysosomal V1 subunit D 
0.94 0.03 0.15 3-hydroxy-3-methylglutaryl-coa synthase precursor ec 4.1.3.5 
0.77 0.05 0.29 tropomyosin 5 slow-twitch alpha tm/htmnm homolog; nonmuscle tpm5 
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xi 
0.86 0.03 0.16 branched-chain alpha-ketoacid dehydrogenase kinase bckdhkin 
0.65 0.03 0.11 solute carrier family 8 sodium/calcium exchanger, member 2 slc8a2 
1.12 0.00 0.02 pkc-zeta-interacting protein zip 
0.82 0.03 0.17 dynamin 2 dnm2; dyn2; iiaa 
0.74 0.03 0.11 protein arginine n-methyltransferase prmt1; 1 hrmt1l2 
0.86 0.00 0.03 rhodanese 
0.66 0.03 0.13 jun b proto-oncogene junb; protein pjunb 
0.91 0.04 0.25 similar to Myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog 
0.95 0.02 0.12 eukaryotic translation initiation factor 4 gamma, 3 
0.72 0.04 0.20 EST 
0.64 0.03 0.16 2-alpha globin 2-alpha-1 globin; major alpha-hemoglobin 
0.63 0.02 0.08 zinc finger protein 53 
0.72 0.02 0.05 EST 
0.74 0.02 0.03 cytochrome p450 4f5 cyp4f5 
0.95 0.02 0.12 tropic 1808 af078811; tropic1808 
0.79 0.03 0.17 rat polymeric immunoglobulin receptor aa -18 to 751 
0.68 0.05 0.06 EST 
0.69 0.02 0.03 EST 
0.61 0.03 0.14 aldolase a, fructose-bisphosphate aldoa; a ec 4.1.2.13 
0.90 0.03 0.17 preprocathepsin d 
0.79 0.03 0.16 chaperone, ABC1 activity of bc1 complex like 
0.61 0.03 0.09 EST 
0.68 0.02 0.08 EST 
0.61 0.03 0.13 EST 
2.23 0.02 0.14 trihydroxycoprostanoyl-coa oxidase thcox 
0.63 0.05 0.27 fatty acid elongase 1 relo1 
0.65 0.04 0.21 ovalbumin upstream promoter gamma nuclear receptor rcoupg 
1.14 0.03 0.18 ARP2 actin-related protein 2 homolog 
0.92 0.02 0.11 EST 
0.79 0.03 0.12 cytoplasmic beta-actin actx; beta actin 
0.91 0.02 0.10 androgen-inducible aldehyde reductase aiar 
0.73 0.03 0.17 cdc5 cell division cycle 5, s. pombe, homolog -like cdc5l; cdc5-like protein 
0.60 0.03 0.10 atp-stimulated glucocorticoid-receptor translocaton promoter gyk 
0.79 0.03 0.17 nedd4 
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0.74 0.03 0.12 poly adp-ribose glycohydrolase parg 
0.68 0.05 0.29 kangai 1 suppression of tumorigenicity 6; metastasis suppressor homolog 
0.81 0.02 0.09 glycine methyltransferase gnmt; aa 1-293 
0.71 0.02 0.09 EST 
0.87 0.04 0.07 cell division cycle 2-like 2 
0.66 0.03 0.14 g-protein beta-2 subunit; g protein beta 2 
0.61 0.02 0.04 zinc finger protein 103 zfp103; kf-1 adgr34 
0.74 0.02 0.05 transmembrane emp24 protein transport domain containing 9 
1.02 0.03 0.19 acidic calcium-independent phospholipase a2 aipla2 
0.90 0.03 0.17 strain fischer nuclear receptor car nr1i3 
0.90 0.03 0.13 branched chain alpha-ketoacid dehydrogenase precursor 
0.75 0.03 0.15 prosaposin sulfated glycoprotein, sphingolipid hydrolase activator psap 
0.68 0.03 0.14 cathepsin h pre-pro-peptide; rch11; ctsh 
0.80 0.03 0.03 beta-galactoside-binding lectin lgals1; protein 
1.14 0.03 0.17 epidermal growth factor receptor egfr 
1.16 0.04 0.07 5'-amp-activated protein kinase catalytic alpha-2 subunit; amp-activated prkaa2 
1.32 0.02 0.17 ARP2 actin-related protein 2 homolog 
0.73 0.04 0.20 interferon-inducible protein 16 loc80875 
0.77 0.03 0.12 putative n-acetyltransferase camello 2 cml 2; cml5; cml2 
0.69 0.02 0.05 triosephosphate isomerase 1 tpi1 
0.87 0.03 0.14 atpase, na+k+ transporting, alpha 1 polypeptide atp1a1 
0.71 0.02 0.09 riken cdna 2510006j11 txn2-pending; trx2 
0.63 0.04 0.18 malic enzyme 3, NADP(+)-dependent, mitochondrial 
0.71 0.02 0.07 EST 
0.61 0.03 0.02 EST 
1.01 0.02 0.06 striated muscle alpha tropomyosin aa 81-284 
0.89 0.00 0.02 3-hydroxyanthranilate 3,4-dioxygenase haao 
1.00 0.02 0.09 alpha-2u protein aa 1-198 
0.61 0.04 0.19 RNA polymerase 1-3 
0.68 0.04 0.19 complement component factor h-like 1 
1.75 0.04 0.47 EST 
0.80 0.02 0.11 sarcosine dehydrogenase sardh 
0.75 0.02 0.06 pyruvate carboxylase pc 
0.64 0.02 0.04 EST 
APPENDIX 
xiii 
2.28 0.05 0.22 similar to Ctps protein 
0.65 0.02 0.07 cytochrome p450 iid3 protein p450 iid3; cyp2d3; p-450 
0.71 0.03 0.13 EST 
1.00 0.02 0.14 cAMP responsive element binding protein 3-like 3 
0.68 0.05 0.28 dipeptidyl peptidase ii dpp ii; dpp2 
0.62 0.03 0.12 ribosomal protein s16 aa 1-146 
0.71 0.02 0.06 EST 
0.96 0.00 0.02 acidic calcium-independent phospholipase a2 aipla2 
0.61 0.04 0.17 ceruloplasmin ferroxidase cp; gpi-anchored 
0.65 0.03 0.16 rrna promoter binding protein 
0.95 0.02 0.08 acidic calcium-independent phospholipase a2 aipla2 
0.96 0.02 0.06 acidic calcium-independent phospholipase a2 aipla2 
0.93 0.00 0.03 acidic calcium-independent phospholipase a2 aipla2 
0.81 0.05 0.30 lmarrlc1a; marrlc2a 
0.86 0.03 0.15 acidic calcium-independent phospholipase a2 aipla2 
0.71 0.03 0.11 catalase ec 1.11.1.6; cat 
1.03 0.00 0.03 acidic calcium-independent phospholipase a2 aipla2 
1.06 0.02 0.08 acidic calcium-independent phospholipase a2 aipla2 
0.97 0.02 0.11 acidic calcium-independent phospholipase a2 aipla2 
1.01 0.02 0.08 bmal1b 
0.65 0.02 0.05 upstream transcription factor 1 usf1; usf-1 
0.68 0.00 0.02 apolipoprotein a-v apoa-v; apoa5 
0.61 0.03 0.11 stress-inducible chaperone mt-grpe#1 grpe#1; precursor 
0.67 0.04 0.21 solute carrier family 14, member 1 slc14a1; urea transporter ut3; ut11 
0.78 0.03 0.12 acidic calcium-independent phospholipase a2 aipla2 
0.62 0.03 0.16 EST 
0.86 0.02 0.11 EST 
0.66 0.02 0.04 coagulation factor x f10 
0.77 0.03 0.03 gtpase rab8b rab8b 
0.71 0.03 0.10 protein-tyrosine kinase csk 
0.67 0.03 0.11 delta subunit of f1f0 atpase 
0.90 0.04 0.07 plakophilin 4 (predicted) 
0.96 0.03 0.16 EST 
0.64 0.02 0.08 hepatic nuclear factor 4 alpha transcription factor 4 hnf4a; hepatocyte; hnf-4 
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0.79 0.02 0.05 cdc37 cell division cycle 37, s. cerevisiae, homolog cdc37 
0.68 0.03 0.16 gaba transporter 
0.84 0.03 0.12 endothelial p22-phox protein p22-phox; cytochrome b558 alpha-subunit cyba 
0.62 0.00 0.01 rat ribosomal protein l13a 
0.65 0.02 0.05 cd14 antigen cd14 
1.26 0.03 0.06 spliceosomal protein sap155 
0.68 0.02 0.05 phosphatidylethanolamine binding protein pbp; phosphatidylethanolamine-binding 
0.62 0.02 0.07 enoyl-coa hydratase, short chain 1, mitochondrial echs1 
0.69 0.02 0.05 EST 
0.97 0.02 0.04 guanine aminohydrolase gah; deaminase gda 
0.66 0.03 0.11 paired-like homeodomain transcription factor 3 pitx3; ptx3 protein 
0.73 0.02 0.08 asialoglycoprotein receptor 1 hepatic lectin asgr1 
0.68 0.02 0.05 lis1-interacting protein nude2 
0.63 0.03 0.11 pituitary tumor-transforming 1 interacting protein 
0.78 0.05 0.36 HypB, AroK, ADK and rho factor domain containing protein RGD1303144 
0.65 0.05 0.29 EST 
0.60 0.03 0.14 organic cation transporter slc22a1 
0.74 0.05 0.30 thiopurine s-methyltransferase tpmt 
0.63 0.03 0.10 putative glycogen storage disease type 1b protein; glucose-6-phosphatase 
1.05 0.02 0.14 amino acid system n transporter 
0.63 0.05 0.27 EST 
0.94 0.02 0.12 liver activating protein lap, also nf-il6, nuclear factor-il6, 
0.89 0.04 0.24 guanine nucleotide binding protein g protein alpha 12 gna12 
0.85 0.03 0.17 tweety homolog 1 (Drosophila) 
0.76 0.02 0.07 EST 
0.94 0.02 0.05 EST 
0.75 0.03 0.17 p21 (CDKN1A)-activated kinase 4 
4.86 0.05 1.95 cytosolic peroxisome proliferator-induced acyl-coa thioesterase 
0.65 0.02 0.03 contrapsin-like protease inhibitor related protein cpi-23; serine 1 
0.87 0.02 0.04 glucose regulated protein, 58 kda grp58; er-60 protease; er60; pi-plc i aa 1-504 
0.72 0.02 0.00 thymidine phosphorylase 
0.67 0.03 0.10 4-hydroxyphenylpyruvic acid dioxygenase hpd; 4-hydroxyphenylpyruvate hppd 
0.66 0.05 0.29 evectin-1 evt1; kpl1 
0.63 0.02 0.09 fructose-1,6-bisphosphatase fru-1,6-p2-ase 
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0.80 0.03 0.16 adp-ribosylation factor 5 arf5 
0.80 0.02 0.07 prostaglandin i2 prostacyclin synthase ptgis; ratpgis 
1.20 0.03 0.31 nadh dehydrogenase subunit 5 nd5 
0.71 0.03 0.13 EST 
entified in the spleen of rats fed rBV-VP60 in comparison with wtBV fed animals. 
change 
log2) 
q-value SD Description 
1.42 0.04 0.12 lsc protein lsc 
0.68 0.03 0.04 putative rna helicase bat1; liver nuclear protein p47 
0.61 0.03 0.04 coagulation factor iii thromboplastin, tissue factor f3; protein 
0.83 0.00 0.02 EST 
0.94 0.04 0.12 12/15-lipoxygenase 12/15-lipoxygenase, 12/15-lo, tk15lo 
0.73 0.04 0.06 rt1.b-1 beta-chain 
0.95 0.04 0.09 invariant polpypeptide of major histocompatibility class ii antigen-associated cd74 
1.02 0.05 0.16 interleukin 1 receptor, type i il1r1; receptor; soluble il-1 
0.80 0.04 0.10 a regulatory subunit of protein phosphatase 2a pp2a ara 
1.11 0.05 0.15 phospholipase a2, group ib, pancreas pla2g1b; pancreatic a-2 
1.60 0.03 0.07 uncoupling protein 2, mitochondrial ucp2; 2; protein-2 
1.44 0.03 0.07 rst transporter homolog 
0.73 0.04 0.07 lung kruppel-like factor lklf 
0.63 0.04 0.06 pv-1 pv1 
0.69 0.00 0.00 ankyrin repeat domain 12 
0.65 0.05 0.12 epithelin 1 & 2; granulin; grn 
0.70 0.05 0.10 ubiquitin-like 5 
0.68 0.00 0.02 5-oxoprolinase atp-hydrolysing oplah; 5-oxo-l-prolinase 
1.00 0.03 0.06 invariant chain aa 1-280 
1.25 0.04 0.12 stress activated protein kinase beta serk2 
0.63 0.04 0.07 EST 
0.78 0.03 0.04 beta-1 adducin add1 
0.95 0.05 0.17 neural visinin-like protein 1 vsnl1; nvp 
0.77 0.05 0.13 pan-2; pan-1 
0.70 0.05 0.11 carboxypeptidase a1 pancreatic cpa1; a precursor; preprocarboxypeptidase 
0.68 0.03 0.03 immunoglobulin kappa-chain igkv 
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1.12 0.04 0.11 carboxypeptidase cpa2 
0.83 0.04 0.08 reading frame preproalbumin 
0.68 0.00 0.03 EST 
1.37 0.04 0.15 ribosomal protein S2 
0.67 0.04 0.07 talin 1 
0.66 0.05 0.09 t-cell receptor alpha-chain c-region precursor 
0.61 0.04 0.06 EST 
0.60 0.03 0.03 coronin, actin binding protein 1b coro1b; coronin-like 
0.63 0.04 0.05 dna polymerase gamma mip1; polg 
0.66 0.05 0.13 yb2 
0.65 0.05 0.11 preproprolactin-releasing peptide loc63850; prolactin-releasing prrp 
1.45 0.00 0.05 cyclase-associated protein homologue cap1; mch1 
0.61 0.05 0.09 EST 
0.71 0.05 0.11 glutamate receptor, ionotropic, ampa4 alpha 4 gria4 
1.55 0.00 0.05 d-beta-hydroxybutyrate dehydogenase; calreticulin; calr 
1.17 0.03 0.07 annexin vi anxa6 
0.63 0.05 0.13 eukaryotic translation elongation factor 2 eef2; ef-2; aa 1-858 
0.64 0.04 0.06 janus kinase 3, protein-tyrosine kinase jak3 
1.15 0.03 0.05 preprocaldecrin; elastase iv 
1.14 0.04 0.12 alpha-actin aa 1-377 
0.65 0.05 0.09 sushi domain containing 2 (predicted) 
0.67 0.04 0.05 EST 
0.71 0.05 0.10 s2 kallikrein; tonin; ton 
0.98 0.05 0.19 nadh dehydrogenase subunit 5 nd5 
0.77 0.03 0.04  
0.61 0.05 0.10 type 2 angiotensin ii receptor at2r; agtr2; type-2 
1.07 0.03 0.06 cathepsin ec 3.4.22.1; b ctsb 
1.16 0.05 0.25 similar to exosome component 10 
1.59 0.05 0.24 atpase, na+k+ transporting, beta polypeptide 2 atp1b2 
0.95 0.03 0.05 proline rich protein 
0.65 0.05 0.13 EST 
1.32 0.00 0.03 light chain 3 subunit of microtubule-associated proteins 1a and 1b; 1a/1b mpl3 
1.64 0.00 0.05 selenoprotein w muscle 1 sepw1; selw 
0.63 0.04 0.08 pctaire-1a protein kinase; pctaire-1b 
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0.67 0.03 0.03 ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast) 
1.05 0.05 0.19 lutheran blood group auberger b antigen included lu 
1.66 0.04 0.12 cofilin 1, non-muscle cfl1 
0.73 0.05 0.15 oligodendrocyte-myelin glycoprotein 
0.64 0.03 0.03 rab11b, member ras oncogene family rab11b 
1.21 0.03 0.06 related to drosophila groucho gene aes; r-esp1 
0.77 0.00 0.01 zyxin 
1.60 0.00 0.04 plasma glutathione peroxidase precursor gpxp 
1.65 0.04 0.14 chymotrypsin-like ctrl; chymopasin 
0.86 0.05 0.17 hemicentin 1 
0.85 0.05 0.13 transient axonal glycoprotein 1 tag-1 tax; precursor 
0.69 0.04 0.06 EST 
0.92 0.04 0.10 sepiapterin reductase ec 1.1.1.153 
1.02 0.04 0.13 fission 1 (mitochondrial outer membrane) homolog (yeast) 
0.61 0.05 0.10 avian myelocytomatosis viral v-myc oncogene homolog myc; c-myc protein 
0.62 0.04 0.05 lyric 
0.71 0.05 0.11 cytoplasmic beta-actin actx; beta actin 
0.79 0.05 0.13 adrenergic receptor, alpha 1c adra1c; alpha1c receptor; alpha1c-adrenergic 
0.77 0.04 0.06 small inducible cytokine a5 rantes scya5 
1.13 0.05 0.17 ovalbumin upstream promoter beta nuclear receptor rcoupb 
0.61 0.05 0.09 immunoglobulin kappa light chain variable region; kappa-chain igkv 
1.20 0.03 0.07 myosin, light polypeptide 2, alkali ventricular, skeletal 
1.30 0.04 0.13 carboxypeptidase b cpb 
0.63 0.04 0.07 mad mothers against decapentaplegic, drosophila homolog 3 madh3; dpp mad3 
1.31 0.05 0.21 adaptor-related protein complex 3, beta 2 subunit (predicted) 
0.61 0.04 0.07 EST 
0.74 0.05 0.11 nadh dehydrogenase subunit 2 nd2 
0.90 0.05 0.18 ribosomal RNA processing 1 homolog (S. cerevisiae) 
1.10 0.03 0.07 pancreatic triglyceride lipase; pnlip 
1.04 0.04 0.10 pancreatic lipase-related protein 2 pnliprp2; lipase 
0.97 0.05 0.13 sperm membrane protein 
0.64 0.05 0.14 anti-idiotype immunoglobulin m light chain; lambda-2 igl 
0.82 0.04 0.10 fatty acid binding protein 1, liver fabp1; fabp; sterol carrier 
0.75 0.05 0.02 tektin 1 tekt1 
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1.13 0.04 0.09 pancreatic secretory trypsin inhibitor type ii precursor 
0.80 0.05 0.12 putative alpha 1b-glycoprotein 
1.33 0.04 0.14 protein kinase c, zeta subspecies; c; pkcz 
0.62 0.04 0.06 colipase pancreatic clps 
0.68 0.03 0.03 EST 
0.68 0.04 0.07 malic enzyme 3, NADP(+)-dependent, mitochondrial (predicted) 
0.94 0.05 0.14 platelete glycoprotein 5 gp5; platelet v 
0.94 0.04 0.10 zinc finger transcription factor gli3 gli3 
0.69 0.04 0.08 retinoic acid receptor beta2 
2.17 0.05 0.31 protein kinase c-binding protein nell1 nell1 
1.13 0.05 0.18 pancreatic lipase related protein 1 pnliprp1; triacylglycerol 
0.68 0.05 0.09 coagulation factor XI 
1.32 0.00 0.04 mhc a-beta rt1.b-b-beta cell surface glycoprotein 
1.33 0.03 0.07 non-muscle alpha-actinin 1 actn1 
0.70 0.05 0.13 gaba-b r2 receptor gaba-b r2; gb2; 2 gaba-br2; gpr51 
0.82 0.04 0.08 immunoglobulin 4g6 light chain variable region 
0.62 0.05 0.09 corticotropin-releasing factor binding protein; crh-binding 
0.63 0.05 0.11 aryl hydrocarbon receptor ahr; ah 
0.72 0.05 0.15 sarcomeric mitochondrial creatine kinase 
0.86 0.05 0.13 cell membrane glycoprotein 110000mr surface antigen homolog 
0.88 0.00 0.01 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activatioprotein 
0.73 0.00 0.03 breakpoint cluster region protein, uterine leiomyoma,  
0.62 0.05 0.11 sperm tail protein spag5 
0.86 0.04 0.09 cardiac potassium channel subunit kv6.2 kv6.2 
1.22 0.05 0.23 immunoglobulin mu-chain igm; mu-immunoglobulin 
0.75 0.04 0.08 j domain protein 1 jdp1 
1.10 0.05 0.23 ribosomal protein l38 
1.22 0.05 0.21 rt1.b-1 beta-chain 
0.68 0.05 0.12 EST 
0.86 0.04 0.11 betacellulin btc 
1.06 0.04 0.10 killer cell lectin-like receptor subfamily c, member 2 klrc2 
0.68 0.05 0.11 nmda receptor glutamate-binding subunit 
1.42 0.05 0.25 transforming growth factor beta-1 gene tgfb1; prepro-tgf-beta 1 aa -23 to 367 
0.83 0.03 0.05 ubiquitin-conjugating enzyme e2n homologous to yeast ubc13 ube2n 
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1.23 0.04 0.11 proto-oncogene fyn p59fyn 
1.03 0.04 0.11 cd37 antigen cd37 
0.72 0.04 0.05 pyrimidine binding protein 2 pybp2 
0.74 0.04 0.06 unconventional myosin myr2 i heavy chain myr2; myr 2 
0.79 0.04 0.06 guanylate cyclase, soluble, beta 2 gtp pyrophosphate - lyase gucy1b2 
0.93 0.05 0.18 profilin pfn1 
0.74 0.00 0.01 lyn protein non-receptor kinase lyn; a tyrosine lyna; b lynb 
0.72 0.04 0.07 unknown 
0.67 0.05 0.12 cbl-b 
1.10 0.05 0.03 calpastatin probably multiple splicing products cast 
0.86 0.05 0.12 adh water channel; complete cds; aquaporin 2 aqp2 
0.74 0.05 0.11 activity and neurotransmitter-induced early gene protein 4 ania-4 ania4 
0.77 0.05 0.15 sequence-specific single-stranded-dna-binding protein ssdp 
1.15 0.05 0.16 carboxypeptidase h precursor ec 3.4.17.10; e cpe; aa 1-476 
1.37 0.04 0.09 reading frame preproelastase ii; elastase precursor; 2, pancreatic ela2 
0.76 0.05 0.15 EST 
0.84 0.04 0.07 pius protein pius 
0.65 0.05 0.10 thymosin beta-4 precursor; peptide; protein; tmsb4x 
0.62 0.04 0.05 vascular cell adhesion molecule 1 vcam-1; molecule-1; vcam1 
1.32 0.00 0.05 EST 
0.80 0.05 0.15 EST 
0.70 0.03 0.04 WD repeat domain 24 
1.25 0.05 0.17 solute carrier family 4, member 2, anion exchange protein 2 slc4a2 
0.99 0.03 0.06 myosin regulatory light chain 17 is 2nd base in codon; mrlcb 
0.67 0.05 0.10 chymotrypsin b chyb; ctrb 
0.81 0.03 0.03 EST 
1.07 0.00 0.03 preproelastase i; elastase; 1 ela1 
0.72 0.04 0.06 ephrin a3 
0.83 0.04 0.10 nadh dehydrogenase subunit 5 nd5 
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entified in the liver of rats fed rBV-VP60 in comparison with wtBV fed animals. 
change 
og2) 
q-value SD Description 
0.82 0.05 0.32 heat shock protein 90, alpha (cytosolic), class A member 1 
0.76 0.04 0.13 endothelin-converting enzyme 1 ece1 
0.66 0.04 0.18 fk506 binding protein 1b 12.6 kda fkbp1b; fk506-binding 
1.08 0.02 0.07 lipopolysaccharide binding protein lbp 
0.86 0.04 0.17 EST 
1.31 0.03 0.17 androsterone udp-glucuronosyltransferase ugt2b2 
1.28 0.04 0.26 interleukin 1 receptor, type i il1r1; receptor; soluble il-1 
0.62 0.03 0.05 angiotensinogen pat 
0.99 0.03 0.08 peroxisomal enoyl-coa: hydrotase-3-hydroxyacyl-coa 
0.88 0.00 0.03 carnitine o-octanoyltransferase crot; octanoyltransferase 
0.63 0.04 0.11 2,4-dienoyl coa reductase 1, mitochondrial decr1; 2,4-dienoyl-coa precursor 
0.65 0.03 0.08 EST 
1.51 0.02 0.07 serine dehydratase aa 1 - 327; sdh2; sds 
1.83 0.04 0.35 rst transporter homolog 
1.51 0.05 0.11 ca2+/calmodulin-dependent protein kinase neuronal isoform delta a ca2 
0.67 0.03 0.09 EST 
0.69 0.03 0.08 betaine-homocysteine methyltransferase 2 
0.60 0.04 0.16 EST 
1.43 0.04 0.37 stress activated protein kinase beta serk2 
0.83 0.04 0.21 synaptic vesicle glycoprotein 2 a sv2a; protein sv2 
0.80 0.03 0.07 betaine-homocysteine methyltransferase 2 
0.82 0.03 0.08 coiled-coil alpha-helical rod protein 1 
0.64 0.04 0.09 transcription factor 1, hepatic lf-b1, hepatic nuclear factor hnf1 tcf1 tcf1 
0.92 0.04 0.20 prostacyclin receptor 
0.65 0.04 0.11 carnitine octanoyltransferase 
0.87 0.04 0.13 zinc finger protein; kidney 1 kid1 
0.82 0.04 0.22 dermatan sulfate proteoglycan-ii decorin; dcn 
0.79 0.05 0.26 ets domain transcription factor pet-1 
0.92 0.04 0.13 neural visinin-like protein 1 vsnl1; nvp 
0.92 0.05 0.26 receptor tyrosine kinase ret 
0.84 0.04 0.13 retinol dehydrogenase type ii 
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0.82 0.03 0.08 glutathione synthetase 
0.98 0.00 0.02 putative zinc finger protein serz-1 
0.64 0.03 0.07 EST 
0.81 0.05 0.25 EST 
0.71 0.05 0.26 EST 
1.37 0.04 0.18 ribosomal protein S2 
0.86 0.04 0.22 atp synthase 
0.60 0.03 0.06 m2 pyruvate kinase pk 
0.82 0.05 0.23 prion protein, structural prnp; protein prp; raprp; prion-related; prn 
0.94 0.05 0.08 tafiib taf2b 
0.61 0.04 0.12 cytochrome p450, subfamily ivb, polypeptide 1 see also d5m4rp1 cyp4b1 
0.64 0.04 0.08 electron transfer flavoprotein alpha-subunit etf 
0.62 0.04 0.12 neurotensin-degrading neutral metalloendopeptidase 
0.64 0.04 0.10 kruppel-like factor 15 kidney klf15; transcription 
0.90 0.04 0.13 type iii multi-pass transmembrane protein 
0.88 0.05 0.27 protein tyrosine phosphatase epsilon ptpepsilon; m 
0.64 0.04 0.14 cyclase-associated protein homologue cap1; mch1 
0.80 0.03 0.09 d-beta-hydroxybutyrate dehydogenase; calreticulin; calr 
0.61 0.04 0.09 sushi domain containing 2 (predicted) 
0.95 0.05 0.27 aminocarboxymuconate semialdehyde decarboxylase 
0.78 0.05 0.22 r8f dna-binding protein loc84382 
0.95 0.05 0.30 activity and neurotransmitter-induced early gene protein 4 ania-4 ania4 
0.66 0.02 0.04 transcriptional repressor crem transcriptional repressor crem, icer 
0.70 0.03 0.08 paired-like homeodomain transcription factor drg11 
0.85 0.03 0.10 phosphatidate phosphohydrolase type 2 ppap2 
0.81 0.04 0.11 proline rich protein 
1.48 0.05 0.49 unidentified reading frame 
0.62 0.04 0.10 light chain 3 subunit of microtubule-associated proteins 1a and 1b; 1a/1b mpl3 
0.62 0.03 0.08 cofilin 1, non-muscle cfl1 
0.66 0.04 0.08 beta-carotene 15, 15'-dioxygenase bcdo 
0.67 0.04 0.16 nuclear factor, interleukin 3, regulated nfil3; nfil3/e4bp4 transcription factor 
0.67 0.04 0.18 SAR1 gene homolog A (S. cerevisiae) 
0.74 0.00 0.01 oligodendrocyte-myelin glycoprotein 
0.77 0.05 0.29 neuronal calcium sensor-1 freq; sensor ncs-1; frequenin-like protein 
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0.65 0.05 0.19 N-myc downstream regulated gene 1 
0.61 0.04 0.01 lipid-binding protein; c-fabp; da11 
0.99 0.05 0.39 adenylyl cyclase type iv; 4 adcy4 
0.61 0.03 0.04 p85 
0.89 0.05 0.35 EST 
0.76 0.04 0.18 antigen identified by monoclonal antibodies 4f2 mdu1 
1.33 0.04 0.18 laminin chain 
1.04 0.05 0.32 platelet-derived growth factor receptor beta pdgfrb 
1.00 0.04 0.14 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10 
0.80 0.04 0.17 pdk2.1 pyruvate dehydrogenase kinase 2 subunit variant p45; pdk2 
0.65 0.03 0.05 atp-stimulated glucocorticoid-receptor translocaton promoter gyk 
0.84 0.03 0.09 adrenergic receptor, alpha 1c adra1c; alpha1c receptor; alpha1c-adrenergic 
0.60 0.05 0.17 kidney androgen-regulated protein kap 
0.76 0.02 0.04 nedd4 
1.25 0.02 0.05 myosin, light polypeptide 2, alkali ventricular, skeletal, slow myl2 
0.60 0.02 0.03 glycine receptor alpha 2 subunit glycine receptor, neonatal glra2 
0.64 0.02 0.03 hepatocyte nuclear factor 6 alpha hnf-6; hnf6; beta 
0.73 0.04 0.15 nuclear gtpase pike pike 
0.66 0.05 0.22 Ras association (RalGDS/AF-6) domain family 1 
0.65 0.04 0.12 n-acetylated alpha-linked acidic dipeptidase-like ileal peptidase i100 naaladasel 
0.90 0.05 0.27 ca2+/calmodulin-dependent protein kinase ii alpha camk2a 
0.65 0.02 0.03 sperm membrane protein 
0.71 0.05 0.27 EST 
0.61 0.03 0.05 solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 
0.77 0.04 0.18 adamts-4 
0.84 0.05 0.24 prestin pres 
0.76 0.05 0.22 putative alpha 1b-glycoprotein 
0.93 0.05 0.29 protein kinase c, zeta subspecies; c; pkcz 
0.62 0.03 0.06 arrestin, beta 1 arrb1; beta-arrestin 
0.63 0.05 0.23 EST 
0.78 0.05 0.05 platelete glycoprotein 5 gp5; platelet v 
0.62 0.04 0.10 rap2a-like protein rap2a; rap2b 
0.81 0.05 0.26 EST 
0.99 0.05 0.29 zinc finger transcription factor gli3 gli3 
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0.61 0.05 0.18 EST 
1.04 0.04 0.26 microtubule-associated protein aa 1-1830; 2 map2; microtubule associated 
0.73 0.04 0.17 EST 
1.25 0.05 0.35 solute carrier family 12, 
0.73 0.05 0.27 brevican brain specific proteoglycan in the aggrecan family bcan; 
0.80 0.02 0.03 utrophin homologous to dystrophin utrn; unnamed protein product 
0.68 0.05 0.07 wingless-type mmtv integration site family, member 4 wnt4; wnt-4 
0.66 0.05 0.24 inositol polyphosphate-5-phosphatase B 
1.03 0.05 0.34 sperm tail protein spag5 
0.68 0.04 0.09 cardiac potassium channel subunit kv6.2 kv6.2 
0.80 0.02 0.05 udp-glucuronosyltransferase 
0.61 0.02 0.04 sorting nexin 3 
1.14 0.04 0.18 ribosomal protein l38 
0.62 0.04 0.10 somatostatin transactivating factor-1 somatostatin transactivating factor-1, 
1.16 0.04 0.25 killer cell lectin-like receptor subfamily c, member 2 klrc2 
0.75 0.04 0.11 nude 
0.90 0.04 0.19 DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 
0.72 0.04 0.13 apoptosis inhibitor protein 3 api3; riap3; of 
0.67 0.05 0.25 rat cyclin e 
0.67 0.03 0.01 trp1 beta variant 
0.87 0.05 0.29 adh water channel; complete cds; aquaporin 2 aqp2 
1.27 0.02 0.07 integrin beta-7 subunit 
0.64 0.04 0.18 glutamate receptor, metabotropic 5 grm5; receptor mglur5 
1.75 0.05 0.50 nuclear core glycoprotein np62; p62; protein aa 1-525 
0.66 0.03 0.06 apical endosomal glycoprotein 
0.80 0.05 0.26 cgrp-receptor component protein 
0.89 0.04 0.16 activating transcription factor atf-4 atf4 
1.08 0.04 0.15 EST 
0.67 0.04 0.16 SH3 and cysteine rich domain 3 (predicted) 
0.63 0.05 0.21 mature T-cell proliferation 1 
0.61 0.05 0.23 glutathione s-transferase yc2 subunit gsta5; transferase gst 
0.73 0.03 0.08 liver activating protein lap, also nf-il6, nuclear factor-il6 
0.71 0.04 0.11 retinoic acid receptor alpha1 
0.74 0.05 0.30 EST 
APPENDIX 
xxiv 
0.94 0.04 0.25 EST 
0.64 0.05 0.18 kidney-derived aspartic protease-like protein kdap; napsin nap 
0.70 0.03 0.05 asialoglycoprotein receptor 2 asgr2; rhl2; hepatic lectin aa 1-301 
0.84 0.05 0.28 homeobox protein 
0.76 0.05 0.23 somatostatin receptor subtype 1 sstr1 
0.77 0.04 0.18 WD repeat domain 24 
0.62 0.04 0.14 solute carrier family 4, member 2, anion exchange protein 2 slc4a2 
0.68 0.03 0.07 dolichol-phosphate (beta-D) mannosyltransferase 1 (predicted) 
0.62 0.00 0.02 d-beta-hydroxybutyrate dehydogenase; calreticulin; calr 
0.78 0.05 0.27 ephrin a3 
1.00 0.04 0.02 odorant receptor 
1.09 0.04 0.16 protease, serine, 23 
entified in small intestine epithelium of rats fed rBV-VP60 in comparison with wtBV fed animals. 
change 
og2) 
q-value SD Description 
-1.30 0.00 0.05 calcium-binding protein, intestinal, vitamin d-dependent 9-kda cabp calb3 
0.76 0.00 0.01 retinoic acid hydroxylase 
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9.2 Equipment 
Centrifuges: 
Centrifuge 5417 C    (Eppendorf/Gilson, Hamburg) 
Centrifuge CL GS-6R   (Beckmann, München) 
Heraeus Labofuge 400   (Heraeus Instruments, Düsseldorf) 
 
Electrophoresis chambers: 
Horizontal gel electrophoresis  (Angewandte Gentechnische Systeme GmbH, 
chamber D3, OWL    Heidelberg) 
RNA gel electrophoresis chamber  (Biometra, Göttingen) 
 
Electrophoresis Power Supply: 
High Voltage Power Pack P30  (Biometra, Göttingen) 
 
Vacuum concentrator: 
Univac D08     (Progen Scientific Ltd, Mexborough, South 
      Yorkshire, UK) 
 
Thermostat:  
Dri-Block® DB-3D    (Techne, Staffordshire, UK) 
 
Homogenizator: 
Ultra Turrax T25 basic   (IKALabortechnik, IKA-Werke GMBH &  
      CO.KG, Staufen) 
 
Microwave:  
R3 V10     (Sharp Corporation, Thailand) 
 
Vortexer: 
Vortex Genie 2TM G 560 E   (Scientific Industries, Bohemia, USA) 
 
pH-meter: 
HI 221 Calibration-Check pH meter (HANNA Instruments, Kehl am Rhein) 
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Laser scanner: 
428 Array Scanner    (Affymetrix Inc., Santa Clara, USA) 
 
PCR instruments:  
PCR express thermal cycler  (Hybaid, Ashford, UK) 
TRIO-thermal block TB 1   (Biometra, Göttingen) 
 
Real-time PCR instrument: 
LightCycler 3     (Roche Diagnostics, Mannheim) 
 
Spectrophotometer: 
Nano Drop® ND-100 Spectrophotometer (NanoDrop Technologies, Wilmington,  
      Delaware USA) 
 
Waterbath: 
Medingen W6    (Prüfwerk Medingen, Medingen) 
 
Magnetic stirrer:  
IKAMAG® RET    (Janke & Kunkel, Staufen) 
 
UV Transilluminator: 
UV Transilluminator TFM 20  (Ultra-Violet Products Ltd, Cambridge, UK) 
 
Gel documentation: 
Kaiser Repro RS1+RA1 5510  (Ultra-Violet Products Ltd, Cambridge, UK) 
QImaging 32-0030C-104   (Ultra-Violet Products Ltd, Cambridge, UK) 
QIGAM Mono 10-bit    (Ultra-Violet Products Ltd, Cambridge, UK) 
Printer P91 D     (Mitsubishi Electric Europe, Ratingen) 
 
Water Purification Systems: 
Milli-Q      (Millipore, Indien) 
  
Sterile filtration: 
ME 24      (Schleicher & Schuell GmbH, Dassel) 
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9.3 Software and databases 
Base SAS® (Version 9.1.3)   SAS Institute Inc., Cary, NC, USA 
DAVID 2007     http://david.abcc.ncifcrf.gov/ 
GAZER (Gene Set Analyzer)  http://expressome.kobic.re.kr/   
      GAzer/index.faces 
GeneSight (Version 3.5)   BioDiscovery Inc., Los Angeles, USA 
ImaGene™ (Version 5)   BioDiscovery Inc., Los Angeles, USA 
Lab Works (Version 4.5.)   Ultra-Violet Products Ltd, Cambridge, UK 
LightCycler (Version 3.5)   Roche Diagnostics, Mannheim 
MAVI Pro (Version 2.6.0)   BioDiscovery Inc., Los Angeles, USA 
NCBI database     http://www.ncbi.nlm.nih.gov/ 
Primer3     http://frodo.wi.mit.edu/ 
QCapture (Version 1.66)   Ultra-Violet Products Ltd, Cambridge, UK 
QVALUE      http://faculty.washington.edu/~jstorey/qvalue/ 
R version 2.5.2 (2007-06-27)  http://www.bioconductor.org/ 
TIGR MultiExperimentViewer  http://www.tigr.org/software/ 
”R” software     http://www.bioconductor.org 
Rat genome database   http://rgd.mcw.edu/genes/?100 
 
9.4 Chemicals, kits and solutions 
9.4.1 Chemicals 
10 x buffer - taq DNA Polymerase    (Promega, Madison USA) 
2-ß-Mercaptoethanole    (Sigma Aldrich Chemicals, Steinheim) 
3-(N-morpholino)propanesulfonic acid, MOPS (Sigma-Aldrich, Steinheim) 
5 x first strand buffer     (Invitrogen, Karlsruhe) 
Acetic acid      (Roche, Mannheim) 
Aqua bidestillata     (Qiagen, Hilden) 
Bovine serum albumin, Cohn Fraction V, BSA (Sigma-Aldrich, Steinheim) 
Bromphenole blue, 0.1 %     (Serva, Heidelberg) 
Desoxynucleoside triphosphates  
(dATP, dTTP, dCTP, dGTP), 10 mM   (Promega, Mannheim) 
Diethylpyrocarbonate 0.1 %, DEPC  (Serva, Heidelberg) 
Di-Natriumhydrogenphosphate, Na2HPO4  (Merck KGaA, Darmstadt) 
Dithiotreitol, DTT, 100 mM     (Invitrogen, Karlsruhe) 
DNase I (10 U/l) + RDD buffer   (Qiagen, Hilden) 
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Ethanol, 96 - 100 %      (Applichem, Darmstadt) 
Ethidiumbromide, 10 mg/μl     (Serva, Heidelberg) 
Ethylene-diamine-tetra-acetic acid, EDTA  (Applichem, Darmstadt) 
Ficoll Typ 400      (Amersham Pharmacia Biotech,  
       Freiburg) 
FluoroLink™ Cy3-UTP, 5 mM   (Amersham, Buckinghamshire, UK) 
FluoroLink™ Cy5-UTP, 5 mM   (Amersham, Buckinghamshire, UK) 
Formaldehyde, 37 %     (Roth, Karlsruhe) 
Formamide, 99.5 %     (Sigma Aldrich Chemicals, Steinheim) 
Magnesium acetate, Mg-ac    (Roth, Karlsruhe) 
Magnesium chloride, MgCl2    (Roth, Karlsruhe) 
Magnesium sulfate, MgSO4    (Roth, Karlsruhe) 
M-MLV Reverse Transcriptase    (Invitrogen, Karlsruhe) 
Potassium acetate     (Roth, Karlsruhe) 
pBR322 DNA/AluI Marker 20   (Fermentas, St. Leon-Rot) 
peq Gold Universal Agarose   (peqLab, Erlangen) 
Poly T12 Primer, 50 pmol/μl    (Sigma Aldrich Chemicals, Steinheim) 
Polyvinylpyrrolidone, PVP    (Sigma-Aldrich, Steinheim) 
Proteinase K, 20 mg/ml    (Roche Diagnostics, Mannheim) 
QIAzol® lysis reagent    (Qiagen, Hilden) 
Rnase-free water     (Qiagen, Hilden) 
RNasin, Ribonuclease Inhibitor, 40U/μl   (Promega, Madison USA) 
Sodium acetate     (Merck KGaA, Darmstadt) 
Sodium chloride     (Roche, Mannheim) 
Sodium citrate     (Roth, Karlsruhe) 
Sodium dihydrogen phosphate   (Merck KGaA, Darmstadt) 
Sodium hydroxide, NaOH    (Roth, Karlsruhe) 
Sodium-Dodecyl-Sulfate, SDS ultra pure  (Roth, Karlsruhe) 
Taq DNA Polymerase, 5 U/μl    (Promega, Madison USA) 
TRIS, 99.3 %      (Roth, Karlsruhe) 
TRIS-Acetate, TRIS-ac    (Roth, Karlsruhe) 
 
9.4.2 Kits 
cDNA Synthesis System    (Roche, Mannheim) 
High Pure RNA Tissue Kit    (Roche, Mannheim) 
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LightCycler® FastStart DNA     
(Master SYBR Green I)     (Roche, Mannheim) 
MEGAscript® T7 Kit      (Ambion, Cambridgeshire, UK) 
QIAquick® Gel Extraction Kit   (Qiagen, Hilden) 
QIAquick® PCR Purification Kit   (Qiagen, Hilden) 
RNeasy® Mini Kit      (Qiagen, Hilden) 
 
9.4.3 Solutions 
TRIS buffer   5 ml  1 M TRIS/HCl (pH 8,0)  
    20 ml  0.5 M EDTA  
    5 ml  10 % SDS 
    70 ml  Aqua bidestillata 
 
TE-buffer   2.5 ml  1 M TRIS/HCl (pH 8.0) 
    0.5 ml  0.5 M EDTA 
    247 ml Aqua bidestillata 
 
10 x TAE-buffer (pH 8.0) 48.46 g TRIS-ac 
    3.72 g  EDTA 
    1 l  Aqua bidestillata 
 
Loading buffer DNA  50 ml  Glycerin, 99 %  
    1 ml  Bromphenole blue, 10 % 
    24 ml  0.5 M EDTA 
    1 ml  1 M TRIS/HCl (pH 8.0)  
 
Agarose gel (0.1 M)  0.75 g  Agarose 
    75 ml  TAE-buffer 
    3 μl  Ethidiumbromide (10mg/μl) 
 
Formaldehyde gel (2.2 M) 30 mg  Agarose 
    21.70 ml DEPC-H20 
    5.37 ml Formaldehyde, 37 % 
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Loading mix RNA  5 μl  Formamide 
    1.75 μl Formaldehyde, 37 % 
     5 μl  10 x MOPS 
     1.0 μl  Loading buffer RNA 
    0.25 μl Ethidiumbromide 
 
Loading buffer RNA  30 ml  Glycerin, 99 %  
    0.25 g  Bromphenole blue 
    200 μl  10 mM EDTA 
    0.25 g  Xylencyanole 
 
10 x MOPS, pH 7.5  83.72 g MOPS 
    13.61 g Na-ac 
    3.72 g  EDTA 
    1 l  Aqua bidestillata 
 
5 x Fragmentation buffer 0.50 ml 1 M TRIS/HCl (pH 8.1) 
    0.12 g  Potassium acetate  
    0.08 g  Mg-ac 
    24.50 ml RNase-free water 
 
Sodium Phosphate   50 mM Di-Natriumhydrogenphosphate 
(pH 8.0)   50 mM Sodium dihydrogen phosphate 
 
20 x SSC stock solution  175.3 g Sodium Phosphate     
(pH 7.0)   88.2 g  Sodium citrate 
 
50 x Denhardt's solution 5 g  Ficoll Typ 400  
    5 g  PVP 
    5 g  BSA 
    500 ml Aqua destillata 
 
Hybridization buffer  50 μl  1 M Sodium phosphate (pH8.0) 
    500 μl  100 % Formamide 
    300 μl  20 x SSC 
    100 μl  50 x Denthardt´s solution 
    50 μl  10 % SDS 
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Washing solution 1  100 ml 20 x SSC 
    10 ml  10 % SDS 
    890 ml Aqua destillata 
 
Washing solution 2  50 ml  20 x SSC 
     950 ml Aqua destillata 
 
Washing solution 3  25 ml   20 x SSC 
     975 ml  Aqua destillata 
 
9.4.4 Analytical consumables 
Centri Sep spin column   (Princeton Seperations, Inc.; NY, USA) 
Cover slip (24 x 50 mm)   (Roth, Karlsruhe) 
Falcon tube (15 ml, 50 ml)   (Roth, Karlsruhe) 
LightCycler® short capillary 
(5 - 47 cm x 50 μm)    (Roth, Karlsruhe) 
Microcon YM-10 concentrators  (Millipore, Indien) 
Servisol® Aero Duster 100   (Ambersil Ltd., Somerset, UK) 
Biosphere pipette filter tips   (Sarstedt AG & Co., Nümbrecht) 
RNase-free pipette tips, sterile  (Eppendorf/Gilson, Hamburg) 
Sterile filter (0,22 μm)   (Millipore, Indien) 
 
Reaction tubes: 
0.2 ml; 0.5 ml; 1.5 ml; 2 ml   (Roth, Karlsruhe) 
Rubber cement    (REMA Tip Top, Poing) 
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9.5 Composition of ALTROMIN® Standard Diet 1310 
Crude Nutrients [%]  Minerals [%]  
Dry Matter  89.0  Calcium  0.9  
Crude Protein  22.5  Phosphorus  0.7  
Crude Fat  5.0  Magnesium  0.2  
Crude Fibre 4.5  Sodium  0.2  
Crude Ash  6.5  Potassium  0.9  
Nitrogen Free Extracts 50.5   
    
Amino Acids [%]                   Vitamins per kg  
Alanine  1.0   Standard  
Arginine  1.5  Vitamin A  15.000 IE | IU   
Aspartic Acid  2.3  Vitamin D3  600 IE | IU  
Glutamic Acid  4.3  Vitamin B1  18 mg   
Glycine  0.9  Vitamin B2  12 mg   
Histidine  0.5  Vitamin B6  9 mg   
Isoleucine  1.0  Vitamin B12  24 mcg   
Leucine  1.8  Vitamin C  36 mg   
Lysine  1.2  Vitamin K3  3 mg   
Met + Cyst  0.7  Vitamin E  75 mg   
Phenylalanine  1.1  Folic Acid 2 mg   
Phe + Tyr  1.9  Biotin  60 mcg   
Proline  1.4  Nicotinic Acid  36 mg   
Serine  1.1  Pantothenic Acid  21 mg   
Threonine  0.8  Choline Chloride  600 mg   
Tryptophan 0.3     
Valine  1.1     
     
Trace Elements [ppm]   
Iron  150   
Manganese  50   
Zinc 60   
Copper 13   
Iodine 1.4   
Selenium 0.6  
Cobalt  0.3    
    
    
Metabolizable Energy     
Calories from protein*  12.5 MJ/kg  (2988 kcal/kg)  
Calories from fat*  27 %    
Calories from carbohydrates*  13 %    
(*calculated using Atwater factors)  60 %    
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THESES 
 
“The application of gene expression profiling in the characterization of physiological 
effects of genetically modified feed components in rats” 
 
Submitted by Dipl.-Ing. agr. Anja Hartmann 
 
Background and aims 
1. Genetic modification of plants has great potential to improve crop productivity as 
well as health or nutritional benefits for consumers. However, unexpected 
alterations may occur as a result of the modification process (e.g. changed plant 
composition). Before introducing such plants into the food chain, the physiological 
impacts of unintended compositional changes on the consumer have to be 
evaluated. 
2. At present, mainly target-based experimental approaches are applied. Though 
these have been criticized as they focus generally on the analysis of single 
molecules/parameters or specific cellular processes. Therefore, the use of non-
target-based profiling tools (transcriptome, proteome or metabolome analyses) 
was discussed lately, as they provide an open-ended broad view of the complex 
cellular processes in the food recipient. 
3. In this study the adequacy of gene expression profiling for the characterization of 
unintended physiological effects caused by an intake of genetically modified 
dietary components was assessed. Possible gene expression changes and 
thereby alterations in biological processes due to the diet were investigated in 
rats. 
4. Specific genetically modified potatoes (VP60-potato or nptII-potato) were fed in 
order to characterize physiological effects in response to alterations in plant 
composition and/or to the “foreign” genes. To specify effects induced solely by the 
VP60 molecule, an additional experiment with a VP60-baculovirus additive was 
conducted. Expression profiles were compared to the corresponding control group 
(non-GM potato or wildtype-baculovirus). 
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5. Thresholds (e.g. False Discovery Rate, Fold change) are commonly used in data 
analysis to define significant expression changes. As a precondition for the 
subsequent investigations, several threshold-settings were tested regarding their 
appropriateness for the data analyzed within this work. 
 
Results and conclusions 
6. Threshold stringency had a great impact on the number of differentially expressed 
genes and its associated biological processes. Consequently, threshold choice 
should always be taken in the context of the experiment and adapted within each 
study. 
7. A False Discovery Rate threshold of  5 % was most appropriate for this work 
since a high reliability of the results was aimed. Additionally a moderate fold 
change filter of  1.5 was chosen. 
8. In the spleen of rats the feeding of VP60-potatoes caused primarily a significant 
down-regulation of lipolysis-, proteolysis- and digestion-related genes and a prior 
up-regulated of genes associated with developmental processes. In small 
intestine epithelium a down-regulation of few immune related genes was 
detected, whereas in the liver expression remained unaffected. 
9. Feeding of a VP60-baculovirus additive also induced a down-regulation of 
lipolysis- and proteolysis-associated genes in the spleen. These consistent results 
indicate that the VP60 molecule is probably at least partially involved in the 
observed expression changes. However, an impact of changes in potato 
composition due to transgenesis and/or somaclonal variation cannot be excluded. 
10. In the liver a feeding of nptII-potatoes led to significant up-regulation of genes that 
are associated with electron transport, alcohol/monosaccharide and lipid 
metabolism. Since the nptII molecule has no known bioactivity these changes are 
probably attributed to alterations in the potato composition. In the spleen and in 
small intestine epithelium no expression differences were observed in response to 
the transgenic feed. 
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Outlook 
11. Gene expression profiling allows a holistic approach to screen for unintended 
physiological side effects caused by an intake of feeds or feed additives as for 
instance genetically modified plants. 
12. Transcriptomics and other “omics” technologies (proteomics, metabolomics) 
provide a great sensitivity in monitoring even slight changes in the complex 
physiological processes which might not be detected with conventional methods. 
Therefore, they could be regarded as a valuable completion of such traditional 
analyses. 
13. Profiling methods could also be useful to characterize alterations in the 
composition of for instance genetically modified plants which are used in feeding 
trials in that this knowledge is important for a thorough interpretation of the results 
from these feeding studies.  
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